incivo is used to treat hepatitis c infection in adults , including chronic hepatis - c disease in adults aged 1865 years or over who were treated with peginterferon alfa - 2b with ribavirin and telaprevir , which belong to a group of medicines called ns3 - 4a protease inhibitors . the nn3  --4a proteome inhibitor stops the growth of heptic c virus . it is used in combination with peggyferon at the same time as ribabovirin . inciVO is used for the treatment of chronic HEpatititis b infection in adult patients who have chronic hpatiti c infections who have not previously been treated with an interferon - basal protocol .
do not use incivo - if you are allergic to telaprevir or any of the other ingredients of this medicine ( listed in section 6 ). - when used with peginterferon alfa and ribavirin . - in addition , some women must take separate contraindications ( e .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will determine the appropriate dose regimen for you based on your age and body weight . the recommended dose regimen is 3 mg twice a day ( taken 6 hours apart ) for children 2 to 8 years of age , and 6 mg twice daily for children and adolescents with both hepatitis c virus infection and human immunodeficiency virus infection . if your doctor decides that you should follow the recommended dosage regimen , you should take both : - one tablet of efavirenz . you should continue to take the recommended dosing regime for 3 to 8 days in a row until your body is able to break down the medicine . it is important that you take incivo within 60 minutes of a meal . some patients may still respond to inci
like all medicines , this medicine can cause side effects , although not everybody gets them . rash : if you develop an itchy skin rash it is very important that you contact your doctor immediately if the rash gets severe . the rashes may also develop other symptoms if , for example , you get the : the s - having a severe skin reaction tell your doctor or nurse immediately . when you develop a skin ras , tell your physician or nurse promptly . your rash may progress to a rash and other symptoms may occur after a few days . such as : fever , tiredness , swelling of the face , and swelling of lymph glands . it is uncommon to get a wide - spread rash with peeling skin which may be accompanied by fever . you may also experience flu - like symptoms , painful
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the bottle after exp . the expiration date refers to the last day of that month . incivo tablets should be stored in the original package in order to protect from moisture . keep the bottle tightly closed in order for carton protection from moisture and light . this medicine does not require any special temperature storage conditions . throw away any tablets via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what incivo contains the active substance is telaprevir . each tablet of inciva contains 375 mg of tel apreVir . the other ingredients are : tablet core hypromellose acetate succinate , calcium hydrogen phosphate ( anhydrous ), microcrystalline cellulose , silica colloidal anhydrOUS , sodium lauryl sulphate , croscarmellose sodium , and sodium stearyl fumarate . film - coat polyvinyl alcohol , macrogol , thec , titanium dioxide ( e171 ), iron oxide yellow ( 233 ). what iu looks like and contents of the pack film  shaped , yellow caplet - shaped tablets , embossed on one side with " gsi " and " tsi 375 " on
the active substance in zinbryta is daclizumab beta , a monoclonal antibody . what zinbyta can be used for zinberyte is used to treat multiple sclerosis in adults . it is used as part of a course of therapy after two ms treatment and in combination with other treatments . in m , inflammation destroys the protective sheath around the nerves that line the central nervous system ( brain and spinal cord ). this loss of myelin ( also called demyelinability ) leads to relapsing mms in adult patients who have repeated attacks ( relapses ) of symptoms that have been caused by the nerve systems damaged . these mc may also lead to problems with your nerves .
do not take zinbryta : if you have previously had a serious allergic reaction to daclizumab or any of the other ingredients of this medicine listed in section 6 . if this applies to you , tell your doctor immediately . warnings and precautions talk to your doctor or pharmacist before taking zinberyt : 6 - if your doctor has told you that you have liver problems . do not use zinbyryte if any of these apply to you ( or you are not sure ), talk to a doctor or nurse before taking any other autoimmune disorders . taking , have recently taken or might take any other medicines , including herbal supplements . tell your pharmacist if , while taking any medicines or supplements you are taking . this includes any possible liver side effects . these medicines can affect how well zingrytta works and whether you (
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of zinbryta is 150 mg once a day . your doctor will do a blood test to check how well your liver is working . zinberyt , for adults , is one 40 mg injection every two weeks . for this blood test your doctor may need to do : a test to see how well you respond to zinbyta . injecting yourself zinBrytа is usually injected under the skin in the thigh , stomach or back . it can be done in the back of your upper arm . after injecting zinbrita you will need to wait at least 7 days before you are given zin bryta and wait until the injections have finished . see section 7 . when to
like all medicines , this medicine can cause side effects , although not everybody gets them . if you get side effects talk to your doctor , pharmacist or nurse . these side effects are mostly mild to moderate and usually disappear after a few weeks . your doctor will discuss these with you and will explain the potential risks and benefits of your treatment . serious side effects liver problems : very common ( may affect more than 1 in 10 people ) unexplained nausea ( feeling sick ) vomiting ( being sick ), stomach pain increased tiredness loss of appetite ( anorexia ) problems with your skin or the whites of your eyes turn yellow ( tea - coloured ) urine 41 uncommon ( may effect up to 1 in 100 people ). severe inflammation of the liver , which can lead to death , should be treated immediately .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the syringe label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the zinbryta pre - filled sYringe in original package in order to protect from light . after first opening , use a new syedringe / pen in , or directly before use . always keep the pen in the original package and keep it in - use refrigerator ( 1 - 7 ) at all times . zinbyta syingringes / pens must be kept in the refrigerator ( not above 30 ) for as long as the expirator date has passed before use is passed .
what zinbryta contains the active substance is daclizumab beta . each pre - filled syringe contains 150 mg daclizuab Beta in 1 ml solution . Each pre  filled pen contains 150 micrograms daclizab beta in 1 millilitre solution  . the other ingredients are sodium succinate , succinic acid , sodium chloride , polysorbate 80 ( see section 2 under ' zinbyta has a low level of sodium '). what zbrytoa looks like and contents of the pack zinberyte is a colourless to slightly yellow solution for injection . it is available in a sYringe / pen ( pre – filled pen ) with or without an attached needle .
wilzin belongs to a group of medicines known as metabolism products . wilsson ' s disease is caused by a rare inherited defect in copper excretion in the liver , the cells of the eyes and the brain . this causes liver damage and neurological disorders . it works by stopping the excretions of food in the intestine and its further accumulation in the body . the exact cause of willson  s illness is not known . however , this treatment is recommended in accordance with local requirements .
do not take wilzin if you are allergic ( hypersensitive ) to zinc or any of the other ingredients of wilszin . take special care with willzin wILzin is only used as initial therapy . warnings and precautions talk to your doctor or pharmacist before taking wulzin : if your doctor has told you that you have signs and symptoms of  Wilson ' s disease and is currently taking another anti - copper agent called penicillamine . wifzin will be given to you at the beginning treatment together with other anti  copper agents such as peniciillamine if : your symptoms are not being controlled the treatment may be reassessed after you have received blood and urine to check that you are receiving sufficient treatment and monitoring 25 to check whether you have insufficient treatment ( copper excess ) or excessive treatment . you should inform your doctor 
what wilzin is available in the different dose regimens . - the dose is based on your child ' s weight . the doctor will calculate the correct dose for your child depending on his or her body weight , and will determine the dose that should be taken for your baby . between 25 mg and 50 mg the usual starting dose is 1 mg / kg of body weight once daily . this can be given as either 25 mg or 50 mg once daily or as 2 mg wilszin 50 mg or 2 mg of willzin 25 mg once weekly . each day the usual dose is either 1 mg of bodyweight once daily and 50mg once daily as 2 g of body fat once daily ( 25 mg ). the usual dosage is 1 to 6 mg of the body weight when you are first starting to take wILzin 25 ml of body poids once daily for 1 to 16 weeks . there
like all medicines , wilzin can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common ( impacts affect 1 to 10 users in 100 ) uncommon ( affect affects 1 to10 users in 1 , 000 ) rare ( affectes 1 . to 10 patients in 10 to 10 ,000 ) very rare ( impacts impacts affect less than 1 patient in 10 10 . 000 ). very rare : the frequency for wilszin intake is not known ( frequency cannot be estimated from the available data ). willzin intake may cause gastric irritation and / or treatment . changes in blood tests may show an increase in some liver and pancreatic enzymes , as well as a decrease in blood red and white cells . reporting of side effects 25 
keep out of the reach and sight of children . do not use wilzin after the expiry date which is stated on the carton and the label after exp . the expiration date refers to the last day of that month . store below 25 . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what wilzin contains the active substance is zinc . each hard capsule contains 25 mg of zinc ( equivalent to 83 . 92 mg zinc acetate dihydrate ) or 50 mg of copper ( equivalent 167 . 85 mg zinc as acdihydrate ). the other ingredients are magnesium stearate . the capsule shell is composed of gelatin , titanium dioxide ( e171 ), brilliant blue fcf ( wmv ) and imprint ink . what whiilzin looks like and contents of the pack wilszin 25 mg hard capsules : white to off - white , biconvex , oval shaped , with " wlzin 50 mg " imprinted on the body . not all pack sizes may be marketed . printing ink contains black iron oxide ( gilead and shellac ).
what biktarvy is biktarivy contains the active substance bictegravir , an antiretroviral medicine known as an integrase strand transfer inhibitor . it is a copy of a gene called emtricitabine , which is an antiRetroviral medicine known only as a nucleoside reverse transcriptasing inhibitor ( nrti ) tenofovir alafenamide , another antirétroviral medication known as  a nuclear nucleome reverse transcriptainse inhibitor ( nutrtis ) biktegrany is used for the treatment of human immunodeficiency virus 1 ( hiv - 1 ) infection . biktaby reduces the amount of hiv in your body . this will improve your immune system and reduce the risk of developing illnesses linked
do not take biktarvy if you are allergic to bictegravir , emtricitabine , or tenofovir alafenamide or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . if also you are taking any of these medicines : - rifampicin , used to treat some bacterial infections such as tuberculosis - saint john ' s wort ( hypericum perforatum ), a herbal remedy used for depression and anxiety . warnings and precautions talk to your doctor or pharmacist before taking biktarivy and during treatment if : you suffer from liver problems or have ever had liver disease , such as hepatitis . your doctor may want to monitor you more closely if
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one tablet once a day . you may need to take : antacids to prevent stomach ulcers , heartburn and acid reflux , such as aluminium , magnesium hydroxide mineral supplements , vitamins , minerals , calcium , iron ( see section 2 ' further information '). your doctor may need a higher dose of these medicines . biktarvy is not recommended if your doctor determines that you need . if a doctor determine that you are on dialysis , tell your doctor before you start taking biktarivy . your doctor will tell you when you may be on dilalysis . patients who are not on diathyroid may find that bikty is too strong
like all medicines , this medicine can cause side effects , although not everybody gets them . if you notice any of the following side effects you should contact your doctor immediately : - inflammation or infection biktarvy may cause a higher risk of developing a range of types of advanced hiv infection ( aids ) and opportunistic infections ( infections that occur in people with a weak immune system ). this may also be a sign of symptoms of inflammation from previous infections . this may occur during hiv treatment . it is thought that these symptoms are due to an improvement in the body ' s immune response , enabling the body to fight infections that may have been present with no obvious symptoms . these are called autoimmune disorders , which are very common as the immune system attacks healthy body tissue . many of the side effects are similar to medicines used to treat hiv infections , but they
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the seal after " exp ". the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . after opening , the seal should be thrown away . store in the original package in order to protect from moisture .
what biktarvy contains the active substances are bictegravir , emtricitabine and tenofovir alafenamide . each biktarivy tablet contains bicentegraVir sodium equivalent to 50 mg bicctegrevir . this is equivalent to 200 mg emptricit abine combined with tenoffovir altafène fumarate equivalent to 25 mg ten ofovir allafenedamide ). the other ingredients are tablet core microcrystalline cellulose , tablet core croscarmellose sodium , magnesium stearate . film - coating polyvinyl alcohol , titanium dioxide ( e171 ), macrogol , the talc , iron oxide red ( 233 ) and iron oxide black ( 183 ). what bikontarvY looks like and contents of
novonorm is an oral antidiabetic medicine containing repaglinide which helps your pancreas produce more insulin and thereby lower your blood sugar ( glucose ). type 2 diabetes is a disease in which your pancras does not make enough insulin to control the sugar in your blood or where your body does not respond normally to the insulin it produces . novonourm is used to control type 2 diabetics in adults as an add - on to diet and exercise : treatment is usually started if diet , exercise and weight reduction alone have not been able to control ( or lower ) your blood glucose . there are several reasons why novonoresm has been prescribed for you . it is important that you also take metformin , another medicine for diabetes . your doctor has prescribed novonorgm for you because your doctor believes that it is safe for you to carry on taking it 
do not take novonorm if you are allergic to repaglinide or any of the other ingredients in this medicine ( listed in section 6 ). if your doctor has told you that you have type 1 diabetes . if the acid level in your blood is raised ( diabetic ketoacidosis ). in case you have a severe liver disease . in case of gemfibrozil , a medicine used to lower increased fat levels in the blood , tell your doctor . warnings and precautions 47 talk to your doctor before taking novonourm : if : you have liver problems . novon orm is not recommended in patients with moderate liver disease ( see section " other medicines and novonorgm "). you have or have had a severely liver disease or kidney problems , as novonlorm may not be suitable for you . you need to be closely monitored while you are
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 0 . 5 mg before each main meal . swallow the tablets with a glass of water immediately before or up to 30 minutes before each major meal , and at least 4 hours after each main meals . do not take more than 30 mg in 16 hours if your blood sugar is too low , or you may get a hypo at the start of treatment . if this happens , do not try to take more novonorm than your doctor tells you to . you may feel that the effect of novonourm is too strong or too weak . your diabetes may get worse . talk to your doctor if any of your treatments are unexpectedly inadequate . it is important that you continue to take this medication as long as your doctors prescribes it to you ,
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia the most common side effect is hypoglacy which may affect up to 1 in 10 people ( see a hypo in section 2 ). if this happens , hypogycaemic reactions are generally mild / moderate but may occasionally develop into hypoglemic unconsciousness or coma . if you experience allergy allergy this may affect more than 1 in every 10 , 000 people . symptoms include swelling , difficulty in breathing , rapid heartbeat , feeling dizzy and sweating . this may be anaphylactic reaction . other side effects which may occur during treatment with novonorm include : very common ( may affect many people ): headache common ( might affect upto 1 in10 people ). common ( must occur in some cases ) - mild - moderate hypo
what novonorm contains - the active substance is repaglinide . - other ingredients are microcrystalline cellulose ( e460 ); calcium hydrogen phosphate anhydrous ; maize starch ; polacrilin potassium ; povidone ( polyvidone ); glycerol ; magnesium stearate ; meglumine ; and poloxamer . the other ingredients in the tablet core are iron oxide yellow ( octocog al ) only in the 1 mg tablets and iron oxide red ( 0 . 2 mg tablets ). what novovonormm looks like and contents of the pack novonORm tablets are oblong , biconvex , round tablets marked with " rvt " on one side and " nvr " on the other . they are engraved with " 1 mg
pumarix is a vaccine for use in adults from 18 years old to prevent pandemic flu ( influenza ). pandepic flu is essentially a type of influenza that happens at intervals that vary from less than 10 years to many decades . it spreads rapidly around the world . the signs of pandedic flu are similar to those of ordinary flu but may be more serious . how pumaris works when a person is given the vaccine , the immune system ( the body ' s natural defence system ) produces its own protection ( antibodies ) against the disease . none of the ingredients in the vaccine can cause flu . as with all vaccines , pumarize may not fully protect all persons who are vaccinated .
pumarix should not be given if you have previously had a sudden life - threatening allergic reaction to any ingredient of this vaccine ( listed in section 6 ) or to any of the substances that may be present in trace amounts as follows : egg and chicken protein , ovalbumin , formaldehyde and sodium deoxycholate . signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of the face or tongue . if any of these effects occur , please tell your doctor . your doctor will decide if a dose is needed and will decide whether to give you the vaccine . you will receive medical treatment in case of an allergy reaction . pumaris should not always be given to children less than 3 months of age . this vaccine should not been given to patients less than 33 months of  age , because there is no information on the safety of pu
pumarix must only be given by a doctor or nurse . adults ( aged 18 and over ) can receive a dose of pumaris equivalent to a similar h5n1 as03 administered by your doctor or other health care professional . children and adolescents : - the recommended dose of pusmarix is based on body weight . - children from the age of 3 - 9 years and adolescents from the ages of 3 to 10 - 17 years , who are able to receive h1n1 . your doctor will decide the appropriate dose for your child . pumarize will be given to your child as an injection into a muscle . this will usually be in the upper arm . should your child misses a scheduled dose , it is strongly recommended that you follow the instructions from your doctor , pharmacist or nurse so that your child completes the course of vaccination .
like all medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions allergic reactions which may cause you to have dangerously low blood pressure . if this is not treated it may lead to shock . doctors are aware of this possibility and have emergency treatment available for use in such cases . other side effects include : very common : may affect more than 1 in 10 people pain where the injection is given headache feeling tired aching muscles or joint pain common ; may affect up to 1 in every 10 people redness or swelling where the inject is given fever sweating shivering diarrhoea feeling sick uncommon : might affect upto 1 in 100 people injection site reactions such as rash , redness and itching where the vaccine is given chills muscle pain where it is given high blood pressure where the vaccination is given redness where the dose is given rash itching feeling sick common 
keep this vaccine out of the sight and reach of children . before the vaccine is mixed : do not use the suspension and the emulsion after the expiry date which is stated on the carton . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). store in the original package in order to protect from light . do not freeze . after the vaccine has been mixed , use the vaccine within 24 hours and do not store above 30 . discard any unused vaccine after the date of mixing .
what pumarix contains active substance : split influenza virus , inactivated , containing antigen * equivalent to : a / vietnam / 5 / 2005 ( h5n1 ) like strain used ( pr8 - ibcdc - 2g2 ) equivalent to approximately 0 . 5 million units haemagglutinin . b ) injected into the pandemic . the vaccine contains an ' adjuvant ' as03 . this adjuvan contains squalene , dol - 1 , 3 - tocopherol , polysorbate 80 and , as adjuants . other ingredients in the vaccine the other ingredients are : sodium chloride , disodium hydrogen phosphate ; potassium dihydrogen phosphat ; water for injections , solvent
somakit toc is a radiopharmaceutical product for diagnostic use only . it contains the active substance called edotreotide . the powder for the injection contains a small amount of a nuclear medicine called gallium ( 68ga ) chloride , which is essentially equivalent to a human ' s equivalent to gallium( 68gga ] eedokreotides . how somamakittoc is given this procedure involves preparing the radiopharmaceutic name and lot number of the carcinoid ( pctfe ) that is cut into smaller pieces . this will be given to you as an injection into a vein , in some cases into larger body areas , as a medical imaging procedure called positron emission tomography . your pet will have a special type of animal
do not use somakit toc if you are allergic to edotreotide or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately and do not take som akit tc . warnings and precautions talk to your doctor or pharmacist before taking somаkit tock . talk to you doctor or nurse before taking this medicine : if your doctor thinks you may have allergic reaction to water or to plants . see also section 4 of this leaflet for more information . before you take sommakit soc , make sure that your doctor knows if or when you have kidney or liver problems . if somagic disease is not recommended , it is not advised to drink enough water before the examination . children and adolescents under 18 years of age . this is because drinking large amounts
there are strict laws on the use , handling and disposal of radiopharmaceutical products . somakit toc will only be used in special controlled areas . this product will only have to be handled and given to you by people who are trained and qualified to use it safely . these persons will take special care for the safe use of this product and will keep you informed of their actions . the nuclear medicine doctor supervising the procedure will decide on the quantity of somаkit tock to be used and will decide upon the quantity to be administered . it will be the smallest quantity necessary to get the desired information . - somamakit willc will be administered in a single vial . each vial contains 200 mbq ( megabecquerel , the unit used to express radioactivity ). administration of somogakit tbq depends on the type of medicine being
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are allergic reactions ( hypersensitivity ). if you are given somakit toc and get symptoms such as warm flush , redness of the skin , swelling , itching , nausea and difficulty breathing , you may be more likely to experience allergic reactions such as stinging at the injection site , or ionising radiation associated with the least risk of cancer and hereditary abnormalities . reporting of side effects get if your doctor gets any side effects talk to your doctor or nurse . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials . the following information is intended for the specialist only . before radiolabelling is performed : on - site visits : somakit toc has been recorded for 4 hours at room temperature ( below 25 ). this medicine does not require any special storage conditions . if the product is tampered with , or if there are any visible signs of deterioration , radioactive products should be disposed of in accordANCE with national regulations .
what somakit toc contains - the active substance is edotreotide . each vial of powder contains 40 micrograms of edeotretide ( as 10- phenanthroline ). - other ingredients are gentisic acid , mannitol , formic acid . sodium hydroxide and water for injections . as well as sodium and radiolabelling , the solution contains hydrochloric acid and radiopharmaceutical preparation . what sommakittoc looks like and contents of the pack somamakit tc is supplied as a glass vial with black flip - off cap . it is a white powder supplied in a clear glass vially with yellow flip , cap , providing a crystal and colourless solution . the radioactive substance is present in ml of solution 
what afinitor is afinitour is an anticancer medicine that contains the active substance everolimus . everolim works by blocking a substance in the tumour by blocking the growth and spread of cancer cells . what afiniitoris is used for afinitur is used to treat hormone receptor - positive advanced breast cancer ( postmenopausal women ) in adults who have been previously treated with non - steroidal aromatase inhibitors and who still have the disease under control . it is used together with a medicine called exemestane , a steroids aromatasiase inhibitor , used as hormonal anticancancer therapy . how afiniteur works afinitoral is used in adult women for advanced tumours , including neuroendocrine tumours that have spread to the stomach or bowels .
before starting cancer treatment your doctor will check with you doctor , pharmacist or nurse if you are unsure . do not use afinitor if any of the following apply to you : - are allergic to everolimus , sirolimus or temsirolim , or any of other ingredients of this medicine ( listed in section 6 ). if this applies to you then , tell your doctor immediately . if the above applies to , you should not be given afinitour . warnings and precautions talk to your doctor before you are given afinitor :- if there are any problems with your liver . tell your healthcare professional if , for example , if your doctor has diagnosed any disease which could have affected your liver or you are due to have a different dose of agoitor than it should . talk to a doctor if conditions such as
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 10 mg . you should swallow the tablet whole with some water . if necessary , vous can take the tablet at any time of the day , with or without food . do not take more afinitor than your doctor tells you to take . patients with liver problems may need a lower dose of agoitor ( 1 tablet of 5 mg or 5 mg of 7 . 5 mg ) to avoid certain side effects . your doctor will tell you how long you should continue to take afinitour . continue treatment as described in this leaflet . don ' t stop taking afinitr without talking to your doctor first . take the medicine pack with you so that you can show the doctor what you have taken . wait and take the next dose of afinitores
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking afinitor and seek medical help immediately if you experience any of the following signs of an allergic reaction : difficulty breathing or swallowing swelling of the face , lips , tongue or throat severe itching of the skin , with a red rash or raised bumps . the following side effects have been reported with afiniter : common : may affect up to 1 in 10 people increased temperature , chills ( signs of infection ) fever , coughing , difficulty breathing , wheezing ( signs and symptoms of inflammation of the lung , also known as pneumonitis ). tell your doctor if your child develops a sore throat or runny nose . itching , redness of the lips / skin ( signs or symptoms of infection or pneumonitic ) cough
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store below 25 . open the blister just before taking the tablets . this medicine does not require any special temperature storage conditions . in case of tampering , the product should be used immediately . if you notice any change in the appearance of the tablets you should contact your pharmacist .
what afinitor contains the active substance is everolimus . each afinitorial 2 . 5 mg film - coated tablet contains 2 , 5 mg of everoli Mus . chacun afinitour 5 mg movie - coating contains 5 mg everolim . every afinitoral 10 mg film coated tablet provides 10 mg of neverolimus ( as mesilate ). the other ingredients are butylhydroxytoluene ( e321 ), magnesium stearate ( k29 / 32 ), lactose monohydrate , hypromellose ( cps ), crospovidone ( a type of tablet ), and lactoses anhydrous ( see section " important information about some of the ingredients of afiniteur "). what afinitor looks like and contents of the pack afinitores 2 : 5 mg tablets are white to slightly yellow
what laventair ellipta is laventaire ellippta contains two active substances umeclidinium bromide and vilanterol . these belong to a group of medicines called bronchodilators . what laVENTair ellpt is used for laventAIR elliрta has been prescribed by your doctor for the treatment of chronic obstructive pulmonary disease ( copd ) in adults . copd is a long - term condition characterised by breathing difficulties that slowly get worse . in copd the muscles around the airways tighten . this medicine blocks the tightening of these muscles in the lungs , making it easier for air to get in and out of the pulmonary lungs in the long term . when used regularly , it can help to control your breathing difficulties .
do not use laventair ellipta 31 - if you are allergic to umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before you start using this medicine . warnings and precautions talk to your doctor , pharmacist or nurse before using laventaire ellippa : - when you have asthma ( don ' t use lavantair elept if any of these apply to you ( or you are not sure ), talk to a doctor before using this product . - asthma - lavent air ellipita is not recommended for the treatment of asthma . talk to you doctor before starting treatment if : you have heart problems or high blood pressure you have an eye problem called narrow - angle glaucoma you have or have had
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation every day at the same time of day . you only need to inhale once a day because the effect of this medicine lasts for 24 hours . don ' t use more than your doctor tells you to use . use laventair ellipta regularly it is very important that you use laVENTair ellptta every day , as instructed by your doctor . this will help to keep you free of symptoms throughout the day and night . laventaire ellippa should not be used to relieve a sudden attack of breathlessness or wheezing . if this happens you must use a quick - acting reliever inhaler ( such as salbutamol ). how to use the inhal
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions if you have any of the following symptoms after taking laventair ellipta stop using the medicine and tell your doctor immediately . uncommon side effects ( may affect up to 1 in 100 people ) skin rash ( hives ) or redness rare side effects( may affect less than 1 in 1 , 000 people ), swelling , sometimes of the face or mouth ( angioedema ), becoming very wheezy , coughing or having difficulty in breathing , feeling weak or light headed ( which may lead to collapse ).
what laventair ellipta contains the active substances are umeclidinium bromide and vilanterol . each single inhalation provides a delivered dose ( the dose leaving the mouthpiece ) of 55 micrograms umeklidinium ( equivalent to 65 microgram of umecidinium brmide ) and 22 microgram ( 0 . 25 ) vilantair ( as trifenatate ) the other ingredients are lactose monohydrate ( see section 2 under ' laventaire ellippa contains lactoses ') and magnesium stearate . what lavantair ellpt  looks like and contents of the pack laventAIR ellipita is an inhalations powder . the ellipine inhaler consists of a light grey plastic body , a red mouthpiece cover and a
tremfya contains the active substance guselkumab , a monoclonal antibody . this medicine attaches to a specific target in the body called il - 23 . what trempya is used for tremmfye is used to treat adults with psoriasis with moderate to severe " plaque ppsuriasi ". plaque ppsori is an inflammatory condition that affects the skin and nails . tremefyan is used in adults to improve the condition of the skin including the appearance of nails , and to reduce symptoms such as scaling , dropping , losing weight , flaking , itching , pain and burning .
do not use tremfya if you are allergic to guselkumab or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before using trempya and tell your healthcare provider . if any of these apply to you ( or you are not sure ), talk to your doctor , pharmacist or nurse before using this medicine . warnings and precautions talk to you doctor / health care professional before using the medicine if : you have an active infection . you have active tuberculosis warnings tremmfyya can potentially cause an infection , including an infection that you have ever had tubercusis . your doctor will check for tubercositis regularly , 36 before and during treatment with trerfyan . tell your physician if there
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose of tremfya is 100 micrograms ( 1 pre - filled syringe ) given by injection under the skin ( subcutaneous injection ). it may be given every 4 to 8 weeks , depending on the size of the injection . injecting trempya yourself your doctor may decide that it would be more convenient for you to inject tretfyya . if your doctor determines that you should inject TREmfYa yourself , you or your caregiver should carefully read and follow the instructions at the end of this leaflet . do not shake trebfyan vigorously as this may affect its activity . you or someone else may also inject a dose of the medicine yourself if there is
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor or nurse straight away if you notice any of the following serious side reactions : serious allergic reaction ( difficulty breathing or swallowing , swelling of the face , lips , tongue or throat , severe itching of the skin , with a red rash or raised bumps other side effects include : reporting of side effects you can help provide more information on the safety of this medicine . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects your doctor can help provides more information about the safety profile of the medicine if it gets serious . for more information , please tell your healthcare professional . some side effects can be serious common ( may affect up to 1 in 10 people 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label of the pre - filled syringe after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the pre- filled
what tremfya contains the active substance is guselkumab . each pre - filled syringe contains 100 mg of gusedlkumbab in 1 ml solution . the other ingredients are histidine , histamine monohydrochloride monohydrate , polysorbate 80 , sucrose and water for injections . what TREmfYa looks like and contents of the pack solution for injection is presented in trempya in a carton pack containing one single - dose glass sYringe or a multipack containing 2 ( 3 packs of 1 ) single  dose pre  filled  ssyrrifades . not all pack sizes may be marketed .
the active substance of trepulmix is treprostinil . treprastinningil belongs to a group of medicines called prostacyclins . prostacycles are hormones produced by the body that help to control blood pressure by relaxing blood vessels . by blocking the action of prostacins this prevents blood from clotting . the active ingredient in tre Pulmix is inoperable chronic thromboembolic pulmonary hypertension ( cteph ). if you have persistent or recurrent ctateph and do not respond adequately to surgical treatment , the doctor will improve exercise capacity ( ability to control symptoms of the disease ). chronic thmboemolic pul hypertension is when blood pressure is too high because the blood vessels of the heart and lungs are not working properly .
do not take trepulmix if you are allergic to treprostinil or any of the other ingredients of this medicine ( listed in section 6 ). if there is still a risk of a disease called " pulmonary veno - occlusive disease ". this is a condition in which the blood vessels in the lungs become swollen due to a higher pressure in the blood vessel between the heart and the arteries becomes larger . if this applies to you , tell your doctor . warnings and precautions talk to your doctor or pharmacist before taking tre Pulmix : if your doctor thinks you may have severe liver disease . talk to you doctor or nurse before taking this medicine if : you have a heart problem such as having a cardiac attack ( myocardial infarction ) within the last six months you have severe changes in heart rate
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , nurse or pharmacist if you are not sure . trepulmix is given as a continuous subcutaneous infusion ( drip ) into the skin through a small tube ( cannula ) in the abdomen or thigh . your doctor will decide how much tre Pulmix you need and how often . you will be given treulmix using a portable pump . this will allow your doctor to take your treprostinil directly into the pump and connect it to the infusion line . in the event of accidental overdose , the rate of infusion may be increased by 1 to 2 . 5 ml per minute ( for example , between 5 and 10 minutes ). the number of infuses may need to be increased further in response to the rate and your condition may require
like all medicines , this medicine can cause side effects , although not everybody gets them . very common : may affect more than 1 in 10 people widening of blood vessels pain at the infusion site reaction at the site of the inffusion site bleeding or bruising at the at the hospital or at the clinic headaches , nausea , diarrhoea jaw pain common ; may affect up to 1 in every 10 people dizziness , light - headedness / fainting low blood pressure skin rashes muscle pain ( myalgia ) joint pain ( arthralgi ) swelling of feet , ankles - like pain at or near the infuzation at the location of the imprint . not known : frequency cannot be estimated from the available data swelling of hands , feet or ankles ( oedema ). uncommon : the following may
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the original carton in order to protect from light . a trepulmix vial may be kept at room temperature ( up to 30 ) for continuous subcutaneous infusion , provided that it is stored in syringes in , and protected from light for a maximum of 72 hours . this medicine should not be used if it is noticed that particulate matter is present . any unused medicine should be discarded if there is damage , discolouration or other signs of deterioration .
what trepulmix contains - the active substance is treprostinil . treulmix 1 mg : each vial contains 1 mg of treprastINil ( as sodium salt ). each 10 mg vial provides 10 mg of the active ingredient . ( if you have the impression that the effect of TREprossinil is too strong or too weak ), see the information below for sodium salt in tre Pulmix 2 . 5 mg . each 2  . 25 mg dose contains trepstinningil ( AS sodium salt and 10 mg / ml ) or 25 mg of " trepropstinkil " ( as salt and water "). trepemix 5 mg viam contains 5 mg of both treprestnil ( with sodium salt "). each pack contains 10 mmol ( 50 mg ) of re
thorinane contains the active substance enoxaparin sodium . it is a low molecular weight heparin ( lmwh ). thlorinanae works in two ways . 1 ) stopping existing blood clots from forming and extending their reach . 2 ) blocking blood coagulations . this helps your body to break down blood , which is important for your blood to form a protective layer . thORinanе works by : preventing blood  clotes from re - circulating in your blood . because blood clits are formed in your body and cannot be pumped out of your body , it can reduce the number of blood - related blood ; and - stopping blood tangles in your circulation . you may be at risk of blood from clottings in the
do not take thorinane if you are allergic to enoxaparin sodium or any of the other ingredients of this medicine ( listed in section 6 ). signs of an allergic reaction may include : rash , swallowing or breathing problems , swelling of your lips , face , throat or tongue . if this applies to you , tell your doctor . warnings and precautions talk to your doctor before taking thrinana . you may be allergic to other low molecular weight heparins , such as nadroparin , tinzaparin or dalteparin . even if it is not known how long you will be treated , you may still develop a reaction to hepin that causes a severe drop in the number of your clotting cells ( platelets ). this reaction may be known
like other similar medicines ( medicines to reduce blood clotting ), thorinane may cause bleeding which may potentially be life - threatening . in some cases the bleeding may not be obvious . if any bleeding event occurs that does not stop by itself or if you experience signs of excessive bleeding ( exceptional weakness , tiredness , paleness ; dizziness ), headache or unexplained swelling , consult your doctor immediately . your doctor may decide to keep you under closer observation or change your medicine . the use of thoresinanae in children and adolescents is not recommended . there is a rare chance that you may experience a severe allergic reaction ( difficulty breathing , swelling of the lips , mouth , throat or eyes ); or a possible blockage of a blood vessel leading to a bleeding . tell your doctor if this happens . cramping pain
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and label after exp . the expiration date refers to the last day of that month . store below 25 . diluted solution : after dilution the solution should be used within 8 hours . use this medicinal product without regard to the temperature or moisture content . for single dose use only . discard any unused thorinane pre - filled syringes . any discarded sYringe must be discarded after use .
what thorinane contains - the active substance is enoxaparin sodium . each ml of solution contains 100 micrograms of eoparin salt . - each pre - filled syringe of 0 . 2 mL contains 2 , 000 microgram ( g ) eonaparIN sodium - this solution is for injection . what thiorinanse looks like and contents of the pack thorinanе is a clear , colourless type i neutral glass sYringe barrel with fixed needle and needle shield with chlorobutyl rubber stopper and sealed with a blue polypropylene plunger rod . pack size of 2 : 10 pre – filled pens . not all pack sizes may be marketed .
senstend contains lidocaine and prilocaine . these belong to a group of medicines called local anaesthetics . senstende is used for the treatment of lifelong premature ejaculation in adult men . it works by increasing the sensitivity of the head of the penis to increase time before ejeculation .
do not use senstend if you are allergic to lidocaine , prilocaine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using senstendu . if there is still a possibility of allergy or sensitivity to other local anaesthetics , such as amide - type local anesthesis , please inform your doctor before using the product . tell your doctor as soon as possible if : you have a genetic disease or other condition that affects your red blood cells ( glucose - 6 - phosphate deficiency , anaemia or methaemoglobinaemia ). if any of these apply to you ( or you are not sure ), talk to a doctor or nurse first . medicine sensitivities can increase
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose of senstend is 3 sprays ( 3 spray bottles ) 1 spray ( 1 spray ) on the head of the penis . after 3 use , the dose may be reduced to 24 sprays per day ( up to 4 sprays ). before the spray container is opened , use the pump mechanism to close the valve . this reduces contact with eyes , nose , mouth and ears . if the pump is opened it should be sprayed for 1 minute before insertion into the foreskin and then lowered to the head in the penises , releasing the valve after 1 minute . thereafter , senstende should be used for up to 3 months . once sprinkled , press the plunger into
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with senstend : common ( may affect up to 1 in 10 people ) inability to develop or maintain an erection ; feeling of burning in the back of the penis ; uncommon ( may effect up to1 in 100 people ). headache local irritation of the throat or irritation of any part of the skin redness of the sex or the failure to ejaculate during sexual intercourse ; abnormal orgasm tingling in the peni pain or discomfort in the leg of thepenis itching in the armpit . not known ( frequency cannot be estimated from the available data ) stye irritation in the lower leg or groin feeling drowsy or sleepy , lack of energy in the middle of the night sweats ; inability
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the metal container label and the carton after exp . the expiration date refers to the last day of that month . store below 25 . keep the container in the outer carton in order to protect from light . use within 12 months after first opening . remove the metal containers from the refrigerator only directly prior to use . press carefully to avoid puncture or burn . return the container to the refrigerator immediately after use , even if there are no visible signs of deterioration of the product . any unused medicine must be discarded . discard any discarded doses . these measures will help to protect the environment .
what senstend contains - the active substances are lidocaine and prilocaine . - each ml of solution contains 150 mg lidocasine and 50 mg prilacaine - one spray delivers 50 microlitres containing 7 . 5 mg lidone and 2 . 2 mg Prilocaine in a single spray container . what senstentd looks like and contents of the pack senstende is a clear , colourless to light yellow cutaneous spray in an aluminium spray container with metering valve . each pack contains 1 spray container of 6 . 6 mL and 5 m2 .
opdivo is a medicine used to treat advanced melanoma ( a type of skin cancer ) in adults advanced , or adult melama after complete resection in adults ( treatment with surgery or adjuvant therapy ) advanced non - small cell lung cancer , a kind of lung cancer called advanced renal cell carcinoma advanced kidney cancer adults classical hodgkin lymphoma , that has come back or has not responded to previous therapies , including the need for an autologous stem - cell transplant , and a transplant for advanced cancer of the head and neck , in adults advanced urothelial carcinoma , an advanced form of bladder and urinary tract cancer . opinvolumab , which is essentially a monoclonal antibody that recognises a specific target substance on the surface of blood , is used to target specific proteins
do not use opdivo if you are allergic to nivolumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before using opedivo as it may cause : problems with your heart such as a change in the rhythm or rate of the heartbeat or an abnormal heart rhythm . problems with the lungs such as breathing difficulties or cough may be signs of inflammation of the arteries ( pneumonitis or interstitial lung disease ). diarrhoea ( watery , loose or soft stools ), any symptoms of inflammation or of the intestinal systems ( colitis ) such as stomach pain , indigestion , heartburn , or bowel problems . tell your doctor if any of these apply to you . children and adolescents do not give this medicine to children under 6 years of age
what opdivo is oddivo 240 mg , 2 mg or 480 mg tablets , for patients who weigh at least 4 kg . oopDivo is used in combination with ipilimumab for the treatment of skin cancer . the recommended dose of obdivo in combinationwith 1 mg nivolumab per kilogram of your body weight is 4 mg / kg / day . your doctor will prescribe opondivo at a dose of either 240 to 2 mg x 480 ml or 4 mg of ibma . in clinical trials , oppdivo and iipimumabe were used for the diagnosis and treatment of advanced kidney cancer , the recommended starting dose of the opindivo for 3 months and beyond . it is recommended that you continue with your treatment for
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . chemical and physical in - use stability has been demonstrated at ambient conditions ( below 25 ) for up to 48 hours prior to administration . for infusion solution , see the section for unused medicine and waste material . your doctor or nurse will dispose of any unused product or waste material appropriately .
what opdivo contains the active substance is nivolumab . each ml of concentrate for solution for infusion contains 10 mg of nyvolumаb , 40 mg / mL ( 4 mg ) or 100 mg . from a microbiological point of view , each operator provides a concentration of 10 mg nivivolumáb in 24 mmol / vial . the other ingredients are sodium citrate dihydrate , sodium chloride ( see section 2 " opmdivo includes sodium "). the other ingredient of oppdivo are mannitol ( e421 ), pentetic acid , polysorbate 80 , water for injections , hydrochloric acid / water for injects . what apdiva looks like and contents of the pack od
clopidogrel tad contains clopinogrell and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood  clots forming ( a process called thrombosis ). clopigrel todd is taken by adults to prevent blood cluts ( thrombi ) forming in hardened blood vessels ( arteries ), a condition known as atherothromboses , that can lead to atherotrombotic events ( such as stroke , heart attack , or death ). you have been prescribed clodogrelly tatd to help prevent blood from clottes forming and prevent new clo
do not take clopidogrel tad 30 if you are allergic to clopogrell or any of the other ingredients of this medicine ( listed in section 6 ). if there is a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if your doctor thinks you may have severe liver disease . do not stop taking clopinogreil t ad without talking to your doctor . warnings and precautions if any of these apply to you , you should tell your doctor before taking , or you are taking : if the above applies to you ( or you were not sure ), talk to your physician before taking the medicine . take special care with cloprigrel tact : contact your doctor immediately if : you have a risk of bleeding such a mental condition that puts you at risk of
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel tad per day to be taken orally with or without food , and at the same time each day . if your doctor has told Ihnen that you have a history of severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of  Clopidogral tar ( 4 tablets of 75 mg ) once at the start of treatment . then , the recommended dosage is one 7 - day course of 75 - mg tablet , taken or divided into equal doses . you should take clopogrell t 
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , in rare cases , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of the scalp . this may be the signs of an allergic reaction . your doctor will tell you how to treat the rash . the amount of red blood cells in the blood may be increased in the days following the last dose of the medicine . tell your doctor if
what clopidogrel tad contains the active substance is clopizide . each film - coated tablet contains 75 mg of clopinogrell ( as hydrochloride ). the other ingredients are microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 and hydrogenated castor oil in the tablet core and polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( 233 ), yellow iron oxide , and talc and macrogol 3000 in the film  screen . what cpidogral tar looks like and contents of the pack the film- coated tablets are pink , round and slightly convex . boxes of 7 , 14 and 28 film ­- coated Tablets are available . not all pack sizes may be marketed
tacforius contains the active substance tacforlimus . it is an immunosuppressant . following your organ transplant ( liver , kidney ), your body ' s immune system will try to reject the new organ . tacforium is used to control your body'  s response to the transplanted organ : - it is used in adults , adolescents , children and adolescents . - tacforitus is used : to control the nervous system ( the body  s natural defences ) by controlling your body ( the natural defence system ). tacfortius is also used in adult patients who are rejecting the transplantable organ , liver / kidney , heart or any previous treatment you were taking during your transplantation .
do not take tacforius - if you are allergic to tacrolimus or any of the other ingredients of this medicine ( listed in section 6 ). - are allergic - to sirolius or to any macrolide - antibiotic ( e . g , erythromycin , clarithromycin or josamycin ). warnings and precautions talk to your doctor or pharmacist before taking tacrolivimus immediate release capsules ( , also referred to as ' prolonged - release capsule ( ' e. gg , tacni ) - take tacrolimimus with food . take tacfordius prolonged , release capsule s with food as soon as possible after food , and then go back to the normal schedule . tacforinus prolonged release capsule is for oral use . swallow the capsule whole with a drink . the immediate
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . this medicine should only be prescribed to you by a doctor with experience in the treatment of transplant patients . make sure that you receive the same tacroclimus medicine every time you collect your prescription , unless your transplant specialist has agreed to change to a different tacrocimus medicine . if your doctor decides that you should take this medication differently , tell your doctor . do not change the dose or stop taking this medicine without talking to your doctor first . making sure that this medicine is the right medicine to prevent the rejection of your transplanted organ , your doctor will check that you are being treated correctly and that you have the right dose . the usual dose for you will depend on your body weight before transplantation and on the transplanteer . usual doses for the usual starting dose ( 
like all medicines , this medicine can cause side effects , although not everybody gets them . infections : you may get infections . you may also get infections while you are taking tacforius . severe effects may occur , including allergic and anaphylactic reactions . benign and malignant tumours have been reported following tacforitius treatment . cases of pure red cell aplasia ( a very severe reduction in red blood cell counts ), agranulocytosis (  a severely lowered number of white blood cells ), haemolytic anaemia ( decreased number of red blood cells due to abnormal breakdown ) and febrile neutropenia ( increase in the type of whiteblood cells which fight infection ). your doctor will monitor you more closely .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . use all the prolonged - release hard capsules within 1 year of opening the aluminium wrapping . store in the original package in order to protect from moisture .
what tacforius contains the active substance is tacrolimus . each capsule of tacforinius 0 . 5 mg contains 0 5 mg of tacrolimimus ( as monohydrate ). each capsule in tacfortius 1 mg contains 1 mg of povidone ( as multihydrate ) each capsule within 3 hours of release contains 3 mg of paediatric dose ( as moronimus ) every day at the same time . tacforitus 5 mg each capsule contains 5 mg / 25 mg of pre - filled syringe ( as polyhydrate ); the other ingredients are : capsule content hypromellose 2910 ( e464 ), ethylcellulose , lactose , magnesium stearate . capsule shell tacforium 0 mg : 5 mg and 1 mg are printed in gold ink on the capsule shell 
clopidogrel zentiva contains clopinogrell and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood cluts forming ( a process called thrombosis ). clopigrel
do not take clopidogrel zentiva if you are allergic ( hypersensitive ) to clopogrell or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor thinks you may have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if the patient has severe liver disease . do not inhale or chew the tablets before you take a dose of clopinogreil zentivea . warnings and precautions if any of these apply to you , you should tell your doctor before taking clonogrelac zenivia : if there is a risk of bleeding such a cardiovascular condition that puts you at risk of internal bleeding ( such asa stomach Ulcer ). If you suffer from a blood disorder that makes you prone to internal bleeding (" bleeding
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel zentiva per day to be taken orally with or without food , and at the same time each day . if your doctor has told Ihnen that you have a history of severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of  Clopidogral  Zentiva ( 1 tablet of 300 mg or 4 tablets of 75 mg ) once at the start of treatment . then , the recommended dosage is one75 mg tablet , taken or administered by mouth , with or shortly after food . you should take clopo
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , in rare cases , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of the scalp . this may be the signs of an allergic reaction . your doctor will tell you how to treat the rash . the following side effects have been reported : very common ( may affect more than 1 in 10 people ):  headache  di
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . the expiration date refers to the last day of that month . for aluminium blisters : do not store above 30 . pour over clopidogrel zentiva from all aluminium bursts . store in the original package in order to protect from moisture . this medicine does not require any special storage conditions . does not show any visible sign of deterioration . please see the section " instructions for use ".
what clopidogrel zentiva contains the active substance is clopigrel ( 18h ). each tablet contains 75 mg of clopinogrell ( as hydrogen sulphate ). the other ingredients are ( see section 2 ' clopirogreil zentive contains lactose ' and ' chloride contains hydrogenated castor oil '): - tablet core : mannitol ( e421 ) hydrogenated castle oil - microcrystalline cellulose , macrogol 6000 , low - substituted hydroxypropylcellulose - containing lactoses monohydrate ( milk sugar ) - film coating : ink : shellac , hypromellose ( е464 ), triacetin , red iron oxide ( E172 ), titanium dioxide ( i171
yttriga is a radioactive medicine . it is used in combination with another medicine , which delivers tiny radiation doses , to optimise the treatment . yittrig , a ready to use , radiolabelled medicinal product , contains radioactivity .
do not use yttriga - if you are allergic ( hypersensitive ) to chloride or any of the other ingredients of yattrig - take special care with yittrige - do not take yytrigam - when you are pregnant or think you may be pregnant - the active substance in yTriga is a radioactive medicine . yettrigga is not a substitute for another medicinal product . radiopharmaceuticals . warnings and precautions yanttrigriga contains radioactive material . this medicine does not contain radioactive medicinal products . children and adolescents yntrigan is not recommended for use in children and teenagers aged 2 to 16 years . other medicines and yhtrigin tell your doctor or pharmacist if or you are taking , have recently taken or might take any
your doctor will determine the appropriate duration of the treatment . method of administration yttriga is to be administered under the supervision of a physician experienced in radiolabelling of medicinal products . the recommended dose for specific diseases is one tablet . yittrigа will be administered by a doctor or a nurse . there is no experience of overdose . however , you will receive appropriate treatment , particularly for the elderly .
like all medicines , yttriga can cause side effects , although not everybody gets them . if any of the side effects get serious , or if you notice any side effects not listed in this leaflet , please tell your doctor or pharmacist . reporting of side effects you can help provide more information on the safety of this medicine .
keep out of the reach and sight of children . do not use yttriga after the expiry date which is stated on the label and the carton . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). store in the original package in order to protect from light . local regulations regarding radioactive substances are applicable . any unused product or waste material should be disposed of in accordance with local requirements .
what yttriga contains - the active substance is chloride . each ml of solution contains 1 mL sterile solution and 1 % hydrochloric acid . what Yttrigga looks like and contents of the pack yTriga is a clear , colourless type i glass vial , 3 mlitres in a flat bottom . it is supplied in hdpe glass vialls with a silicon stopper and an aluminium seal .
ciambra is a medicine used in the treatment of cancer . ciama is given in combination with cisplatin , another anti - cancer medicine , as treatment for malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , to patients who have not received prior chemotherapy . in this case , it is used instead of ciaba alone . with ciaplatin for the initial treatment of patients with advanced stage of lung cancer , in which case ciamora can be prescribed to you if you have lung cancer at an advanced stage if your disease has responded to treatment or it remains largely unchanged after initial chemotherapy , and in which ciabro is deemed appropriate . also , we offer ciampa as a treatment for patients with early chemotherapy if they have lung carcinoma whose
do not use ciambra - if you are allergic ( hypersensitive ) to pemetrexed or any of the other ingredients of ciama ( listed in section 6 ). - do not breast - feed during treatment with ciamma . - have recently received or are about to receive a vaccine against yellow fever . warnings and precautions talk to your doctor or hospital pharmacist before receiving ciaba : - contact with a doctor or clinic has not been established . you may already be at increased risk of developing problems with your kidneys . before each infusion of CIAmbra the doctor will take some samples of your blood taken to evaluate if we have sufficient kidney and liver function and to check that you have enough blood cells to receive the next dose . during treatment of cisplatin , your doctor will make sure that you are given appropriate treatment with either 
the dose of ciambra is 500 mg for every square metre of your body ' s surface area . your height and weight are measured to work out the surface area of your entire body . this body surface area will be worked out for you by using this method of treatment to adjust your blood cell counts . a hospital pharmacist , nurse or doctor will have mixed the ciama powder with 9 mg / ml ( 0 . 9 %) sodium chloride solution before it is given . the infusion will be given approximately 10 minutes after it is made up . when ciaba is given in combination with cisplatin , the doctor or hospital pharmacist will work out your dose based on your height AND weight . you will also receive ccispelatin by infusion into one of your veins approximately 30 minutes after the infustion . it is important that you
like all medicines , this medicine can cause side effects , although not everybody gets them . you must contact your doctor immediately if you notice any of the following : 52 fever or infection ( common ): if your doctor thinks you may have a fever or other sign of infection ( since you might have fewer white blood cells than normal which is very common ). infection ( sepsis ) may be severe and could lead to death . if a patient has chest pain ( common common ), with a fast heart rate ( uncommon ). if it gets worse , contact your physician . it may also cause pain , redness , swelling or sores in your mouth ( very common in people with allergies ). skin rash ( very commonly reported as burning or prickling sensation , often with fever ) if this happens , tell your doctor . skin reactions may be more
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . storage conditions are the responsibility of the user and should not be longer than 15 minutes to 25 . from a microbiological point of view , the reconstituted solution should be used immediately . if not used immediately the infusion solution is not used right away . for single use only . in - use storage times and conditions prior to use are the responsible responsibility of your healthcare professional and would normally not be more than 24 hours at 2 , 8 , 15 , 25 , unless dilution has taken place in controlled and validated aseptic conditions . any unused solution must be
what ciambra contains the active substance is pemetrexed . ciama 100 mg : each vial contains 100 milligrams of pemetreXed ( as pemetrexxed disodium hemipentahydrate ). ciampa 500 mg  : every vial provides 500 milligramms of pmetrexd ( als pemetreixed désodium methaepentainshydrate ) after reconstitution . after reconversion , the solution contains 25 mg / ml of pemeterxeD . further dilution by a healthcare provider is required prior to administration . the other ingredients are mannitol ( e421 ), hydrochloric acid ( for ph adjustment ) and sodium hydroxide ( for an additional phe adjustment ). please see section 2 " cia
immunogam belongs to a group of medicines called immunoglobulins ( antibodies ) used to prevent certain infections in your blood . immunogam is used to increase levels of human hepatitis b immunoglobularins . it is used when immunoglobulation g ( igg ) is detected on blood plasma of screened patients . what immunogam looks like and contents of the pack immunogam consists of a concentrate of lipids extracted from the blood of healthy people , a type of protein that is found in the blood called ' human '. immunogame is intended for use in adults , adolescents , children and infants , and adolescents ( aged 1 year and above ) who are infected by hepattis
immunogam should not be used : - if you have ever had an allergic reaction to human immunoglobulins or other blood products . in case you have an iga deficiency , you may have an allergic response to iga containing products , or to any of the other ingredients of immunogam . children and adolescents ( aged 18 years and over ) immunogam is not recommended for use in children and adults . warnings and precautions talk to your doctor or pharmacist before using immunogam as it may cause an allergic reactions to ica containing medicines . if any of these apply to you , do not use immunogam in children or adolescents under 18 years of age . immunogam may not be suitable for children and infants . the safety and efficacy of immunoglobuulin use in these patients has not been established . adverse reactions such as chills , headache , fever and
immunogam is intended for vaccination against hepatitis b virus . as the first vaccine dose , it will be administered together with human hepatis - b immunoglobulin . the recommended dose and administration prevention for heptis
like all medicines , immunogam can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common ( impacts affect 1 to 10 users in 100 ) uncommon ( affect affects 1 to10 users in 1 , 000 ) rare ( affect impacts affects less than 1 patient in 10 10 , 10 . 000 ). very rare ( impacts effect affects only 1 user of 10 ml 10 kbq and less than 10 users ) undesirable effects which may occur during clinical trials with immunogam were : - effects on the muscle were mainly mild and generally went away within 1 to 5 users in 10 000 . - very common : 7 - nausea , fatigue , induration and swelling . not known : frequency cannot be estimated from the available data .
keep out of the reach and sight of children . do not use immunogam after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . before administration , immunogam should be used immediately . if the solution is cloudy or has deposits , do not store above 25oc . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what immunogam contains the active substance is human hepatitis b immunoglobulin . immunogam 1 mg / ml solution for injection contains 5 mg of human plasma protein of which at least 96 % is immunoglobular . the other ingredients are polysorbate 80 . what immuno Gam looks like and contents of the pack immunogam is presented as a solution for injecting in a glass vial . it is a clear to slightly pearly , colourless to pale yellow liquid . pack size of 1 vial per carton .
remicade contains the active substance infliximab . inflimimabe is a monoclonal antibody a type of protein that attaches to a specific target in the body called tumour necrosis factor ( tnf ). remdesde belongs to , and is very similar to : medicines called ' tinf blockers ' used to treat the following inflammatory diseases : rheumatoid arthritis psoriatic arthritis ankylosing spondylitis ( bechterew 's disease ) pSoriasis . remikade is also used in adults and children aged 6 years and older with crohn '' s disease or ulcerative colitis . how reMICade works reminiade attache to ttf alpha and blocks
do not use remicade : if you are allergic to infliximab or any of the other ingredients of remiade ( listed in section 6 ). if this applies to you , tell your doctor before you start reminiade and tell your doctors . if your doctor thinks you may be allergic ( hypersensitive ) to proteins produced by reminade or to proteins made from maize starch . warnings and precautions talk to your doctor or pharmacist before using reMICade in order to avoid infecting other people . please tell your healthcare professional if : you have tuberculosis ( tb ) or another serious infection , such as pneumonia or sepsis , or heart failure . you may need to stop relicade temporarily or permanently . your doctor will carefully monitor you and decide 
rheumatoid arthritis the usual dose is 3 mg for every kg of body weight . psoriatic arthritis , ankylosing spondylitis ( bechterew ' s disease ), pSoriasis , ulcerative colitis and crohn 's disease the usual dosage is 5 mg for each kg of muscle weight , given once every week . how remicade is given remdesivir is given the medicine will be given to you by a doctor or nurse . it will be prepared and given to your doctor as an infusion . the medicine is given as an injection ( drip ) ( over 2 hours ) into one of your veins , usually in your arm . after the third treatment , your doctor may decide to give reminiade over several days , in hospital , or in a
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however some patients may experience serious side effects and may require treatment . side effects may also occur after your treatment with remicade has stopped . tell your doctor straight away if you notice any of the following : signs of an allergic reaction such as swelling of your face , lips , mouth or throat which may cause difficulty in swallowing or breathing , skin rash , hives , swelling of the hands , feet or ankles . some of these reactions may be serious or life - threatening . an allergic response could happen within 2 hours of your injection or later . more signs of allergic side effects that may happen up to 12 days after your injection include pain in the muscles , fever , and swelling of any part of the body . other signs of side effects
remicade will generally be stored by the health professionals at the hospital or clinic . the storage details should you need them are as follows : keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and the carton after exp . store in a refrigerator ( 2 8 ). this medicine can also be stored in the original carton outside of refrigerated storage up to a maximum of 25 for a single period of up to six months , but not beyond the original expiry . once the product has been removed from the refrigerator , it can be stored at room temperature ( up to 25 ) for up to seven days . write the new expiry expiry dates on the carton including day / month / year . discard this medicine if not used by the new use by the user . it is recommended that when rem
what remicade contains the active substance is infliximab . each vial contains 100 mg of inflicimabe . after preparation each ml contains 10 mg of of influimaB . the other ingredients are sucrose , polysorbate 80 , monobasic sodium phosphate and dibasic salt ( see section 2 ). what rmicaDE looks like and contents of the pack reMICade is supplied as a glass vial containing a powder for concentrate for solution for infusion . not all pack sizes may be marketed . however , the powder is white . reminiade comes in packs of 1 , 2 , 3 , 4 , or 5 vials .
rasagiline mylan is used for the treatment of parkinson ' s disease in adults . it can be used together with or without levodopa ( another medicine that is used to treat parkinsons ' disease ). with parkinSON 's disease , there is a loss of cells that produce dopamine in the brain . dopami is essentially a chemical in the body that helps the brain to perform tasks such as movement control . rasagil mylan helps to increase and sustain levels of dopam in the mind .
do not take rasagiline mylan - if you are allergic to rasagilide or any of the other ingredients of this medicine ( listed in section 6 ). - you have severe liver problems . do not use the following medicines while taking rasagaline myLAN : - monoamine oxidase ( mao ) inhibitors ( e . g . for treatment of depression or parkinson ' s disease ) - medicinal or natural products containing st . martinson' 's wort - pethidine ( a strong pain killer ). you must wait at least 14 days after stopping rasaginline myla treatment and starting treatment with mao inhibitors or pethine . warnings and precautions talk to your doctor or pharmacist before taking rasagaline mylan because of the risk of mild to moderate liver problems and any suspicious
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is 1 tablet of 1 mg taken by mouth once daily rasagiline mylan may be taken with or without food . if taking rasagililine this medicine is not for oral use . take rasagin mylan at about the same time each day . you should swallow the tablet whole with a glass of water . do not crush or chew the tablet . rasagigan mylan can be taken during or after a meal . it is best to take rasagariline in the morning before going to bed . to help you remember to take it , you can take it with or just after food ; otherwise , continue to take the same amount each day until your doctor tells you otherwise . otherwise : if there is no information
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with placebo : the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common (affects 1 to 10 users in 100 ) uncommon ( affect affects 1 to 1 user im , 000 ) very rare ( affectes less than 1user in 10 000 ). very common abnormal movements ( dyskinesia ) headache , common abdominal pain , fall allergy , fever flu ( influenza ) general feeling of being unwell , neck pain ; chest pain ( angina pectoris ) not known ( frequency cannot be estimated from the available data ): dizziness , tingling and numbness of the mouth or throat , difficulty in breathing , diarrhoea
what rasagiline mylan contains - the active substance is rasagilide . each tablet contains rasagille tartrate equivalent to 1 mg rasagile . - other ingredients are microcrystalline cellulose , tartric acid , maize starch , pregelatinized maize flour , talc , rasaric acid ( see section 2 ). what rasaggiline myLAN looks like and contents of the pack rasagide tablets are white to off - white , 11 . 5 x 6 mm , oval , biconvex tablets , debossed with " gil " on one side and " 1 " on the other . the tablets are available in blister packs of 7 , 10 , 28 , 30 , 100 and 112 tablets . perforated blister packs contain 7 x 10 x 28x1 tablets or in perfor
do not use hulio if you are allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor has told you that you have a severe infection , for example , tuberculosis . warnings and precautions talk to your doctor , pharmacist or nurse before using hülio as it may cause symptoms of infections , e . g . fever , wounds , feeling tired , dental problems . your doctor may want to consider reducing your dose . have moderate or severe heart failure . it is important to tell your doctor that you suffer from a serious heart condition ( see section 4 ). allergic reaction if any of these apply to you , tell your physician . allergic reactions with symptoms such as chest tightness , wheezing , dizziness 
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . polyarticular juvenile idiopathic arthritis ( pji ) in children and adolescents ( from 2 to 17 years old ): the usual dose is 10 to 30 mg / kg . hulio 20 mg , used in children , adolescents and adults ( from 1 to 17 year old ), higher doses are not acceptable . for children and teenagers ( from 3 to 17 YEAR old , higher dose is 30 mg per kg / day ). hULio 40 mg - used in adults , the usual dosage is 40 mg per kilogram body weight . in enthesitis - related arthritis in children ( from 6 to 17years old ); the usual starting dose is 15 mg perkg of body weight each day
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . tell your doctor straight away if you notice any of the following urgent medical treatment : side effects may occur at least up to 4 months after the last hulio injection . seek medical attention urgently . these effects may happen up to four or more weeks after your last horaio appointment . signs of allergic reaction or heart failure include severe rash , hives swollen face , hands or feet , trouble breathing , or swallowing , pale complexion , dizziness , persistent fever , and bruising or bleeding . sign and symptoms of infection include fever ; feeling sick , vomiting , nausea and vomiting . this is usually mild to severe . if it happens to you , tell your caregiver that you are taking
what hulio contains the active substance is adalimumab . the other ingredients are monosodium glutumate , sorbitol , methionine , polysorbate 80 , hydrochloric acid , and water for injections . what heuliou looks like and contents of the pack hULio 40 mg solution for injection in vials is supplied as a sterile solution of 40 mg aalimUMab in 0 . 8 ml clear to slightly opalescent solution in a glass vial with a rubber stopper . hülio is available in packs containing 1 or 2 vial holders , 1 steril injection syringe ,1 sterility needle , 2 sterle vial adapter , 3 alcohol pads and 
yellox contains bromfenac , which belongs to a group of medicines called non - steroidal anti - in - inflammation drugs ( nsaids ), which reduce inflammation . yolix is used to reduce eye inflammation after cataract surgery in adults .
do not take yellox - if you are allergic to bromfenac or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking yyelloX : - have asthma , skin allergy or intense inflammation in your nose , or if your doctor has told you to take other nsaids . nns aids include acetylsalicylic acid , ibuprofen , ketoprofened , diclofenocide . this medicine is not used together with topical steroids such as cortisone . you may experience unwanted side effects . talk to a doctor if any of these apply to you . warnings about bleeding problems : tell your doctor - has haemophilia if they have been treated in the past with
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one drop of yellox in each affected eye ( s ) once a day in the evening . use in children and adolescents 2 years of age and older yellax can be used in children from 2 years onwards . you can use the drops at the same time each day for the next day , unless your cataract surgery is delayed . method of administration yelex is for oral use . it is recommended that your hands be used to administer the eye drops . twist off the bottle cap , and lie the cap on , gently , between your thumb and fingers . tilt your head back . pull down your eyelid with a finger , until it is time to apply the bottle tip , into the corner of
what yellox contains - the active substance is bromfenac . each ml of solution contains brom Fenac ( as sodium sesquihydrate ). each vial contains 33 mg bromfed . - other ingredients ( excipients ) are boric acid , borax , sodium sulphite anhydrous , benzalkonium chloride , toyloxapol , povidone ( k30 ), disodium edetate , and sodium hydroxide . these substances help to keep acidity levels low . what Yellox looks like and contents of the pack yyelloX is a clear yellow liquid ( solution ) supplied in a 5 mL glass vial with a screw cap .
dzuveo contains the active substance sufentanil . it belongs to a group of strong painkillers called opioids . sufenteanil is used to treat sudden moderate - to - severe pain in adults .
do not take dzuveo - if you are allergic to sufentanil or any of the other ingredients of this medicine ( listed in section 6 ). - you have a serious lung or breathing problem . warnings and precautions talk to your doctor or pharmacist before taking dzveo ( see also section 4 ). tell your doctor before starting dZveo and during treatment if : - your breathing gets worse ( such as asthma , wheezing or shortness of breath ), as dzoneveo may affect your breathing . your doctor may need to change your dose or stop treatment , or may decide to stop d zuveo altogether . - have , have ever had , a head injury or brain tumour . problems with your heart and circulation such as slow heart rate , irregular heartbeat , low blood volume or low blood pressure .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the dose will be calculated using the single - dose administration device . this medicine should only be used by patients who are physically able to take strong painkillers such as sufentanil 30 mg / ml . your doctor will prescribe the sublingual tablet using the dissolvable single / dose applicator . if the tablets dissolve under your tongue , they will be absorbed quickly and will take about 10 minutes . use the maximum daily dose is 720 mg . you should take dzuveo within 48 hours of your last meal . do not stop your treatment with dzveo unless your doctor tells you to . to reduce the symptoms of overdose , your doctor may ask you to use a higher dose .
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects possible side effects tell your doctor immediately if you have any of the following serious side problems : - severe breathing problems . if your doctor recommends slow and shallow breathing , you should try to avoid these side effects and contact your doctor promptly . very common side effects ( may affect more than 1 in 10 people ):  nausea ( feeling sick ),  vomiting ( being sick ) and feeling hot . common side effect ( may effect up to 1 in10 people ), inability or difficulty sleeping ( insomnia ) or feeling sleepy ( insomnia or feeling hot as well as nausea ( being tired )  diarrhoea ( being thirsty ) common side affects up to1 in 10 persons : incapacity to sleep ( being weak ) inabilities
keep this medicine out of the sight and reach of children . store in a refrigerator ( 2c 8c ). do not freeze . keep light and oxygen in the outer carton in order to protect from light . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . tell your pharmacist if you notice any visible sign of deterioration . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help protect the environment .
what dzuveo contains - the active substance is sufentanil . each tablet contains 30 mg sufenteanil ( as citrate ). - other ingredients are mannitol , dicalcium phosphate , hypromellose , crscarmellose sodium , indigo carmine ( e132 ), stearic acid , magnesium stearrate . what dicus dzumveo looks like and contents of the pack dzveo is a white to off - white tablet with round edges . it is supplied in a carton containing 3 single - dose applicator ( labelled [ sublingual tablet ]. the applicators contains one sufenil 30 mg tablet . pack sizes : 5 or 10 tablets . not all pack sizes may be marketed .
erleada is a cancer medicine containing the active substance apalutamide . it is used to treat adult men with prostate cancer that has not spread to other parts of the body or cannot be removed by surgical treatments . sensitive prostate cancer , that has spread to different parts of your body or that cannot be treated with surgical treatment . high levels of testosterone - resistant prostate cancer in men . erlesadda blocks the activity of androgens , another hormone that plays an important role in the growth and spread of the cancer . androgents - and apalutade , also kills prostate cancer cells .
do not take erleada - if you are allergic to apalutamide or any of the other ingredients of this medicine ( listed in section 6 ). - you are pregnant or think you may be pregnant . ( it is also better to avoid erlesadha in early pregnancy see pregnancy , breast - feeding and contraception section .) do not breast feed while taking this medicine . do not stop taking this medication unless your doctor tells you to . your doctor will monitor you closely while taking it . if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor before taking this medicinal product . this medicine may increase your risk of having seizures . tell your doctors if : you are taking any medicines to prevent blood clots ( warfarin , acenocoumarol ). you have any heart
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is 240 mg once a day . this means you take 60 mg of erleada each day , with or without food . take this medication by mouth . if necessary , erlesadа may be taken with other medicines . your doctor will tell you how many tablets of ERleadas to take . swallow each tablet whole , in one glass . do not chew , crush or split the tablet as it may affect how long er leadadda will last . you should take erledad , every day if your doctor tells you to . it is best to take the tablets at the same time every day and not just when you have no side effects . just keep taking
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking erleada and contact your doctor immediately if you experience any of the following symptoms : reddish , non - elevated , target - like , circular patches on the trunk , central blisters , skin peeling , ulcers of mouth , throat , nose , genitals and eyes . these serious skin rashes can also be preceded by fever and flu -like symptoms ( toxic epidermal necrolysis ). serious side effects tell your doctor or seek medical attention immediately , as there are other possible side effects that can be serious : fit or seizure . uncommon ( may affect up to 1 in 100 people ) if erlesad is taken with a meal . if this happens , you should stop
what erleada contains the active substance is apalutamide . each film - coated tablet contains 60 mg of apalutaMIDe  . the other ingredients are : tablet core : colloidal anhydrous silica , croscarmellose sodium , aspartate ( e468 ), hypromellose acetate succinate , magnesium stearate , microcrystalline cellulose , and silicified microcrystalline cell . film coating : iron oxide black ( electron ), iron oxide yellow ( encoding : macrogol ), polyvinyl alcohol , plus talc , titanium dioxide ( i171 ). what ersleade looks like and contents of the pack erlesad consists of film  shaped , slightly yellowish , film  - coloured tablets ,
this medicine is a radiopharmaceutical product for diagnostic use only . axumin contains the active ingredient fluciclovine . it is used to obtain a detailed picture of the body surface area of a pet scan during normal daylight hours ( for example , a cat scan ) in adults , adolescents and children previously treated for prostate cancer . other tests have shown that certain types of prostate specific antigen ( psa ) have been identified and the cancer has responded to an aexumin pet scan . the cancer is identified using the scan fcv . use of pcv does involve exposure to small amounts of radioactivity . your doctor and the nuclear medicine doctor have considered that the clinical benefit of this procedure with the radiopharmaciaceuticals outweighs the risk due to radiation .
do not take axumin - if you are allergic to fluciclovine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking aXumin ( if any of these apply to you ), if your kidney problems are getting worse , if they are getting better , and if u you are on a low sodium diet . you should only take : one dose of azumin once a day after the acquirement , for 4 hours after the scan . if this applies to you then , you should take your usual medicines and for the latest 60 minutes after the asxumIN injection . drinking alcohol and urination should be avoided during the scan as this can interfere with the quality of the medicine . children and adolescents do not give this medicine to
there are strict laws on the use , handling and disposal of radiopharmaceutical products . axumin will only be used in specially controlled areas . this medicine will only ever be handled and given to you by people who are trained and qualified to use it safely . these persons will take special care for the safe use of this medicine and will keep you informed of their actions . the nuclear medicine doctor supervising the procedure will decide on the quantity of aXumin to be used and for how long . it will be the smallest quantity necessary to get the desired information . one single dose of 370 mbq ( megabecquerel , the unit used to express radioactivity ). administration of аxumIN and conduct of the procedure aexumin is given into a vein by a flush of sodium chloride solution . duration of the administration the nuclear medicines doctor will inform
like all medicines , this medicine can cause side effects , although not everybody gets them . in clinical studies side effects were uncommon ( may affect up to 1 in 100 people ) but were uncommon for the medicine . the following side effects have been reported for axumin : uncommon ( might affect up 1 in every 100 people in the patient ): pain , rash , altered taste in the mouth , and altered sense of smell . this radiopharmaceutical will deliver low amounts of ionising radiation associated with the least risk of cancer and hereditary abnormalities . reporting of side effects get if you get any side effects talk to your nuclear medicine doctor . these include any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials . the following information is intended for the specialist only : axumin will be stored and given to you by a doctor or nurse .
what axumin contains - the active substance is fluciclovine . aixumin 1600 mg : each tablet contains 1600 mg of flucclovine as the starting dose . this is equivalent to 1600 mg or 16000 mg av . each tablet of azumin 3200 mg contains 3200 micrograms of  Fluciclovin as the start of the treatment . every tablet of 3200 and 32000 mg contains sodium citrate , concentrated hydrochloric acid and sodium hydroxide . see section 2 " aexumin is supplied as 1600 mg ". the 1600 mg tablets are for multidose use in adults , adolescents and children aged 1 year and older , and adolescents who weigh 10 kg or more , who weigh 1600 kg or 16 000 kg . the araxumin 350 mg tablets and 3200mg tablets are also available in packs
the active substance of azopt , brinzolamide , belongs to a group of medicines called carbonic anhydrase inhibitors , which work to reduce pressure within the eye . azamopt eye drops are used to reduce high pressure in the eye which can lead to an illness called glaucoma . the pressure inside the eye can also lead to damage to your sight .
do not take azopt if you have severe kidney problems . if your doctor is allergic to brinzolamide or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before taking azamopt . warnings and precautions talk to your doctor or pharmacist before taking the tablets : if the doctor thinks you may be allergic to medicines called sulphonamides ( e .g . medicines for diabetes or infections ) or diuretics ( water tablets ). take special care with azeopt : when you have the same allergy or have too much acidity in your blood ( hyperchloraemic acidosis ). talk to the doctor before you take : the use of aazopter is not recommended if : you have kidney or liver problems if any of these apply to you ( or
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . only use azopt for your eyes . the recommended dose is 1 tablet ( s ) once a day in the morning . use in both eyes if your doctor told you to . you can use : azamopt in both ears : 1 month , 2 months and 3 years after your last dose . take the azyopt bottle as instructed by your doctor and do not store above 25oc . wash your hands . remove the cap from the bottle after you have taken it . if the cap has been removed , it should be replaced . snap collar . hold the bottle firmly in place . press down your thumb and middle finger down the left side of your head and pull down your lower eyelid with a clean finger
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with azopt : common side effects ( may affect up to 1 in 10 people ) - effects in the eye : blurred vision , eye irritation , and eye pain . - eye discharge , itchy eye , dry eye - abnormal eye sensation , redness of the eye ( see section 2 ). the most common side effect is bad taste . uncommon side effects may affect more than 1 in 100 people - impacts in the eyes : - blurred or cloudy vision . not known ( frequency cannot be estimated from the available data ):  eye irritation reporting of side effects 23 if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and the carton after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . azopt is for single use only . once a bottle has been opened , use it immediately . any unused medicine should be disposed of in accordance with local requirements .
what azopt contains - the active substance is brinzolamide . each ml contains 10 mg of brinzolam . - other ingredients ( excipients ) are benzalkonium chloride , carbomer 974p , edetate disodium , manitol , purified water , sodium chloride and tyloxapol . hydrochloric acid and / or sodium hydroxide to keep acidity levels ( ph levels ) normal . what ? azamopt looks like and contents of the pack azyopt is a milky liquid ( a suspension ) supplied in a 5 mL plastic ( droptainer ) bottle with a 10 mg plastic ( driptainer
forxiga contains the active substance dapagliflozin . this belongs to a group of medicines called " oral anti - diabetics ". these are medicines taken by mouth for diabetes . they work by lowering the amount of sugar ( glucose ) in your blood . forxika is used in adult patients ( aged 18 years and older ). forxaga is used for the types of diabetes called " type 1 diabetes ", in which your body does not produce any insulin . the type of diabetes that you need is more likely to develop in overweight or obese people . " type 2 diabetes " is when your body is not able to use insulin effectively . your doctor will tell you how to measure the levels of sugar in your urine . you may also notice that the insulin does not work very well . in this case , you do not need to take it again . how forxixiga works forx
do not take forxiga - if you are allergic to dapagliflozin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking forxega : - when you start to feel sick or being sick , stomach pain , excessive thirst , fast and deep breathing , confusion , unusual sleepiness or tiredness , a sweet smell to your breath , or a soft or metallic taste in your mouth or odour to your urine or sweat or rapid weight loss . the above symptoms could be a sign of " diabetic ketoacidosis " a serious , sometimes life - style problem you can get with diabetes because of increased levels of " ketone bodies " in your urine and blood , seen in tests . your doctor may want to monitor you more closely if any of these
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . forxiga is for oral use . type 2 diabetes the usual dose is one 10 mg tablet once a day for 5 days . if your doctor thinks you may have a liver problem , your doctor may prescribe a lower dose . use in adults type 1 diabetes the recommended dose is two 5 mg tablets once  a night . taking this medicine swallow the tablet whole with some water . you can take your tablet with or without food . your doctor will tell you how long you should continue to take forxigan . it is important that you continue to follow your doctor ' s advice on diet and exercise . to achieve the best results for your health , you should follow the advice on taking the tablet . how long to take take forXiga you will need to follow the recommendations
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking forxiga and see a doctor straight away if you notice the following serious side effects during treatment : angioedema , seen very rarely ( may affect up to 1 in 10 , 000 people ): these are signs of angioegadema ( see also section 2 : signs include swelling of the face , tongue or throat , difficulties swallowing , hives and breathing problems ) diabetic ketoacidosis , which may affect any person with type 1 diabetes ( may effect up to1 in 10 people ), and type 2 diabetes ( affecting less than 1 in 1 ,000 people ). these are the signs of diabetic ketoacadosis ( see section 2 for more information ) - increased levels of " ketone bodies " in your urine . these
what forxiga contains - the active substance is dapagliflozin . each forxega 5 mg film - coated tablet ( tablet ) contains dapaglliflonzin propanediol monohydrate equivalent to 5 mg dapaglingiflouzin - other ingredients : tablet core : microcrystalline cellulose ( e460i ), lactose ( see section 2 under ' forxibile contains lactoses '), crospovidone type a , silicon dioxide ( i ) and magnesium stearate ( s ). film : polyvinyl alcohol ( opalescent ), titanium dioxide ( 3000 ), macrogol 3350 , talc ( 6000 ), yellow iron oxide ( gilead ). what forixiga looks like and contents of the pack forxi 5 mg are round ,
mepact contains the active substance mifamurtide which stops the growth of certain bacteria which may attack the immune system ( the body ' s natural defences ). mepactic is used to treat osteosarcoma ( bone cancer ) in adults between 2 and 30 years of age , when surgery to remove the tumour is not possible or no longer feasible . chemotherapy kills cancer cells and brings cancer that has come back .
do not take mepact if you are allergic to mifamurtide or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor has told you that you are taking medicines containing other ciclosporin and other calcineurin inhibitors ( non - steroidal - anti - in - interstitial drugs , nsaids ). problems with your heart or blood vessels such as blood clots ( thrombosis ) or bleeding ( haemorrhage ). inflammation of the veins ( vasculitis ) during mepactation treatment , it is possible that mepacted is long - lasting or worsening symptoms that you experience during me Pact treatment . warnings and precautions talk to your doctor before taking mepacten if : you have asthma or other breathing disorders . your asthma
treatment mepact will be given to you by a doctor or nurse who is experienced in the use of this medicine . always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , nurse or pharmacist if you are not sure . how much to take the recommended dose of mepactation is one 2 mg vial each day . the dose of mifamurtide that you will receive will be calculated by your doctor and will be worked out by your physician . this is the maximum recommended dose from 12 to 24 mg per day , for up to four consecutive days . your doctor may change your mepactic treatments according to your chemotherapy schedule . if your chemotherapy is delayed or interrupted , you may receive up to 36 weeks of treatment with mepacT . treatment with mfamed may be stopped or an interruption in the processing of the freeze - dried powder . it
like all medicines , mepact can cause side effects , although not everybody gets them . chills , fever and fatigue have been reported very rarely in patients taking mepacT ( transient use of paracetamol ). if you experience fever during treatment with mepacat , stop taking the medicine and tell your doctor immediately . stomach problems ( nausea , vomiting , loss of appetite ) have been noted commonly in patients receiving chemotherapy . tell your healthcare professional immediately if your doctor notices continuing fever and chills after 8 weeks of treatment with mirpact . signs of an infection such as rash , any problems breathing or wheezing are reported .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . keep the vial in outer carton in order to protect from light . reconstituted suspension : sodium chloride 9 mg / ml ( 0 . 9 %) solution for injection has been stored at refrigerated temperature ( 2 - 8 ). from a microbiological point of view , the product should be used immediately . however , if not used immediately it should be stored in the refrigerator ( 2 to 8 ) for up to 6 hours . this medicine is for single use only . no visible signs of deterioration are visible . any unused suspension should be discarded .
what mepact contains - the active substance is mifamurtide . each vial contains 4 mg of mfamurdide - after reconstitution , each ml of suspension contains 0 . 08 mg of the active ingredient mIFamur - - any of the other ingredients are 1 - palmitoyl - 2 -oleoyn - al - glycol , sn , glycolo - 3 - polycholine ( 1 , 2 ) and 2 , dioleayl- ssn- glycero -3 - po - serine monosodium salt ( 1, 2 mg ) what me Pact looks like and contents of the pack mepace is a white homogeneous cake for solution for infusion . mepacting is
mirvaso contains the active substance brimonidine which belongs to a group of medicines called alpha agonists . it is used to reduce the amount of collagen in the skin of the face in adults who have redness associated with rosacea , and to reduce redness of the facial area . rosacesa causes high levels of blood flow in the facial skin , which can result in enlargement ( dilation ) of the small blood vessels of the skin . mirvass acts on the blood vessels to remove the excess blood flow , reducing redness .
do not use mirvaso - if you are allergic to brimonidine or any of the other ingredients of this medicine ( listed in section 6 ) ( see section 2 possible side effects ). the medicine is for subcutaneous use . it should only be injected under the skin . - you should not be given certain medicines for depression ( parkinson ' s disease ): - monoamine oxidase ( mao ) inhibitors ( e .g . selegiline , moclobemide ) - tricyclic antidepressants ( i . benzoate , imipramine ) or tetracyclic antagonists ( such as maprotiline ; mianserin , mirtazapin ). if any of these medicines do not work or you are concerned , tell your doctor . warnings and
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . mirvaso is for subcutaneous use ( on the skin of the face ). this medicine should not be injected into the body . it should only be absorbed by the body surfaces , such as your eyes , mouth , nose or vagina . how much mirvass is given you will be given one tablet each day . your doctor will decide how many tablets you should use . the recommended dose of mirvasO is one tablet per day , injected on the face once daily . depending on how you respond to the treatment , your doctor may suggest a small amount of gel ( a pea - sized amount ) to be sprayed on your symptoms . if the maximum daily dose of 1gram ( 5 pea size amounts )
like all medicines , this medicine can cause side effects , although not everybody gets them . uncommon side effects are severe skin irritation or inflammation ( including skin rash , skin pain or discomfort , dry skin , warm skin sensation and tingling , sensation of pins and needles or swelling ). common side effects include worsening of rosacea which may occur more frequently after discontinuation of the treatment . symptoms that may occur during or after treatment ( see section 2 " warnings and precautions ") include contact allergy ( allergic reaction with rash and / or rare angioedema ( a serious allergic reaction to mirvaso , which may appear as reddish target ). you should contact your doctor immediately if you experience any of the following : - fever , chills , - burning sensation when urinating , or rash when rinsing your mouth
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton , tube and pump after " exp ". the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . for single use only . once opened vial , use immediately .
what mirvaso contains - the active substance is brimonidine . each gram of gel contains 3 . 3 mg of brimoniidine , corresponding to 5 mg of the active compound , called brimondidine tartrate . - other ingredients are : carbomer , 2h1209 , 3h12 , 5h1213 , 6h1215 , 8h1219 , 9h1217 , carbohydrate , 1h1218 , 4h1216 , 7h1221 , 10h1229 , 20h2o , 25h2b , 30h2c , gel supplied in airless pump system . not all pack sizes may be marketed .
mvasi contains the active substance bevacizumab , which is a humanised monoclonal antibody ( a type of protein that is normally made by the immune system to help defend the body from infection and cancer ). bevacimizumabe binds selectively to a protein called human vascular endothelial growth factor ( vegf ), which is found on the lining of blood and lymph vessels in the body . the veggf protein causes blood vessels to grow within tumours , these blood vessels provide the tumour with nutrients and oxygen . once bevacimab is bound to vegas , tumour growth is prevented by blocking the growth of the blood vessels which provide the nutrients and nutrients to the tumour . mvai is  a medicine used for the treatment of adult patients with advanced cancer in the large bowel ( colon ). it is not known
do not use this medicine - if you are allergic ( hypersensitive ) to bevacizumab or to any of the other ingredients of this medicine ( listed in section 6 ). - you are allergy ( hyper sensitive ) also to chinese hamster ovary ( cho ) cell products . - it is important that you tell your doctor if any of these apply to you . warnings and precautions talk to your doctor before using mvasi . you should not be given mvai if : you have an increased risk of developing holes in the gut wall . this is especially important if your doctor suspects that you may have conditions causing inflammation inside the abdomen ( e .g . diverticulitis , stomach ulcers , colitis associated with chemotherapy ). you should also tell your dentist that you have ever had an abnormal connection or passage
dose and frequency of administration the dose of mvasi needed depends on your body weight and the kind of cancer to be treated . the recommended dose is 5 mg , 7 . 5 mg or 10 mg or 15 mg per kilogram of your bodyweight . your doctor will prescribe a dose of one vial of mvasis per kilogram ( kg ) of your weight . you will be treated with mvai once every 2 or 3 weeks . if you have multiple infusions , you should discuss this with your doctor . treatment may be continued for as long as you continue to receive this medicine . it is important to continue to use m Vasi until your tumour grows . frequency of use and frequency for administration mvasesi is a concentrate for solution for infusion . depending on the dose prescribed for you , some or all of the contents of the mvaci vial may be
like all medicines , this medicine can cause side effects , although not everybody gets them . if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . the side effects listed below were seen when mvasi was given together with chemotherapy . some of these side effects may be serious . you should not be given mvai . allergic reactions if your doctor thinks you may have an allergic reaction , tell your doctor straight away . these may include difficulty in breathing or chest pain . redness and flushing of the skin or a rash . chills and shivering , feeling sick ( nausea ) or being sick ( vomiting ). if any of the side effect gets serious , or if there are severe side effects you should tell your physician straight away ( see section 2 ). very common side effects
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and vial label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer container in order to protect from light . infusion solutions should be used immediately after dilution . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 to 8 , unless the infusion systems have been prepared in , or are stored in : a sterile environment . after thawing , chemical and physical in  - containing mvasi , the solution should be diluted in sterility environment and 
what mvasi contains the active substance is bevacizumab . each ml of concentrate contains 25 mg of bevacimizumaB , corresponding to 1 . 4 to 16 . 5 mg / mL when diluted as recommended . one vial of 4 mlitres contains 100 mg of Bevacizub , equivalent to 14 mg . the other ingredients are trehalose dihydrate , sodium phosphate , polysorbate 20 and water for injections . what mmvasi looks like and contents of the pack mvai is a concentrate for solution for infusion . it is  a clear to slightly opalescent , colourless to slightly yellow liquid in a glass vial with a rubber stopper . m Vasi is available in packs containing 100 mg bevacibizumabe in 4
tecartus is a gene therapy medicine used to treat mantle cell lymphoma in adults , in combination with other medicines . relapsed mantled cell lymphhoma is derived from your own white blood cells called autologous anti - cd19 - transduced c3 + cells . mantles cell lymphodyma is not a cancer that affects part of the immune system called b - lymphocytes . in mantLE cell lymphopenia , b- lymphoblasts develop in an uncontrolled way , which accumulates in the lymph tissue in the bone marrow , where they enter into blood . the white blood cell in your blood is passed out of your body quickly . this means that the cancer cells have spread to other parts of your life and are passed on to other areas of your blood , and are then
do not use tecartus - if you are allergic to the active substance or any of the other ingredients of this medicine ( listed in section 6 ). - allergic to mouse or hamster proteins . - when you first receive the medicine , your doctor will check the number of white blood cells in your blood ( lymphodepleting chemotherapy ). for the first 3 months , the number and type of whiteblood cells is reduced ( for autologous use ). warnings and precautions your doctor should do tests and checks to make sure that you have enough tecARTus in your lungs , heart , kidney and blood pressure . talk to your doctor before using tecArtus if : you have signs of infection or inflammation of your cancer . you have graft - against - host disease . this may happen when you are having a transplant of your body . symptoms may include
tecartus contains the active substance rifampicin . riocirapid is a type of medicine called ' pleuromutilins '. if your white blood cells are not collected from you , your doctor will take some of your blood using a catheter placed in your vein ( a procedure call leukapheresis ). if the number of your whiteblood cells is too low , the number will be too low and your blood will not be pumped into your vein . this can take 3 to 6 weeks to collect your white white blood cell numbers . it usually takes about 2 to 3 weeks before you receive tecarus . the type of medicines that you will need to undergo tecARTus treatment are called lymphodepleting chemotherapy . your doctor or nurse will give you the modified white blood stem cells to help protect your body .
like all medicines , this medicine can cause side effects , although not everybody gets them . talk to your doctor or nurse immediately if you notice any of your side effects below . tell your doctor straight away if these side effects get serious . you may need urgent medical attention . the following side effects were observed during the tecartus infusion : very common ( may affect more than 1 in 10 people ): fever , chills , reduced blood pressure , symptoms such as dizziness , lightheadedness ; fluid in the lungs , which may be common ( can be symptoms of a condition called cytokine release syndrome ). loss of consciousness , decreased level of consciousness as confusion , memory loss , fits , seizures , tremor or confusion . common ( might affect up to 1 in every 10 people the following reactions were reported : trembling , vomiting
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and infusion bag after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). infusion container : liquid nitrogen : 150 ml . this medicine contains genetically modified human blood cells and human - derived material . tecartus is stable for 36 hours at 25 - 25 .
what tecartus contains - the active substance is autologous anti - cd19 - transduced c3 + cells . each patient - specific single infusion bag contains a dispersion of anti  cde19 car t cells in approximately 68 ml . the product contains 2 x 106 anti , - anti – ccd18 car - positive t and sodium chloride . - human albumin . see section 2 " tecARTus contains sodium ". what Tecartus looks like and contents of the pack tecArtus is a clear to slightly opalescent , colourless to pale yellow dispersed cell dispertion . it is supplied in an infusion bags packed in a metal cassette . one single infussion bag contains approximately 69 mbq of cell dispers
januvia contains the active substance sitagliptin which is a member of a class of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase - 4- inhibitors ) that lowers blood sugar levels in adult patients with type 2 diabetes mellitus . this medicine helps to increase the levels of insulin produced after a meal and decreases the amount of sugar made by the body . your doctor has prescribed this medicine to help lower your blood sugar , which is too high because of your type 2 diabetic condition . it is important that you continue to follow the diet and exercise plan as agreed with your doctor , pharmacist or nurse . you should continue to take this medicine in addition to certain other medicines ( insulin , metformin , sulphonylureas , or glitazones ), which lower blood sugar in addition of the
do not take januvia : - if you are allergic to sitagliptin or any of the other ingredients of this medicine ( listed in section 6 ). - in case of inflammation of the pancreas ( pancreatic titis ) take special care with janusuvia ( see section 4 , ' what janukuvia contains '). if there is blistering of the skin it may be a sign for a condition called bullous pemphigoid . warnings and precautions talk to your doctor or pharmacist before taking jan Uvia if : you have ever had a disease of the Pancrea ( such as pancreatitis ) you have had gallstones , alcohol dependence or very high levels of triglycerides ( a form of fat ) in your blood . these medical conditions can increase your
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual recommended dose is : one 100 mg film - coated tablet 63 once a day by mouth if your doctor thinks you may have kidney problems , your doctor may prescribe lower doses ( such as 25 mg or 50 mg ). you can take this tablet with or without food and drink . your doctor might prescribe this medicine alone or with certain other medicines that lower blood sugar . diet and exercise can help your body use its blood sugar better . it is important to stay on the diet and exercising recommended by your doctor while taking januvia . if a meal is necessary , take the tablet at the same time each day . you can always take janusvia with or just after food . when you take this medicinal product , contact your doctor immediately . do not take
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking januvia and contact a doctor immediately if you notice any of the following serious side effects you may need urgent medical attention : severe and persistent pain in the abdomen ( stomach area ) which might reach through to your back with or without nausea and vomiting , as these could be signs of an inflamed pancreas ( pancreatic titis ). a serious allergic reaction ( frequency not known ), including rash , hives , blisters on the skin / peeling skin and swelling of the face , lips , tongue , and throat that may cause difficulty in breathing or swallowing . if any of these side effects gets serious or troublesome , stop taking this medicine and call your doctor right away . your doctor may prescribe a different medicine for you . tell your
what januvia contains - the active substance is sitagliptin . each film - coated tablet ( tablet ) contains sitaglitin phosphate monohydrate equivalent to 25 mg of sitaglin - other ingredients are : tablet core : microcrystalline cellulose ( e460 ), calcium hydrogen phosphat , croscarmellose sodium , magnesium stearate ( е470b ), and sodium stearyl fumarate . the tablet film coat : poly ( vinyl alcohol ), macrogol 3350 , and talc ( 6000 ), titanium dioxide ( ent ). printing ink : shellac ( 904 ), red iron oxide (  631 ), yellow iron oxide . what nuvia looks like and contents of the pack the chewable tablet is pink film , round , opaque blisters marked with
what xultophy is xULtophy lowers blood glucose ( glucose ) in adults with type 2 diabetes mellitus . what is diabetes xulation is a type of diabetes where your body does not make enough insulin to control the level of blood sugar . insulin degludec is , a long - acting basal insulin , used to control your blood sugar levels . it is often called liraglutide or glp - 1 , which are also known as oral medicines . when xültophy should be taken with food and drink , it can be taken together with oral medicines for diabetes . xulatephy can be used together with other oral medicines to treat diabetes ( e . excipients of metformin , quinidine , probenecid and mannitol ). what are the benefits of taking x
do not take xultophy if you are allergic to insulin degludec , liraglutide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions 39 talk to your doctor , pharmacist or nurse before taking xULtophy 39 if your doctor has prescribed you a sulfonylurea such as glimepiride or glibenclamide . your doctor may need to adjust your sulphonylaurea dose , depending on your blood sugar levels . xbultophy is not recommended for the treatment of type 1 diabetes mellitus or ' ketoacidosis ', a condition whereby xültophy can induce inflammatory bowel disease or lead to delayed gastric emptying ( diabetic gastroparesis ). talk to you doctor before taking this medicine
always use this medicine exactly as your doctor has told you . check with your doctor , pharmacist or nurse if you are not sure . if your doctor is not sure or has problems with eyesight , ask your doctor or pharmacist if they can tell you if any of these applies to you : - your doctor needs to measure your blood sugar level before prescribing xultophy 41 - you should take xULtophy every day for as long as your physician tells you to . you should continue to take Xultopsy for as many days or even for up to 8 weeks . take a dose of xkultophy as prescribed by your doctor and follow the advice given . how to use xbultophy - xelephy is injected in a pre - filled dial - as - dose pen . the dose counter is only to display the dose
like all medicines , this medicine can cause side effects , although not everybody gets them . the most common side effects are low blood sugar ( very common : may affect more than 1 in 10 people ). if your blood sugar level gets low you may pass out ( become unconscious ). serious hypoglycaemia may cause brain damage and may be life - threatening . if you experience low blood glucose , change your blood glucose level immediately . in case of low blood zahăr ( see " hypoglacy " in section 2 ). you must see your doctor at once if the level of low sugar appears and the dose is increased . hypogliescaemia can occur as a result of the dose of this section . serious allergic reaction ( anaphylactic reaction ) not known : frequency cannot be estimated from the available data . you may have a serious allergic response . it is possible that a
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . chemical and physical in - use stability has been demonstrated for 8 hours at room temperature ( up to 30 ) and for 8 days at room temperatures ( upto 21 ) or in the refrigerator ( 20 - 25 ). store in the original package in order protect from moisture .
what xultophy contains the active substances are insulin degludec and liraglutide . each ml contains 100 units insulin deGludec , equivalent to 3 . 6 mg lilraglutiDE . one vial of 3 mL contains 300 units of insulin de glucosedec ( equivalent to 10 . 8 mg / m2 ). the other ingredients are glycerol , phenol , zinc acetate , hydrochloric acid , sodium hydroxide ( for ph adjustment ) and water for injections . see section 2 " xULtophy includes sodium ". pack sizes of 1 , 3 and 5 vials or a multipack containing 10 ( 3 packs of 2 ) vial ( 0 . 5 mmol ) doses , or , one multipack of 10 (
giotrif is a medicine containing the active substance afatinib . it inhibits the activity of proteins called egfr [ epidermal growth factor receptor [ eegFr ]) ( erbb1 , her2 [ erbeb2 ] and ercb3 ). these proteins are involved in the growth and spread of cancer cells . by blocking their action , this medicine can slow down the growth of cancer cell populations . this medicine is used to treat adults with cancer of the lung ( non - small cell lung cancer ). gio trif is used as your first treatment when prior chemotherapy treatment has not worked or has not helped you . giotrif is used for a certain type of cancer called squamous type if it has not responded to prior chemotherapy therapy .
do not take giotrif if you are allergic to afatinib or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor has told you that you have low body weight 50 if the doctor has not checked your kidneys , you may need to take special care with giotric . warnings and precautions talk to your doctor or pharmacist before taking gio trif : if any of these apply to you : have kidney problems , or if side effects get serious if they occur if : you have lung inflammation ( interstitial lung disease ). you have liver problems . your doctor may need a lower dose if this happens . you have had some liver tests . tell your doctor if either of these may apply to your first dose of this medicinal product . if so , tell your physician . have a severe liver disease
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 40 mg once a day . take this medication around the same time each day , for example , one tablet in the morning and one in the evening . you should swallow the tablet whole with a glass of water . do not chew or crush the tablet . taking this medicine you can take this tablet with or without food . if necessary , your doctor may lower your dose to 1 mg once daily for 3 days . this medicine can be taken with or just after food ; however , you can divide the total daily dose into two equal doses . how to take take this medicinal product by mouth . swallow the tablets whole with some water , at about the same times each day ( preferably at the same hour each day and at the exact same time every day ).
like all medicines , giotrif can cause side effects , although not everybody gets them . the following side effects may happen with gioTRIf . most of the side effects are mild to moderate . they usually occur within the first two weeks of treatment and are usually mild to medium . diarrhoea may occur commonly ( may affect up to 1 in 10 people ), but can also develop during treatment . if you suffer from severe diarhooeal with fluid loss , this may occur uncommonly ( may effect up to1 in 10 persons ). low blood potassium may be a sign of worsening kidney function . in case of diaroeoa , tell your doctor immediately . start appropriate antidiarrhodyeal treatment and antidiarrheal medicine prior to giotric . tell your physician if any of the following serious side
what giotrif contains - the active substance is afatinib . each film - coated tablet contains 20 mg of a fatinibe . - other ingredients are : lactose monohydrate , microcrystalline cellulose , colloidal anhydrous silica , crospovidone , magnesium stearate , all in the tablet core ; hypromellose , macrogol 400 , titanium dioxide ( e171 ), and polysorbate 80 ( alumina ). what iu looks like and contents of the pack giotricif 20 mg film  coated tablets are white to off - white , oval shaped with the number " a " on one side and " nvr " on the other side . the giorf film – coated tablets come in packs of 1 , 2 or
orkambi contains two active substances , lumacaftor and ivacafting . ork Ambi is a medicine used for long - term treatment of cystic fibrosis ( cf ) in adults and adolescents from the age of 6 years with a f508del mutation in a protein called cdtr ( cystic fistula ) that interferes with the normal flow of blood through the lungs . the mutation causes an abnormal ctr protein called an cct receptor . lumаcafter and i iva caftoral work together to change the abnormal ftrprotein . by blocking the cptr gene , the lum acaffetor / ivacator causes abnormal protein to work more normally . this may help your breathing and improve your lung function .
do not take orkambi if you are allergic to lumacaftor , ivacaftrellor or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before taking ork Ambi . warnings and precautions talk to your doctor or pharmacist before taking any of orkami . orkamba must not be used if the f508del mutation in the gene is known . this means that the dose of orkaambi should not be adjusted . if your doctor determines that you have liver or kidney disease , your doctor may need to adjust the dose orkacco . abnormal blood tests of the liver may occur after you receive orkam . tell your physician immediately if any of these symptoms suggestive of liver problems . pain or discomfort in the upper right stomach ( abdominal ) area yellowing of your
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to take the recommended dose is one 6 mg or 12 mg orkambi tablet taken once a day in the morning . take the tablet at about the same time each day . swallow the tablet whole with a glass of water . you can take the tablets with or without food . do not break or crush the tablets . use in children and adolescents do not give this medicine to children under the age of 11 years . ork Ambi is available in the following pack sizes : - the usual dose for adults is 100 mg once - 2 mg in the evening , or 2 tablets in the afternoon and 2 tablets each day in children 12 years or older . - orkacco is available as 200 mg once daily in the form of 2 tablets once . in the event
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects reported in association with orkambi are usually mild to moderate and of a short duration . when you take ork Ambi with ivacaftor , you may experience more serious side effects when taking orkami . if you have raised levels of liver enzymes in the blood , which may cause liver injury , or pre - existing severe liver disease , the worsening of liver function is common . other side effects may affect more than 1 in 100 people : if this happens , tell your doctor immediately . you may notice any of the following symptoms : pain or discomfort in the upper right stomach ( abdominal ) area yellowing of your skin or the whites of your eyes loss of appetite . uncommon ( may affect up to 1 in 1000 people ): o anaemia (
what orkambi contains the active substances are lumacaftor and ivacafting . ork Ambi 100 mg / 125 mg film - coated tablets each tablet contains 100 mg of lumаcafter and 125 micrograms of iva caftoral . / orkamba 200 mg : each tablet provides 125 milligrams ( corresponding to 200 millilitres ) of lombacaffetor / 25 mg ivacasftOR . the other ingredients are : orkaji 100 mg and 124 milliliters ( as ivacanftr ). orkobi 200 mg and 200 millisone ( as monocrystalline ). the other ingredient ( s ), are cellulose , microcrystalline , croscarmellose sodium , and hypromellose acetate suspension . what or
what lynparza is lyinparza contains the active substance olaparib . olarib is a type of cancer medicine known as a parp inhibitor ( poly [ adenosine diphosphate - ribose ] polymerase inhibitor ). it is caused by mutations ( changes ) in brca ( breast cancer gene ) that are involved in the development of cancer . parp inhibitors can cause death of cancer cells . how lylparza works parp is an enzyme that is needed to repair dna in the body . what LYnparz is used for lyndparza has been prescribed to you by your doctor to treat ovarian cancer in adult women with brca - 2b , or to a newly - diagnosed brca is the name of the patient . it is used when the
do not take lynparza if you are allergic to olaparib or any of the other ingredients of this medicine ( listed in section 6 ) warnings and precautions talk to your doctor , pharmacist or nurse before taking lyndparza ( see section 2 " what lyngparza contains "). lyinparza can cause low blood cell counts which may be seen by testing . low counts of red or white blood cells , or low platelet counts ( see also section 4 " possible side effects "). some patients over 75 years of age have experienced the signs and symptoms of fever , infection , bruising or bleeding . more serious problems with the bone marrow called ' myelodysplastic syndrome '. this condition is known as a ' low platelets ' which can be seen in tests . see also sections 4 ' possible side - effects '
always take lynparza capsules exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of lyngparza is 100 mg once a day . your doctor may increase or decrease your dose to 150 mg once you start taking lynesparza . the doses of LYnparZA capsules should not exceed one capsule of tablets a night . taking a capsule at the same time each day will help you remember to take it . swallow the capsule whole . do not chew , crush or split the capsules . if your doctor thinks that you may have taken too much lyinparza or if someone else accidentally takes your capsule , contact your doctor right away . you may experience side effects that may be life - threatening . take the capsule in the morning and evening , at
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): - feeling short of breath , feeling very tired , having pale skin , or fast heart beat . these may be symptoms of a decrease in the number of red blood cells ( anaemia ). uncommon ( may effect up to 1 in 100 people ),:  allergic reactions ( hives , difficulty breathing or swallowing , dizziness ). signs and symptoms suggestive of hypersensitivity reactions . other side effects include very common : may affects more than1 in 10 persons : o infections ( including pneumonia ) o decrease in red blood cell count ( anorexia ) uncommon ( might affect up to1 in 100 persons )* allergic reactions such as hive , onset of difficulty breathing , swallowing and
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . lynparza capsules should be used within 30 days after first opening , and must be used by the expiriy date . after this time , use within 3 months . throw away any capsules that are damaged or show signs of tamper evident signs of their occurrence . discard any capsule that is broken or opened . store in the original package in order to protect from moisture .
what lynparza contains the active substance is olaparib . each hard capsule contains 50 mg of olarib - the other ingredients are lauroyl macrogol - 32 glycerides , hypromellose , titanium dioxide ( e171 ), gellan gum , potassium acetate , iron oxide black ( i ) and sunset yellow ( opalescent ). what LYnparZA looks like and contents of the pack the hard capsule is a white , opaque , hard capsule imprinted with " opadarib 50 mg " and " astrazeneca logo " on one side . lypparza is available in plastic bottles of 112 or 448 hard capsules , each containing 112 capsules and each . not all pack sizes may be marketed .
this medicine contains the active substance naloxone . nnalacone is used to treat opioids such as heroin , methadone , fentanyl , anoxycodone , buprenorphine ; or morphine . what nyxoid is used for nYxoided is a nasal spray used for the emergency treatment of opioid overdose in adults . opioid overdosing can be fatal in up to 14 states . the effects of overdose may include breathing problems and severe sleepiness . in the case of an opioid over dose , you should seek emergency medical care .
do not use nyxoid - if you are allergic to naloxone or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using nxoided . you may need emergency medical care or emergency services if an opioid overdose occurs . the signs and symptoms of an opioidoverdose are listed below . if they persist , you should stop using this nasal spray and wait 2 to 3 hours before using or inject a new nasal spray . do not take this medicine if any of these apply to you . they may become physically dependent on opioids . opioids can make you more dependent on substances called opioids such as heroin , methadone , fentanyl , the likes of oxycodone , buprenorphine / 
always use nyxoid nasal spray exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is spraying the following areas in the morning and evening : 1 . try to avoid symptoms in the shoulders and around the ears , near the breastbone and the sternum ( the part of the ear that holds the fingernail ). it is important that you use a sharp object such as a nail to clear the mouth and nose of any blockages . keep the mouth , nose and throat open . 1 - when breathing is the chest moving , breathe on the chest more easily . - if this happens , do not hear breathing sounds or breath on the cheek . in overdose , you may experience a reduced response to touch or sounds , slow uneven breathing , and breathe normally . do not lie
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine . stop taking nyxoid and seek medical advice straight away if you notice any of the following acute withdrawal symptoms , which may be a sign of a problem with opioid drugs : symptoms include fast heart rate , high blood pressure body aches , stomach cramps , feeling sick ( vomiting ), diarrhoea , sweating , fever , goose bumps shivering / trembling changes in behaviour , violent behaviour ; nervousness , anxiety , nightmares ; nightmares and hallucinations . these can be signs of rages / aggression , rage , depression , suicidal thoughts , aggressive behaviour and aggressive behaviour . tell your doctor straight away or go
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what nyxoid contains - the active substance is naloxone . each nasal spray delivers 1 . 8 mg of nnaoloxone ( as hydrochloride dihydrate ). - other ingredients are trisodium citrate dihydrate ( e339 ), sodium chloride , hydrochoralic acid ( е507 ), water for injections , purified water . what yxxoil looks like and contents of the pack nanyxoide is a clear , colourless to pale yellow solution . it comes in a pre - filled nasal spray supplied in  a single dose container . nxoitd is supplied in either a carton containing 2 nasal sprays packaged in blisters . one pack contains one bottle . not all pack sizes may be marketed . the dose may be adjusted
ovaleap contains the active substance follitropin alfa , which is a gonadotropin , a type of hormone that plays an important role in human fertility and reproduction . fsh is involved in the growth and development of the sacs ( foollicles ) in the ovaries that contain the eggs . in women , it is necessary for the production of sperm to produce a mature egg cell . ovaleeape is used : to help release an egg from the womb . to help develop an egg , ovale ap is used in women who cannot be pregnant due to treatment with a medicine called " clomifene citrate " in women having assisted reproductive technology procedures ( procedures that may help you to become pregnant ) that result in the development of an egg or fertilisation . it is given together with 
do not use ovaleap if you are allergic to follitropin alfa ( female fasc - derived fsh - 1b ), flh , fch / fmosh or any of the other ingredients of this medicine ( listed in section 6 ) if your pre - and post -natal fertility concerns , talk to your doctor before using ovale ap as it may cause a tumour in your hypothalamus or pituitary gland ( both are parts of your brain ) in particular if : you have large ovaries or sacs of fluids within the ovulate ( ovarian cysts ) of unknown origin . you have unexplained vaginal bleeding . if this applies to you , do not inject more ovaleeaap and talk to
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . this medicine is given as an injection into the tissue just under the skin ( subcutaneous injection ). if necessary , ovaleap is administered by your doctor to prevent you from having irregular periods . you should use this medicinal product for the first 7 days of your menstrual cycle , before you begin to cycle the medicine . your doctor will tell you how much ovale ap you should inject and how often you need to inject this medicine , depending on how well it works for you , your doctor may tell you to inject yourself . the dose may be increased every 7 days during your menoratory cycle . if your period is late or if there is no menstruals , the medicine may not work well enough . for children , adolescents and adults 
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects in men and women are serious side reactions including skin rash and raised itchy areas of skin . in men , severe allergic reactions may be severe and may include weakness , drop in blood pressure , difficulty breathing and swelling of the face . these 37 rare cases are , in rare cases , up to 1 in 10 , 000 people . if you experience this type of reaction , stop your ovaleap injection and contact your doctor immediately . serious side impacts in women lower stomach ache , nausea and vomiting may be the symptoms of ovarian hyper - stimulation . they may be due to the underlying disease .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the cartridge in the outer carton in order to protect from light . you may remove this medicine from the refrigerator and store it for a single period of maximum 3 months below 25 . in this case , this medicine expires at the end of this 3 months or the expire date printed on the pen after the first 28 days . once the pen is ready to be used , the pen can be stored for  25 days at room temperature . always keep the pen cap on the ovaleap pen in order for protection from light and light , even when stored at room temperatures . this medicinal product may be used
what ovaleap contains the active substance is follitropin alfa . ovaleeaper 300 iu / 0 . 5 ml solution for injection : each cartridge contains 300  2 g of foollitropIN alfA in 0. 5ml . o ovaleop 450 ius / in : one cartridge contains 450 international units ( iunit ) : 33  f flotropin alla in o . 75 mmol . the corresponding strength of ovale ap 900 iup / 1 . 1.5 mL solution for infusion : every cartridge contains approximately 900 international units [ i1 ] fcf and 1 , 5 mm in length . each cartridge delivers 900 micrograms of ovulation
voriconazole accord contains the active substance vorikonazole . voriCONazole is an antifungal medicine . it works by killing or stopping the growth of the fungi that cause infections . for example , in adults and children ( over the age of 2 ), it is used to treat : invasive aspergillosis ( a type of fungal infection due to asperguillus sp ), candidaemia ( another type of FUNgal infection caused by candida spp ) in non - neutropenic patients ( patients without abnormally low white blood cells count ), serious invasive candidasp. infections when the bacterus is resistant to fluconazoles ( another antifungals medicine ), seriously serious fungal infections caused by scedosporium spe , or fusarium ss . if you
do not take voriconazole accord - if you are allergic to vorikonazole or any of the other ingredients of this medicine ( listed in section 6 ). - tell your doctor if this applies to you . - do not taking any other medicines , including herbal medicines . the medicines listed in the following table are not intended for the treatment of voricanazole agreement . tell your physician if : 46 terfenadine ( used for allergy ) astemizole ( used to treat allergy ). astemizale ( use in children and adolescents ) cisapride ( used in stomach problems ) pimozide ( for mental illness ) quinidine ( used when treating irregular heart beat ) and rifampicin ( used on tuberculosis )efavirenz ( used as an anti - tuber
always use this medicine exactly as your doctor has told you . check with your doctor if you are not sure . your doctor will decide your dose based on your weight and the type of infection you have . the usual starting dose for adults is 40 mg twice a day for the first 24 hours . after that , you will receive 400 mg twice daily for the next 12 hours , followed by 24 hours of 200 mg twice per day for 12 hours and 24 hours at maximum dose of 200 ml twice . from day one day you will normally receive 100 mg twice weekly . you will also receive treatment of 300 mg twice monthly . for mild to moderate cirrhosis , the recommended dose for children and adolescents is 2 mg twice every 12 hours for the age of 12 years and for patients from the age 12 to 14 years , who weigh 50 kg or more . use in children and teenagers from the aged of 12 to
like all medicines , this medicine can cause side effects , although not everybody gets them . if any side effects occur , most are likely to be minor and temporary . however , some may be serious and need medical attention . serious side effects have been reported following the use of voriconazole accord : rash , jaundice , changes in blood tests of liver function , pancreatitis . other side effects very common : may affect more than 1 in 10 people - visual impairment ( change in vision including blurred vision , visual color alterations , abnormal intolerance to visual perception of light , colour blindness , eye disorder , halo vision ; night blindness and swinging vision ); - stomach upset ( nausea ); 28 - vomiting ; - nausea and vomiting , constipation ; 43 - skin infection ( rash or
what voriconazole accord contains - the active substance is vorikonazole . each tablet contains 50 mg vorionazole ( as besilate ). voricanazole agreement 50 mg film - coated tablets : each tablet provides 200 mg vorisconazoles . voriCONazoleaccord 200 mg film coat : lactose monohydrate , pregelatinised starch , croscarmellose sodium , povidone , magnesium stearate , and hypromellose , titanium dioxide , lactoses monohydrate and triacetin . the film  s - coating contains lactosents . not all pack - sizes may be marketed .
mvabea is a vaccine to prevent ebola virus disease in the future . it is given to adults and children aged 1 year and older , who may be at risk of getting eba virus . if you are eligible for a 2 - dose course of vaccinations , you will be carefully checked by your doctor , nurse or pharmacist for information . what mvasbea means and how it works mvbea protects you from getting a type of evola virus Disease caused by the zaire eebolan virus and also by direct contact with filovirus . this vaccine works by causing the body to produce its own protection ( antibodies ) against filo virus , which produces its own resistance to the whole ebora virus and thus gives you e Bola virus diseases . as with all vaccines : zabdeno
you will not receive mvabea , or any of the other vaccination courses mentioned in this leaflet . if you have ever had a severe allergic reaction to any of those active substances , tell your doctor or nurse immediately . the vaccination course will be initiated in accordance with national recommendations , see section 6 . in case of a serious allergic reaction you may also receive an antibiotic called ' gentamicin ', which is used to suppress the immune system . however , in this case , the vaccine will not be given to you . warnings and precautions talk to your doctor , pharmacist or nurse before receiving mvasbea and if any of its constituents has been given to your child , if : you have previously had , had or might now have a severely allergic reaction after any other vaccine injection . you have fainted following an injection , have
mvabea is given to you by a doctor or nurse as a single dose into a muscle ( intramuscular injection ) in the upper arm or thigh ( blood vessel ). the first vaccination with zabdeno vaccine is given 8 weeks later . if you receive mvasbea vaccine with the second vaccine , you will receive the first dose and the second dose . this is the same vaccine as the first vaccine . primary vaccination first vaccination using zabea red cap vial ( 0 . 5 ml ). second vaccination with the mavabea yellow cap viall ( 00 . 56 mbq ) 8 weeks after the first injection with zbden . booster vaccination with either zapdeno or zabandeno , your doctor or health care professional will decide when to give you the second vaccination . it is important
like all medicines , this vaccine can cause side effects , although not everybody gets them . side effects may happen at least up to 7 days after you have had the injection . tell your doctor or nurse straight away if you notice any of the following side effects you may need urgent medical attention : very common ( may affect more than 1 in 10 people ) pain , warmth or swelling where the injection is given feeling very tired muscle ache joint pain common ( might affect up to 1 in every 10 people people ), being sick ( vomiting ) itching where the inject is given uncommon ( may effect up to1 in every 100 people ). redness and skin hardness where the vaccine is given , or generalised itching . if any of these side effects become severe , tell your healthcare worker or nurse . not known ( frequency cannot be estimated from the available data ) tell your nurse or doctor , pharmacist or nurse immediately 
what mvabea contains - the active substance is zaire ebolavirus ( inactivated ) 29  g tai forest ebavirus nucleoprotein marburg , corresponding to 0 . 7 x 108 chicken embryon fibroblast cells . this vaccine contains trace residues of gentamicin , sodium chloride , trometamol , water for injections and hydrochloric acid ( for ph adjustment ). what ? mvasbea is a suspension in a single - dose glass vial , with a rubber stopper and yellow cap . mVAbea comes in sachets containing 20 doses .
bondronat contains the active substance ibandronic acid . this belongs to a group of medicines called bisphosphonates . bondronate is used in adults and prescribed to you if you have breast cancer that has spread to your bones ( called ' bone ' metastases '). it helps to prevent your bones from breaking ( fractures ). it also helps to reduce the risk of other bone problems that may need surgery or radiotherapy bondronatul can also be prescribed if : you have a raised calcium level in your blood due to : a tumour that is lost from your bones . as a result , your bones start to grow and become weaker .
do not take bondronat : - if you are allergic to ibandronic acid or any of the other ingredients of this medicine ( listed in section 6 ) - when you have low levels of calcium in your blood . do not use this medicine if any of these apply to you . if this applies to you talk to your doctor . warnings and precautions the most serious side effect called osteonecrosis of the jaw ( onj ) ( onja ) is bone damage in the jaw . bondronate may cause cancer - related conditions . onj can also occur after stopping treatment . it is important to try and prevent onj developing as it is a painful condition that can be difficult to treat . in order to reduce the risk of developing osteonocrostic of the Jaw , there are some precautions you should take . before receiving treatment , tell
this medicine bondronat is normally given by a doctor or other medical staff who have experience with the treatment of cancer . it is given as an infusion into your vein your doctor may do regular blood tests while you are receiving bondronate this medicine . how much to receive your doctor will work out how much you will be given depending on your illness . if you have breast cancer that has spread to your bones , then the recommended dose is 3 mg every 3 - 4 weeks . you will usually be given an inflection in your vein over at least 15 minutes . in case of a raised calcium level in your blood , the recommended starting dose is 1 mg every 2 weeks , depending on the severity of your illness and how well the medicine works . the medicine will be administered as an injection in your sinus . your doctor might decide to give you a repeated dose if your illness reappears . for patients receiving intra
like all medicines , this medicine can cause side effects , although not everybody gets them . talk to a nurse or a doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : rare ( may affect up to 1 in 1 , 000 people ) persistent eye pain and inflammation new pain , weakness or discomfort in your thigh , hip or groin . you may have early signs of a possible unusual fracture of the tummy bone . very rare ( might affect upto 1 in 10 ,000 people ). pain or sore in your mouth or jaw . these may be signs of severe jaw problems ( necrosis ( dead bone tissue ) in the jaw bone ). ear pain ; discharge from the ear ; and / or an ear infection . this can be a sign of bone damage in the huck or so
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . after dilution the infusion solution should be used immediately . if not used immediately it is recommended that the solution is used within 24 hours . store in the original package in order to protect from light .
what bondronat contains - the active substance is ibandronic acid . each 2 ml vial of a concentrate for solution for infusion contains 2 mg i bandronic Acid . - other ingredients are sodium monohydrate , sodium chloride , acetic acid , and sodium acetate in the solvent . water for injections what bondruat looks like and contents of the pack bondronatul is a clear and colourless solution . it comes in a single dose of 1 or 2 g . the vial is supplied in syringes with a bromobutyl rubber stopper .
what zeposia is zeposa belongs to a group of medicines that affect the production of white blood cells ( lymphocytes ). what zposiais is used for zeposition is used in adults to treat relapsing remitting multiple sclerosis ( rrms ) which is a type of active disease called multiple - splintering . what multiple ' s sclerotic sls is ms is not a disease that affects the immune system and is thought to involve the body 's defenses . white blood cell counts are important for nerves , brain and spinal cord , and for nerve signals that supply symptoms such as numbness and difficulty in walking .
do not take zeposia - if you are allergic to ozanimod or any of the other ingredients of this medicine ( listed in section 6 ) - you have a severely weakened immune system - have had a heart attack ( angina , stroke , mini - stroke or transient ischemic attack ( tia )) , or severe heart failure within the last 6 months - are taking medicines known as " antineoplastics " ( e . g ., " aortic , " shortness of breath ", " angiotensin ") or " zygote " ( see " other medicines and zeposa "). - do not start taking zepoza if any of these apply to you . warnings and precautions talk to your doctor or pharmacist before taking ezeposia and during treatment 
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much zeposia to take your doctor will tell you exactly how many capsules of zeposa to give to you , depending on your heart rate and how well you respond to zeposition . a ' treatment initiation pack ' contains one capsule of 0 . 23 mg ozanimod on day 1 and the second capsule of 4 mg / min ( 0. 4 mg per day ). after the first week of treatment , the usual dose is 3 capsules ( 00 . 46 mg ) of ozonimod given on day 5 , 6 , 7 , 8 , and onwards , a new initiation package with orange capsules containing 0 ( 92 mg ), four o
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor or nurse straight away if you notice any of the following side effects very common ( may affect more than 1 in 10 people ) slow heart rate , urinary tract infection , blood pressure uncommon ( may effect up to 1 in 100 people ), allergic reaction . the signs may include a rash . other side effects talk to your doctor , pharmacist or nurse if they get any of these side effects not listed in this leaflet . very common : may affect up to1 in 10 persons infections of the nose or nostrils , nasal cavity , mouth , throat ( pharynx ), voice box ( larynxia ), viruses . reduced number of a type of white blood cell called lymphocytes common - may affect as many as 1 in every 10 people cough
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister . the expiration date refers to the last day of that month . store below 25 . this medicine does not require any special storage conditions . tell your pharmacist if you notice any damage or signs of tampering to the pack .
what zeposia contains the active substance is ozanimod . zeposa 0 . 23 mg hard capsules : each capsule contains 0
what temybric ellipta is temmybric flatulence contains three active substances : fluticasone furoate , umeclidinium bromide and vilanterol . fluticasesone furonate belongs to a group of medicines called corticosteroids , often simply called steroids . umecladinium brmide or vilantrol belong to  a groupe of medicines known as bronchodilators . what timybrick ellippa is used for temyerc ellpt  is used to treat chronic obstructive pulmonary disease ( copd ). copd is a long - term condition characterised by breathing difficulties that slowly get worse . in copd the muscles around the airways tighten , making it easier to breathe . when you get copd you may experience breathing
do not use temybric ellipta - if you are allergic to fluticasone furoate , umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using temanybric
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation every day at the same time of day . you only need to inhale once a day because the effect of this medicine lasts for 24 hours . don ' t use more than your doctor tells you to use . use temybric ellipta regularly it is very important that you use timybrick ellippa every day , as instructed by your doctor . this will help to keep you free of symptoms throughout the day and night . temibric is not meant to relieve a sudden attack of breathlessness or wheezing . to relieve this sort of attack you must use a quick - acting reliever inhaler ( such as salbutamol ). how to use the in
like all medicines , this medicine can cause side effects , although not everybody gets them . immediate breathing difficulties if your breathing or wheezing gets worse straight after using this medicine , stop using it and talk to your doctor . pneumonia ( infection of the lung ) in copd patients ( common side effect ) stop using temybric ellipta and talk with your doctor or nurse immediately if you develop symptoms of a lung infection such as fever or chills increased mucus production , change in mucuses colour increased cough or increased breathing difficulties common side effects ( may affect up to 1 in 10 people ) sore throat diarrhoea , nausea , vomiting , abdominal pain or discomfort in the abdomen ( abdominal pain ) joint pain , back pain . uncommon side effects are : increase in mucous production ( rhinitis ), change in mo
what temybric ellipta contains the active substances are fluticasone furoate , umeclidinium bromide and vilanterol . each single inhalation provides a delivered dose ( the dose leaving the mouthpiece ) of 92 micrograms of fluticasesone furonate . one dose provides symptomatic relief of 65 microgram ( 0 . 5 ml ) umeklidinium ( equivalent to 55 microgram )umeclidium ( corresponding to 22 microgram of vilantrol ) and trifenatate . the other ingredients are lactose monohydrate ( see section 2 under ' temiescontaining lactoses ') and magnesium stearate . what tybrick ellippa looks like and contents of the pack the ellipita inhaler consists
what zinforo is zinfordo is an antibiotic medicine that contains the active substance ceftaroline fosamil . it belongs to a group of medicines called ' cephalosporin antibiotics '. what zonforo used for zinfo is used to treat infections of the skin , or the tissues below the skin that cause an infection of the lungs called : ' pneumonia ', which can be treated with zinfuro . how zin foro works zinforum works by killing certain bacteria , reducing the risk of serious infections .
do not take zinforo if you are allergic to ceftaroline fosamil or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor thinks you may be allergic , ask your doctor for advice . if the above applies to you , tell your doctor before taking zin foro . warnings and precautions talk to your doctor or pharmacist before taking this medicine if : you are taking other cephalosporin antibiotics you have had previous severe allergic reactions to other antibiotics such as penicillin or carbapenem . your doctor will be able to give you more information . talk to the doctor before you take , if any of these apply to you before taking the medicine . before taking your first dose of zinfordo you should tell your physician if: you have kidney problems . you have ever had seizures ( convulsions
the recommended dose of zinforo is 600 mg given every 12 hours . your doctor may increase your dose to 600 mg every 8 hours if you have some infections . the recommended starting dose is 8 mg given twice a day . if necessary , your doctor will decide how much zinforceo you need . you will be given the dose every 12 hour . it is given as a drip directly into your vein ( intravenously ) over a period of 5 minutes . this is followed by 60 minutes up to 120 minutes , with an increased dose . depending on response to treatment , you may be given an additional dose every 5 or 14 days . for skin infections , the recommended daily dose is 5 to 7 days for pneumonia . patients with kidney problems if your doctor determines that you have kidney problems it is important that zinForo is removed from your body through your kidneys . in
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : tell your doctor straight away if you notice any of these symptoms - you may need urgent medical treatment : sudden swelling of your lips , face , throat or tongue , a severe rash , swallowing or breathing problems - these may be signs of a serious allergic reaction ( anaphylaxis ) and may be life - threatening . diarrhoea - stool that contains blood or mucus during or after treatment with zinforo , or it may be a sign of medicines that slow bowel movement ( see section 1 ). this is common in people who take less than 1 in 10 doses . you will have a blood test called a ' coombs test ' which will be performed before
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store below 30 . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what zinforo contains the active substance is 600 mg ceftaroline fosamil . the other ingredients are arginine , skimmed , and saline . what zforo looks like and contents of the pack zinfordo is a pale yellowish to light yellow powder supplied for solution for infusion in a vial . it is available in packs containing 10 vials .
pregabalin pfizer belongs to a group of medicines used to treat epilepsy , neuropathic pain and generalised anxiety disorder ( gad ) in adults . peripheral and central nuropathic pain : pregabaltin ppfizer is used to relieve long lasting pain caused by damage to the nerves . a variety of diseases can cause peripheral neursopathic pain including diabetes and shingles . pain sensations may be described as hot , burning , torsion , shooting , stabbing , sharp , cramping , angioedema ( such as pain sensation that may be perceived as burning  , or throbbing ), shooting / stabbing or sharp . it can also be used to prevent cramping and aching , and tingling , feeling numbness , difficulty in breathing , coughing - up
do not take pregabalin pfizer if you are allergic to pregabaltin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking pregabaalin in order to reduce the risk of an allergic reaction . these symptoms include swelling of the face , lips , tongue , and throat , as well as diffuse skin rash . should you experience any of these reactions , you should contact your physician immediately . pregabhalin can cause dizziness and somnolence , which could increase the occurrence of accidental injury ( fall ) in elderly patients . therefore , take special care with pregab alin ppfizer and tell your doctor if any of them occur . the visual effects may be blurring or loss of vision , or other changes in eyesight , many of which are temporary
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . pregabalin pfizer is for oral use only . peripheral and central neuropathic pain , epilepsy or generalised anxiety disorder : take the number of capsules as instructed by your doctor . the dose , which has been adjusted for you and your condition , will generally be between 150 mg and 600 mg each day . your doctor will tell you to take pregabaltin . you should take pregamalin in the morning and in the evening , at about the same time each day ( approximately 15 - 15 minutes apart ). 59 you should swallow pregabain ppfizer whole , with a drink of water , either with or without food . in the afternoon and evening : you should wait at least 15 minutes before having breakfast .
like all medicines , this medicine can cause side effects , although not everybody gets them . very common : may affect more than 1 in 10 people dizziness , drowsiness , headache . common ; may affect up to 1 in every 10 people increased appetite . feeling of elation , confusion , disorientation , decrease in sexual interest , and irritability . disturbance in attention , lack of motivation , difficulty finding words , hallucinations , panic attack , loss of memory , an increase in sex drive , depression , anxiety , sleepiness . uncommon : might affect upto 1 in 100 people increased sextortion , disturbance in sexual activity , increased sensitivity to noise , abnormal taste , fainting , increase in sexual desire , elevated sinning , reduced consciousness and / or in
what pregabalin pfizer contains the active substance is pregabailin . each hard capsule contains either 25 mg , 50 mg ; 75 mg / 100 mg . the other ingredients are 150 mg  , 200 mg : 225 mg or 300 mg pregaballin - the other ingredient ( excipient ( s ) are lactose monohydrate , maize starch , talc , gelatine , titanium dioxide ( e171 ), sodium laurilsulphate , anhydrous colloidal silica , black ink containing shellac ; black iron oxide ( i . e . propylene glycol , potassium hydroxide ) 75 mg, 100 mg ( corresponding to 200 mg or 225 milligrams ), titanium dioxide [ e1520 ], iron oxide red
xadago is a medicine that contains the active substance safinamide . it stimulates dopamine in the brain . stimulation of the brain is an important part of the functioning of your brain , and in this way it helps to control your movement . xdagon is used in adults to treat parkinson ' s disease . parkinsons ' disease causes sudden switches in the way the heart beats . this can cause you to not be able to move or you may have difficulties moving . when x ad ago works , the medicine can be used together with levodopa which is used , in combination with other medicines , to treat and prevent parkinSON '
do not take xadago - if you are allergic to safinamide or any of the other ingredients of this medicine ( listed in section 6 ). - do not start taking the following medicines : monoamine oxidase ( mao ) inhibitors ( e . g . selegiline , rasagiline ), moclobemide , phenelzine ; isocarboxazid , or tranylcypromine . this is because treatment for parkinson ' s disease , used for depression , has been shown to work . also , pethidine ( a strong pain killer ). you must wait at least 7 days before you start x ad ago treatment and for at least a year after you start treatment with mao inhibitors , such as
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose of xadago is 50 mg once a day . however your doctor may prescribe a higher or lower dose to a maximum of 100 mg once per day , depending on how well the medicine works . take xdagon by mouth once  a week . if your doctor determines that you should take a lower dose of either 50 mg or less , contact your doctor immediately . patients with moderately reduced liver function may need a dose of 50 mg . you should swallow the tablet whole with some water . your doctor will prescribe the strength that is right for you , so it is unlikely that you will be given too much . warnings and precautions talk to your doctor before taking x ad ago
like all medicines , this medicine can cause side effects , although not everybody gets them . hypertensive crisis ( very high blood pressure that can lead to collapse ) has been reported in patients with neuroleptic malignant syndrome ( ppm ). the signs include confusion , sweating and muscle rigidity ( hyperthermia ). pde5 may increase level of enzyme creatine kinase in your blood ( serotonin syndrome ). it also causes confusion . it also induces hypertension ( muscle stiffness ), hallucinations and hypotension . side effects in patients who have parkinson ' s disease are safinamide and levodopa . other side effects include parkinsons ' disease , sulfatinamide , and levonavir . the frequency of these effects is very high for several days . very
what xadago contains - the active substance is safinamide . each 50 mg tablet contains 100 mg of ssafirinamide ( as methansulfonate ). - other ingredients are : - tablet core : microcrystalline cellulose , crospovidone type a , magnesium stearate , silica colloidal anhydrous - film coating : pregelatinised maize starch , shellac , indigo carmine ( e132 ), hypromellose , macrogol ( 8000 ), titanium dioxide ( е171 ), iron oxide red ( i ) what Xad ad is supplied as teardrop - shaped , white to off - white oval tablet with " s50 " debossed on one side and " n
zytiga is a medicine that contains the active substance abiraterone acetate . it is used to treat adult men with prostate cancer that has not spread to other parts of the body . zytige can lower the levels of testosterone in your blood when it is too high , and prostate cancer is not caused by zyta . this is if you have disease that cannot be controlled by hormone therapy or if your doctor is taking a treatment that lowers testosterone ( androgen deprivation therapy ). it is taken in combination with another medicine , prednisone or predniesisolone , to treat high blood pressure , which is not controlled by the body and due to fluid retention in your airways .
do not take zytiga - if you are allergic to abiraterone acetate or any of the other ingredients of this medicine ( listed in section 6 ). - when you are pregnant warnings and precautions talk to your doctor , pharmacist or nurse before taking zytigea . this medicine may cause severe liver damage . - in case of prostate cancer , your doctor may need to reduce the dose of this medication . do not exceed the recommended dose of the medicine . talk to you doctor before taking this medicine if any of these apply to you . warnings about side effects tell your doctor before you take this medicine and if your doctor thinks any of your medical conditions are serious , including medical conditions that could increase your risk of liver problems , high blood pressure , heart failure , low blood potassium . low blood sodium can increase the risk of heart rhythm problems . tell your
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is 1 , 000 mg once daily . you should take this medication by mouth . zytiga is for oral use . swallow the tablet whole . do not crush , chew or chew the tablet . take zytigea at least 2 hours after you have taken zymiga . how to take take ztiga with food . it is best to take a medicine that contains prednisone or predniesone together with a glass of water . prednosone is taken to help the body make its own way . your doctor will tell you how long you should continue to take the prednesone . only take prednésone if your doctor tells you to stop . taking predneyis
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking zytiga and tell your doctor immediately if you experience muscle weakness , muscle twitches , a pounding heart beat or palpitations . these may indicate that your level of potassium in your blood is low . they also indicate that you do not have enough potassium . other side effects may occur : common ( may affect up to 1 in 10 people ) - a build up of fluid in your legs or feet . this may indicate low blood potassium in the blood , seen in liver function test , high blood pressure , urinary tract infection , diarrhoea , vomiting , abdominal pain , wind , chills , or a feeling of general discomfort or tiredness . uncommon ( may effect up to1 in 100 people ). - low
what zytiga contains - the active substance is abiraterone acetate . each tablet contains 250 mg abériateron aate . - other ingredients are microcrystalline cellulose , croscarmellose sodium , lactose monohydrate , magnesium stearate , povidone ( k32 ), colloidal anhydrous silica , sodium laurilsulfate ( e487 ). see section 2 " zytigea contains lactoses ". what zetiga looks like and contents of the pack - zyta tablets are white to off - white , approximately 9 . 5 mm in diameter . the tablets are packaged in a plastic bottle with a child - resistant closure . pack size of 120 tablets .
hefiya contains the active substance adalimumab , a medicine used for the treatment of the following inflammatory diseases : polyarticular juvenile idiopathic arthritis , and enthesitis - related arthritis paediatric plaque psoriasis , paediatic crohn ' s disease , or paediatri non - infectious uveitis the active ingredient in hepiyo is a monoclonal antibody . monoclonosal antibodies are proteins that attach to a specific target in the body . aad limumаb is able to attach to an antibody called tumour necrosis factor ( tnf ), which is present at increased levels in the inflammatory disease and causes the inflammation in these diseases . polyarticulary juvenile  iidisis /
do not use hefiya if you are allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor has told you that you have a severe infection , including tuberculosis , sepsis ( blood poisoning ) or other opportunistic infections ( unusual infections associated with a weakened immune system ). symptoms of infections , for example , fever , wounds , feeling tired or dental problems ( see " warnings and precautions "). if any of these apply to you , do not inject more heficiyo and contact your doctor immediately . if in doubt , you should contact your dentist who may advise you to stop using heifiye . warnings : talk to your doctor or pharmacist before using hfia :
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor if you are not sure . the usual starting dose is 40 mg once a week . your doctor may increase the dose to 20 mg once every week , or to 40 mg after the first week if necessary . polyarticular juvenile idiopathic arthritis age or body weight how much and how often to take ? notes children , adolescents and adults from 2 years of age weighing 30 kg or more 40 mg twice a day . children weighing 10 kg to less than 30 kg 20 mg twice daily enthesitis - related arthritis age and body weight what and how much to take? notes kids , teenagers and adults between the ages of 6 years and 30 kg 40 mg every other week not applicable children . adolescents from 6 years of old weighing 15 kg to more than 30kg 20 mg every second week
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . side effects may occur up to 4 months or more after the last hefiya injection . seek medical attention urgently , if you notice any of the following signs of allergic reaction or heart failure : severe rash , including hives ; swollen face , hands , feet ; trouble breathing , swallowing ; shortness of breath with exertion or upon lying down or swelling of the feet . tell your doctor as soon as possible , as these may be signs and symptoms of infection such as fever , feeling sick , wounds , dental problems , pneumonia , cold sores . not known ( frequency cannot be estimated from the available data ): joint pain 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2c 8c ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . alternative storage : when needed ( for example when you are travelling ), hefiya can be stored at room temperature ( up to 25 ) for a maximum period of 14 days be sure to protect it from light and receive room temperature storage . once removed from the refrigerator for re - use , your pre – filled yringer must be used within 14 days or discarded , even if it is later returned to the refrigerator . you should record the date when your pre
what hefiya contains the active substance is adalimumab . each pre - filled syringe contains 20 mg of aad alimamab in 0 . 4 ml of solution . the other ingredients are adipic acid , citric acid monohydrate , sodium chloride , mannitol , polysorbate 80 , hydrochloric acid and sodium hydroxide and water for injections . what HEfia looks like and contents of the pack heifiye 20 mg solution for injection ( injection ) in pre  0 4 . 8 mL clear to slightly opalescent , colourless to slightly yellowish solution , is contained in a single - use clear type i glass sYringe with a stainless steel needle with  
ritemvia contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to the surface of a kind of white blood cell called " b - lymphocyte ". when ritsimabe sticks to its surface , the cell dies . ritemevia is used for the treatment of several different conditions . the patients who have been given ritemmvia have two different types of : a ) non - hodgkin ' s lymphoma this is the disease of the lymph tissue ( part of the immune system ) that affects a particular type of whiteblood cell called b- lymphoocytes ; riteMvia may be given to you together with other medicines called " chemotherapy ". in this case , your doctor will decide how to treat you .
do not take ritemvia if you are allergic to rituximab , other proteins which are like ritsimabe , or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor determines that you have a severe active infection at the moment . if the doctor determine that you are at risk of having a weak immune system . warnings and precautions talk to your doctor , pharmacist or nurse before taking ritemevia : if : you have severe heart failure or severe uncontrolled heart disease , including granulomatosis with polyangiitis , microscopic polyangitis and pemphigus vulgaris . do not have ritemillionvia unless your doctor has told you that you do . you have ever had or might now have hepatitis infection . your doctor may want
your doctor will assess your response to ritemvia during this treatment . you will be observed closely during this procedure . this medicine will be given to you in a hospital or clinic in southwestern Ontario . it is very important that you are treated promptly and not given any side effects . ritemevia is given as a drip ( intravenous infusion ). medicines given before each ritemmvia administration before you are given rite
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate but some may be serious and require treatment . rarely , some of these reactions have been fatal . infusion reactions during or within the first 24 hours of the infusion you may develop fever , chills and shivering . less frequently , people may experience pain at the inffusion site , blisters , itching , sickness ( nausea ), tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat irritation , cough . you may also experience a rash . tell your doctor or nurse immediately if you experience any of the following while you are being treated with ritemvia : very common : may affect more than 1 in 10 people infection of the mouth or throat , sore throat . common 
what ritemvia contains the active ingredient in ritemevia is called rituximab . the vial contains 100 mg of ritzimaB . each ml of concentrate contains 10 mg of Rituximib  .the other ingredients are sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what ritamvia looks like and contents of the pack ritemmvia is a clear , colourless solution , supplied as a concentrate for solution for infusion in a glass vial . pack of 2 vials , each carton containing one vial of 2 mL .
capecitabine teva belongs to the group of medicines called " cytostatic medicines ", which stop the growth of cancer cells . capecitebine - tva contains capecitationbine , which itself is not a cytotic medicine . only after being absorbed by the body is it changed into an active anti - cancer medicine ( more in tumour tissue than in normal tissue ). cape citationbine tingle is used in the treatment of colon , rectal , gastric , or breast cancers . furthermore , capecitébine tulva is used to prevent new occurrence of colon cancer after complete removal of the tumour by surgery . Capecitabin t Eva may be used either alone or in combination with other medicines .
do not take capecitabine teva - if you are allergic to capecitebine or any of the other ingredients of this medicine ( listed in section 6 ). you must inform your doctor if your doctor thinks you may have an allergy or over - reaction to this medicine , - as you may already have had severe reactions to fluoropyrimidine therapy ( a group of anticancer medicines such as fluorouracil ), - you are pregnant or breast - feeding ,- you have low levels of white cells or platelets in the blood ( leucopenia , neutropenia or thrombocytopenia ), or - your doctor has told you that you have severe liver or kidney problems , or you know that you do not have any activity of the enzyme dihydropyrimedehydrogenase ( dpd ) ( complete d
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . capecitabine should only be prescribed by a doctor experienced in the use of anticancer medicines . your doctor will prescribe a dose and treatment regimen that is right for you based on your body surface area . this is calculated from your height and weight . the usual dose for adults is 1250 mg / m2 of body surface surface area taken two times a day . two examples are provided here : a person whose body weight is 64 kg and height is 1 . 64 m has a body surfacearea of 1 , 7 m2, and should take 4 tablets of 500 mg and 1 tablet of 150 mg two times daily . a man whose doctor has given you a quote for the dose is 150 mg . an adult whose
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking capecitabine teva immediately and contact your doctor if any of these symptoms occur : diarrhoea : if you have an increase of 4 or more bowel movements compared to your normal bowel movement each day or any diarhooeal at night . vomiting : when you vomit more than once in a 24 - hour time period . nausea : whenever you lose your appetite , and the amount of food you eat each day is much less than usual . stomatitis : may cause pain , redness , swelling or sores in your mouth and / or throat . hand - and - arm pain : stop taking this medicine and tell your doctor immediately if this happens . you may need to take 
what capecitabine teva contains the active substance is capecitebine . capecitationbine trava 150 mg film - coated tablets each film , contains 150 mg capeciabine , is a purplish product . - capecitingbine treva 500 mg film film  coated tablets fiecare film : - contains 500 mg capacitabine the other ingredients are : lactose , microcrystalline cellulose ( e460 ), hypromellose ( 6000 ), crscarmellose sodium , magnesium stearate ( е572 ), macrogol 400 ( 8000 ), all in the tablet core : indigo carmine ( k29 ), capelazine ( 5000 ), yellow iron oxide (  ), red iron oxide . what capacitebine toeva looks like and contents of
what silodosin recordati is silofosine recordatis belongs to a group of medicines called alpha1a - adrenoreceptor blockers . siloudooshin recordat is selective for the receptors located in the prostate , bladder and urethra . by blocking these receptors , it causes smooth muscle in these tissues to relax . this makes it easier for you to pass water and relieves your symptoms . what siladosenti is used for siloncordati can be used in adult men to treat the urinary symptoms associated with benign enlargement of the prostate ( prostatic hyperplasia ), such as : difficulty in starting to passwater , a feeling of not completely emptying the bladder , an increased need to pass urine , even at night .
do not take silodosin recordati if you are allergic to siloudoosine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking silonosan recordatis : before eye surgery if there is cloudiness of the lens ( cataract surgery ), your doctor will examine your eye 26 before prescribing silonedosesin recordattai . this is a very rare but potentially life - threatening side effect of medicine that can cause a loss of muscle tone in the iris ( the coloured circular part of the eye ) after a surgery . your doctor and / or surgeon will take appropriate precautions when deciding on the appropriate use of medicine / surgical techniques . sillodon recordata may not be suitable for you during cataract surgery and should be
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose of silodosin recordati is 8 mg once a day . take the capsule always with food , preferably at the same time each day , as long as your dose is maintained at all times . do not break or chew the capsule , but swallow it whole , even if it is not possible . patients with kidney problems if your doctor has decided that you have moderate kidney problems the usual dose of this purpose silonosine recordatis is 4 mg once per day ; if the dose is disturbed you may take sildodostati for up to 4 weeks , you should take si lodooshin recordatif twice a morning , to avoid feeling dizzy or feel weak
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience any of the following allergic reactions : swelling of the face or throat , difficulty in breathing , feeling faint , itchy skin or hives . the most common side effect is an improvement in the quality of life . one such side effect of silodosin recordati is dizziness . dizziest when standing up and occasionally fainting is common . if this happens , do not take any more steps to prevent dizziening . sometimes a person may feel weak or dizzy . usually , the symptoms of dizziity and fainting are usually mild to moderate and go away within a few hours of stopping silofosine recordatis and usually disappears after a while preparing for surgery ( eye surgery ). if
what silodosin recordati contains siloudoosine recordatin 8 mg the active substance is silonosun . each tablet contains 8 mg of silonedosesin . the other ingredients are : mannitol ( e421 ), magnesium stearate , sodium laurilsulfate , gelatin , titanium dioxide ( е171 ). silofoshin recordatis 4 mg theactive substance is : silolinosen . every 4 mg of the active ingredient is sillodousin ; the other ingredient is mannintol , magnesium STEarate and sodium laursulfATE . - the other components are ; gelatin, titanium oxide (  e171 and yellow iron oxide (
kinzalmono belongs to a class of medicines known as angiotensin ii receptor antagonists . angioTENsin Ii is a substance produced in your body which causes your blood vessels to narrow , thus increasing your blood pressure . kinzialmonome blocks the effect of angiostensin 1 , so that the blood vessels relax , and your blood temperature is lowered . this medicine is used to treat essential hypertension ( high blood pressure in adults ). ' essential ' means that the high blood tension is not caused by any other condition . high blood Pressure , if not treated , can damage blood vessels in several organs , which could lead sometimes to heart attack , heart or kidney failure , stroke , or blindness .
do not take kinzalmono if you are allergic to telmisartan or any other ingredients of this medicine ( listed in section 6 ). if there is still a possibility that you can get pregnant , it is also better to avoid kinzialmona in early pregnancy see pregnancy section . if your doctor determines that you have severe liver problems such as cholestasis or biliary obstruction ( problems with drainage of the bile from the liver and gall bladder ) or anyother severe liver disease . take special care with kinzualmonou if any of the following apply to you : - if You have diabetes or impaired kidney function and you are treated with a blood pressure lowering medicine containing aliskiren . talk to your doctor before taking kinzzalmon if this applies to you as you may need to take a dose
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of kinzalmono is one tablet a day . try to take the tablet at the same time each day , so you can easily take a tablet with or without food . you should swallow the tablet whole . it is important that you take kinzialmona every day until your doctor tells you otherwise . if your doctor thinks that the effect of kinszalmonio is too strong or too weak , talk to your doctor about it . for treatment of high blood pressure , the usual dose of one kinzzalmonome 40 mg tablet once a night will usually lower blood pressure over the 24 - hour period . your doctor may prescribe a lower dose of just 20 mg . when kinzonzalmino is taken
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects can be serious and need immediate medical attention : you should see your doctor immediately if you experience any of the following symptoms : sepsis * ( often called " blood poisoning ", is a severe infection with whole - body inflammatory response ), rapid swelling of the skin and mucosa ( angioedema ); these side effects are rare ( may affect up to 1 in 1 , 000 people ) but are extremely serious and patients should stop taking the medicine and see their doctor immediately ( see section 2 ). if these effects are not treated they could be fatal . possible side effects of kinzalmono common side effects ( may effect up to1 in 10 people ] low blood pressure ( hypotension ) in patients with cardiovascular events . uncommon side effects (19 may affect more than 1
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton after " exp ". the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . you should store your medicine in the original package in order to protect the tablets from moisture . remove your kinzalmono tablet from the blister only directly prior to intake . store in the refrigerator ( 2 - 8 ). do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what kinzalmono contains - the active substance is telmisartan . each tablet contains 20 mg telmesartan ( as meglumine ). - other ingredients are povidone , meglumin , sodium hydroxide , sorbitol ( e420 ) and magnesium stearate . what kinszalmonio looks like and contents of the pack kinzialmona 20 mg tablets are white to almost white , round tablets . kinzzalmonome is available in blister packs of 14 , 28 , 56 or 98 tablets , each containing one tablet . not all pack sizes may be marketed .
what afstyla is a fsyla product is based on a human clotting ( coagulation ) factor viii product . the active ingredient in a Fstlyla is lonoctocog alfa . what sfyla used for aFstуla is used to treat and prevent bleeding episodes in patients with haemophilia a ( inborn factor ixii deficiency ). factor ii is necessary for blood clot formation . it helps the blood to cloting . as factor  vii increases the tendency to bleed . how afferstyingla works factor vii is required for haemeophilio a to clut . aaffstingla is suitable for use in adults and children .
you should not be given afstyla - if you have ever had an allergic reaction to any ingredient of ayla ( listed in section 6 ). - you are allergic to hamster proteins . warnings and precautions 46 talk to your doctor before you are given : a fsyla use the name and batch number of your aaf yla and keep it in the original package in order to maintain a record of the batch number . also keep the date of your treatment diary in the patient alert card included in your treatment with ahstlyla . allergic ( hypersensitivity ) reactions have been reported in patients receiving a lot of doses of : one or more of , but may develop symptoms of allergic reactions . early signs of allergic reaction include hives , generalised skin rash , tightness of the chest , whe
your treatment should be initiated under the supervision of a doctor experienced in the treatment of blood clotting disorders . always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose of  afstyla for treatment of your disease the site should be located near the bleeding your clinical condition . reconstitution and administration general instructions the powder must be mixed with the solvent ( liquid ) immediately before use .  patients must be observed according to aseptic conditions . use a fsstlyla with other medicines and solvents see section 6 . it is recommended that the solution be clear or slightly opalescent and colourless . do not use the solution if it is cloudy or if particles are present . please refer to the instructions for use at the end of this leaflet . any
like all medicines , afstyla can cause side effects , although not everybody gets them . tell your doctor immediately if you experience symptoms or signs of allergic reactions . allergic reactions are rare and may occur in up to 1 in 10 people . if your doctor determines that you may be more prone to allergic reactions you may experience the following symptoms : hives , generalised urticaria ( itchy rash ), tightness of the chest , difficulty in breathing , wheezing , low blood pressure , dizziness , anaphylaxis ( bleeding ). in children not previously treated with factor viii medicines : development of inhibitor antibodies ( see section 2 ) very commonly reported in children less than 1 in every 10 patients ; new treatment with factor vii ( more than 150 days of treatment ). the risk of developing inhibitors is uncommon .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . before the afstyla powder is reconstituted it may be kept at room temperature ( up to 25 ) for a single period not exceeding 3 months . record the date from when you start to store it at roomtemperature . please record the end of this period on the product carton . use the reconstructed product immediately after reconstitution . this product is for single use only . discard any unused product after reconstituted solution appropriately .
what afstyla contains the active substance is lonoctocog alfa . each vial contains 250 mg / 2 . 5 ml solution for injections the solution contains 100 mg of lonoctcog alla - once the solution has been reconstitution for 2 - 5 syringes . after reconstitution with 2  . 4 mL water for injection , the solution provides 200 mg of LonoctoCog alfata , once the product has been prepared and given 1000 mg . upon reconstitution and 2 , 5 - mmol , each methanol solution contains 400 mg of honoctocorg alba and 1500 mg of solution for inject . following reconstitution ( 5 % water for injects the solutions contains 300 mg of loctocogg alfA and 2000 mg of the solution for infusion ). after
praxbind contains the active substance idarucizumab . i darucizum ab is a reverse agent . dabigatran ( pradaxa ) is  a blood thinner medicine used in the prevention of blood clot formation . the active ingredient in prauchbind is used to rapidly trap dabigаtran in the blood . you must not have to take praxiabind to avoid the need for emergency surgery or urgent procedures . it is used in adults to prevent uncontrolled bleeding .
do not take praxbind : - if you are allergic to idarucizumab or any of the other ingredients in this medicine listed in section 6 . - you suffer from a genetic disease called hereditary fructose intolerance ( hereditarian ) tolerance to the substance sorbitol ( e420 ) or any other ingredients of this medicine ( listed in sections 6 ). this is because some patients have experienced serious adverse reactions when they took praXbind . warnings and precautions talk to your doctor or pharmacist before taking this medicine . your doctor will be closely monitoring the effects of dabigatran and other medicines to prevent blood clots . dabig atran is removed from the body through the bloodstream , causing blood coagulation . you may be given medicines to help prevent blood from clottings , depending on your medical
praxbind will be given to you by a doctor or nurse . the recommended dose is one 5 mg vial of 2 . 5 mg dabigatran per day . you will receive this medicine for one 5 - minute period . this medicine is given intravenously ( into a vein ) by your doctor or a nurse , under the supervision of your doctor . your doctor will decide how many days of treatment you need . during your treatment , you will be monitored for signs of blood clot formation . after you are given dabig atran , it is given to your body for approximately 24 hours . if you miss a dose of this medicine , please contact your doctor to reschedule the missed dose . do not take more than one dose in one day , as this medicine may not be as effective as it should . it is important that you take
like all medicines , this medicine can cause side effects , although not everybody gets them . reporting of side effects get if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what praxbind contains the active substance is idarucizumab . the other ingredients are sodium acetate trihydrate , acetic acid , and sorbitol ( e420 ), polysorbate 20 and water for injections . what pxbind looks like and contents of the pack praxxbind is a clear to slightly opalescent , colourless to slightly yellow solution in a glass vial with a butyl rubber stopper and an aluminium cap .
temomedac contains a medicine called temozolomide . this medicine is an antitumour agent . temogrammedaac is used for the treatment of specific forms of brain tumours : in adults with newly - diagnosed glioblastoma multiforme . in this case temmedaic is first used together with radiotherapy ( concomitant phase of treatment ) and after that alone ( monotherapy phase of treating ). in children 3 years and older and adult patients with malignant gliomema , such as glibombomum multiforma or anaplastic astrocytoma ( mdm ). temtemomediac can be used in these tumours when they return or get worse after standard treatment .
do not take temomedac - if you are allergic to temozolomide or any of the other ingredients of this medicine ( listed in section 6 ). - you may have had an allergic reaction to dacarbazine ( an anticancer medicine sometimes called dtic ). signs of allergic reaction include feeling itchy , breathlessness or wheezing , swelling of the face , lips , tongue or throat . - some people will get certain types of blood cells that are severely reduced ( myelosuppression ), such as your white blood cell count and platelet count . these blood cells are important for fighting infection and for proper blood clotting . your doctor will check your blood to make sure you have enough of these cells before treatment is started . warnings and precautions talk to your doctor , pharmacist or nurse before taking temmedaac and during treatment
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . dosage and duration of treatment your doctor will work out your dose of temomedac . this is based on your size ( height and weight ) and if there is a recurrent tumour and / or you have had chemotherapy treatment in the past . you may be given other medicines ( anti - emetics ) to take before and , during treatment with temac to prevent nausea and vomiting . patients with newly - diagnosed glioblastoma multiforme if a combination of treatment is required , treatment will occur in two phases : radiotherapy ( concomitant phase ) followed by treatment with only temonac ( monotherapy phase ). the dose of the temokac will be
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you have any of the following : - a severe allergic ( hypersensitive ) reaction ( hives , wheezing or other breathing difficulty ), - uncontrolled bleeding , - seizures ( convulsions ), you , your doctor or nurse will immediately stop temomedac treatment . these may be due to a reduction in certain kinds of blood cells . this may cause you to have increased bruising or bleeding  ( anaemia ), red blood cells which may cause fever and reduced resistance to infections . the reduction in blood cell counts is usually short - lived . in some cases , it may be prolonged and may lead to reversible . for some patients , the reduction may be severe . it may also lead to ana
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store in the original package . capsules should be used within 30 days after first opening . tell your pharmacist if you notice any change in the appearance of the capsules . this medicine does not require any special storage conditions .
what temomedac contains the active substance is temozolomide . temokac 5 mg : each tablet contains 5 mg of temazolomide ( as monohydrate ). temmedaac 20 mg  : one tablet contains 20 mg of mezozolomid ( as bipolar disorder ). the usual dose of momed ac 100 mg , each tablet contain 100 mg of mozozoolide ( als bildbild ). another strength of  temtemodac 140 mg - each tablet delivers 140 mg of mammalian tyrosine ( as mesilate ). furthermore , temac 180 mg ; each tablet releases 180 mg of miz temizolomide once a day . another strength is  150 mg temozalomide as an off - white to pale brownish
cialis is a treatment for adult men with erectile dysfunction . this is when a man cannot get , or keep a hard , eer penis suitable for sexual activity . ciali will help you to get a good , hard ed penis capable of sexual activity at any time . the active substance tadalafil belongs to a group of medicines called phosphodiesterase type 5 inhibitors . it helps the body to relax the blood vessels in your penis , helping the flow of blood into your penises . when cialising keeps your penit at a normal level , it will return you to your normal level of ecg ( e .g . sexual stimulation ). you should not use cialist if you think that you do not have eerect . you should discuss with your doctor whether
do not take cialis - if you are allergic to tadalafil or any of the other ingredients of this medicine ( listed in section 6 ). - do not chew or dissolve the tablet . - are taking any form of organic nitrate or nitric oxide donors such as amyl nitsrite . this is a group of medicines (" nites ") used to treat angina pectoris (" chest pain "). cialist has not been studied in this group of people . the use of these medicines is not recommended if nîrate is used in patients with serious heart disease . you should tell your doctor if your doctor has told you that you have recently had a heart attack within the last 90 days . also , if the patient has had , or has recently had, a stroke within the past 6 months . warnings and
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . cialis tablets are for oral use . swallow the tablets whole with some water . the tablets can be taken with or without food . how much to take the recommended dose is one 5 mg tablet taken once a day at about the same time of the day . your doctor may increase your dose to 2 . 5 mg once - a week . you should not take more ciali than your doctor tells you to . do not take cialist if your doctor thinks that you may have taken more . to help you get an erection , you should contact your doctor , who will tell you how long you should keep taking cialisk . it is important that you keep taking the medicine every day , as instructed by your doctor to achieve the best results for your
like all medicines , this medicine can cause side effects , although not everybody gets them . side effects were mainly seen while patients were being given the medicine or shortly after (" sexuants "). allergic reactions including rashes ( frequency " experienced in a rapid fashion ) have been reported ( frequency experienced in chest pain ). nitrates have been shown to increase ( frequency observed in priapsim ). men who have a prolonged and possibly painful erection after taking cialis should stop the ererector completely and continue for at least 4 hours without treatment . tell your doctor immediately if you experience sudden loss of vision ( frequency not known ). other side effects have been noted in more than 1 in 10 people , but the frequency cannot be estimated from the available data : headache , back pain , dizziness , sensation of spinning head , difficulty in walking or
what cialis contains - the active substance is tadalafil . each tablet contains 2 . 5 mg of tdalala fil . - other ingredients are : tablet core : lactose monohydrate ( see end of section 2 ), croscarmellose sodium , hydroxypropylcellulose , microcrystalline cellulose ; sodium laurilsulfate ; magnesium stearate . film - coat : - lactoses monohydrate , indigo carmine ( e132 ), indigestive carmine yellow ( 8000 ), triacetin ( 6000 ), titanium dioxide ( е171 ), iron oxide yellow ( red ), and talc . what ciais looks like and contents of the pack cialist 2 , 5 mg / 2 mg film  2 mg
enyglid is an oral antidiabetic medicine containing repaglinide which helps your pancreas produce more insulin and thereby lower your blood sugar ( glucose ). type 2 diabetes is a disease in which your pancras does not make enough insulin to control the sugar in your blood or where your body does not respond normally to the insulin it produces . enyingglid helps control the level of sugar in the blood after you have started treatment . diet and exercise enzyglid can also be used in combination with metformin , another medicine for diabetes .
do not take enyglid : - if you are allergic to repaglinide or any of the other ingredients of this medicine ( listed in section 6 ). - have type 1 diabetes . enyingglid may lower the acid level in your blood ( diabetic ketoacidosis ). warnings and precautions talk to your doctor or pharmacist before taking enYglid ( see also section 4 ). you have a severe liver disease . you take gemfibrozil ( a medicine used to lower increased fat levels in people with liver problems ) or have moderate liver 28 disease ( see section 2 . in this case , you should not take the enlyd tablets ). your doctor may want to monitor you more closely . talk to you doctor or nurse before taking the tablets . your doctor will also monitor you during treatment with ennyglide : whether you have
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended starting dose is 0 . 5 mg before each main meal . swallow the tablets with a glass of water immediately before or up to 30 minutes before each major meal , or up 4 hours before each special meal if your doctor recommends a higher dose than 30 mg , the maximum recommended daily dose is 16 mg . if necessary your doctor may adjust your dose based on your blood sugar . do not take more enyglid than your doctor tells you to . contact your doctor if a hypo is observed . you may find it helpful to visit your doctor immediately if this happens . take the medicine pack with you , and take the box with you to show the doctor . it is important not to miss a dose of enYglid .
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia the most common side effect is hypoglacy which may affect up to 1 in 10 people . Hypoglycasemic reactions are generally mild / moderate but may occasionally lead to hypoglemic unconsciousness or coma . if this happens , medical help is immediately available . allergy allergy is very rare ( may affect less than 1 in every 10 , 000 people ). symptoms include swelling , difficulty in breathing and rapid heartbeat , feeling dizzy and sweating . this may be anaphylactic reaction . other side effects include : common ( may effect up to1 in 10 ) stomach pain . common ( might affect upto 1 in 100 people ) vomiting . very rare : diarrhoea , nausea , flatulence ( wind 
what enyglid contains - the active substance is repaglinide . each tablet contains 0 . 5 mg , 1 mg or 2 mg replinide in each tablet . - other ingredients are : microcrystalline cellulose ( e460 ); calcium hydrogen phosphate , anhydrous ; croscarmellose sodium ; povidone k25 ; in the powder : glycerol , magnesium stearate , meglumine , poloxamer , yellow iron oxide ( i ) only in the 1 mg tablets and red iron oxide( e172 ) not all pack sizes may be marketed . the 2 mg tablets in 0. 5 ml solution are white , round and biconvex with bevelled edges . 1 mg tablet is pale brown , or yellow , and
what azacitidine mylan is azacitacitide mylan contains the active substance azacutidine . what zacitine mylanis used for azaсitidine is a type of medicine known as an anti - cancer agent . how azacindidine myLAN works aza citidine myla contains the same active substance as human ' s own protein . you have been given azacitemylan because you were not able to have a stem cell transplantation to treat : - higher - risk myelodysplastic syndromes ( mds ). - chronic myelobomonocytic leukaemia ( cmml ). this is uncommon - acute myeloid leuk aemia [ aml ]. these are diseases which affect the bone marrow and can cause problems with normal blood cell production . 
do not take azacitidine mylan - if you are allergic to azacitacitamine or any of the other ingredients of this medicine ( listed in section 6 ). - have advanced liver cancer . - are breast - feeding . warnings and precautions talk to your doctor or pharmacist before taking azaсitidine melan : - when you have decreased counts of platelets , red or white blood cells - kidney disease - liver disease if your doctor thinks you may have a heart condition , heart attack or lung disease . blood test : your doctor will do blood tests before you start treatment with azacricitine mylan and during treatment it is called a ' cycle '. this is to check that you have enough blood cells and that your liver and kidneys are working properly . talk to you doctor or nurse before taking this medicine if any of
before giving you azacitidine mylan , your doctor will give you another medicine to prevent nausea and vomiting at the start of each treatment cycle . the recommended dose is 75 mg per m2 body surface area . your doctor or nurse will work out your dose of this medicine based on your general condition , height and weight . you will normally receive azaCitidine Mylan once every 3 weeks , but this " treatment cycle " will be repeated every 4 weeks . for more information on dosage and duration , please refer to section 6 " how to take this medicine ". it is given as an injection under the skin ( subcutaneously ) by your doctor . it may be given under the same area of skin on your thigh , tummy or upper arm . if you have any further questions on the use of this product , ask your doctor
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience any of the following side effects as these may be signs of drowsiness , shaking , jaundice , abdominal bloating and easy bruising . these may also be symptoms of liver failure and can be life - threatening . swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting and reduced appetite . common : confusion , restlessness and fatigue . symptoms may include : tremor , drooling , sleepiness . uncommon : headache , stomach pain . very common , may affect more than 1 in 10 people a feeling of being unwell , headache . not known : frequency cannot be
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and the carton . your doctor , pharmacist or nurse are responsible for storing azacitidine mylan . they are also responsible for disposing of any unused azaсitidine melan correctly . this medicine will be given to you in a hospital or clinic and will store it in its original package . the suspension must be taken immediately before it is given to your child . storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 1 hour at 2oc to 8oc . when the azacitamylan suspension is prepared using water for injections that has not been refrigerated , the suspension should be used within 8 hours after it is prepared and kept refrigerate it . if the za
what azacitidine mylan contains - the active substance is azacitacitide . one vial of powder contains 100 mg azacentidine . after reconstitution with 4 ml of water for injections , the reconstituted suspension contains 25 mg / mL azacitecitine . -the other ingredient is mannitol ( e421 ). what zacittine mylan looks like and contents of the pack azacritidine myLAN is a white powder for suspension for injection and is supplied in a glass vial containing 100 mg of aza citidine - each pack contains 1 or 7 vials .
duotrav eye drop solution contains two active substances , travoprost and timolol . travapross is a prostaglandin analogue which is naturally present in the eye . in the same way titmololl is  a beta blocker which reduces the amount of fluid within the eye and thus reduces pressure within the lid . duotratrav is used to treat high pressure in the eyes which can lead to an illness called glaucoma .
do not use duotrav if you are allergic to travoprost , prostaglandins , timolol , beta blockers or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using duotrav : if your child has respiratory problems such as asthma , severe chronic obstructive bronchitis , or severe lung disease . if the child develops wheeziness or difficulty in breathing , especially in patients with long - standing cough , as these may be signs of breathing problems . take special care with duotar : the child must be observed for at least six hours after using duatrav and if he / she has severe hay fever if they develop a slow heartbeat , heart failure or 
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one drop in the eye or eyes , once a day in the evening . only use duotrav in both eyes if your doctor told you to . you should use duotrom when you wake up . do not use dutrav on other eyes . if the effect of duotrav is too strong or too weak , talk to your doctor straight away . duotar can be used as long as your eyes are working properly . when to use duatrav if needed , you can use eye drops at any time of the day , at any hour , 2 hours , 3 hours or 4 hours after using a bottle ( see section 1 ). wash your hands . before using the bottle , twist off
like all medicines , this medicine can cause side effects , although not everybody gets them . you can usually carry on taking the drops , unless the effects are serious . if you are worried , talk to your doctor or pharmacist . stop using duotrav and tell your doctor straight away . very common side effects ( may affect more than 1 in 10 people ) - the eye eye redness . common side effect ( may effect up to 1 in every 10 people in adults )- the effect of the eye cornea inflammation with or without surface damage . this can cause eye pain , blurred vision , abnormal vision . dry eye , itchy eye ; eye discomfort ; signs and symptoms of eye irritation , burning and stinging . uncommon side effects are ( may effects up to1 in every 100 people ). - allergic reactions . reporting of side effects 23 if your doctor gets
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store below 30 . throw away the container 4 weeks after first opening to prevent infections . write the date of opening on the carton and carton label in the space provided . this medicine does not require any special storage conditions . for children , the doctor will check the storage conditions of the tablets before giving you duotrav . tell your doctor if you notice any particles in the solution or if the solution is discoloured .
what duotrav contains the active substances are travoprost and timolol . each tablet contains 40 mg travaprostic substance ( equivalent to 5 mg tilmololl ). the other ingredients are titmololly maleate , polyquaternium - 1 , mannitol , propylene glycol / polyoxyethylene hydrogenated castor oil 40 mg and boric acid . the other ingredient ( s ) are sodium chloride , sodium hydroxide / hydrochloric acid , purified water . sodium hydroXide or hydroch chloric acid are added to keep acidity levels ( ph levels ) normal .
nplate ' s active ingredient , romiplostim , is a protein that reduces low platelet counts caused by immune ( idiopathic ) thrombocytopenic purpura ( itp ). itp is prick - like illness in which your body 's immune system fails to produce enough platelets to control the number of platelets that your body produces . platelets are important for your blood to help prevent blood clots forming . very low platelets count can lead to bruising and serious bleeding . n plate is used to treat children ( aged 1 year and above ) and adults with spleen removed . chronic itp in patients who have not previously received corticosteroids or immunoglobulins . it is very important that you also read the package leaflets for these medicines .
do not take nplate if you are allergic to romiplostim or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor thinks you may be allergic to other medicines belonging to the group of escherichia coli ( e . coli ). warnings and precautions before you take , you should tell your doctor if : you have a low blood platelet count ( thrombocytopenia ) and you are not sure if any of these apply to you , ask your doctor for advice . before you start taking n plate , your doctor will check your platelet counts regularly . you have an increased risk of blood clots . blood clats can occur during blood coagulation . your doctor should also check your blood globin levels . tell your physician if: you suffer from liver problems
the recommended dose for adults is 1 to 17 g of nplate . n plate can be given as an injection under the skin ( subcutaneous ). it can be administered by your doctor or a nurse , or by a caregiver . the recommended dosage for adults and children aged 1 to 18 years is n Plate . your doctor will decide on the dose that is right for you . how much nplatte is given your doctor may decide how much you should take . however , your doctor can decide for how long you should be treated . for adults , adolescents and children , nplace can be used for one or two courses of one course . dose the doctor or nurse will check your platelet counts regularly . you will have regular blood samples to check your plates to make sure that the number of your platelets is within the normal range . this will help your plate platelet count to be checked regularly 
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : itp common ( may affect up to 1 in 10 people ): headache . allergic reaction upper respiratory tract infection common ( might affect upto 1 in every 10 people): bone marrow disorder with increased bone mmarrow fibres trouble sleeping ( insomnia ) dizziness , tingling or numbness of the hands or feet ( paraesthesia ) migraine . redness ofthe skin , flushing , pain in the joints . uncommon ( may effect up to1 in every 100 people ). diarrhoea . not known ( frequency cannot be estimated from the available data ) : vomiting . reporting of side effects 23 if you get any side effects you can help provide more information on the safety of this medicine the panel headed " warning
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . this medicine should be used within 30 days after first opening . store in the original package in order to protect from moisture .
what nplate contains - the active substance is romiplostim . one ml of n plate contains 125 micrograms of solution for injection . each vial contains 230 microgram ( g ) of romicoplostig . - each mL of solution contains 124 microgram( gg ] romoplost ). each viam contains a deliverable amount of 0 . 25 mla solution , equivalent to 125 mbq of roostim per millilitre . the delivered dose is 500 microgram / m2 of solution . an n Plate 250 microgram per millimeime ( corresponding to 375 microgram [ gbq ]) of the romisplostostim ( 850 microgram *) delivers a delivered amount of 250 microgramm
what tovanor breezhaler is this medicine contains an active substance called glycopyrronium bromide . this belongs to a group of medicines called bronchodilators . what tovonor  Breezhalers is used for this medicine is used to make breathing easier for adult patients who have breathing difficulties due to : a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten . that makes breathing difficult . the use of this medicine blocks the tightening of these muscles in the lungs , making it easier for air to get in and out of the pulmonary system . if you use this medicine once a day , it will help to reduce the effects of copd on your everyday life .
do not use tovanor breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before using tovanour breezehaler: - patients with kidney problems - suffer from an eye problem called narrow - angle glaucoma - patient with difficulty passing urine . during treatment with tovanlor brezhaler stop using this medicine and tell your doctor immediately if :  you experience tightness of the chest , coughing , wheezing or breathlessness immediately after using to vanor brewinghaler ( signs of bronchospasm ). if this occurs , stop using tonor  Breezhalers and tell the doctor .  there may be difficulties in breathing or swallowing . swelling of the
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much tovanor breezhaler to use the usual dose is to inhale the content of one capsule each day . you only need to inhale the content and the full dose of this medicine . the usual time to inhle is 24 hours . do not use more than your doctor tells you to use . elderly ( age 75 years and over ) you can use this medicinal product if your doctor has told that you are to use it . this medicine is for inhalation use ; you can inhalate this medicine at any time of the day , with or without food . these instructions tell you how to use them . for this medicine you will find an inhaler and capsules ( in blisters ) that contain the medicine as
what tovanor breezhaler contains - the active substance is glycopyrronium bromide . each capsule contains 63 micrograms of glycopyrmonium broMIDe , equivalent to 50 microgram ( 8 microgram ) glycopyronicum . the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is equivalent to 44 microgram of glycopirronium / ml . - other ingredients of the powder contained in the capsule are lactose monohydrate and magnesium stearate . what to vanor brewinger looks like and contents of the pack tovanour breezehaler 44 microlitres inhalation powder , hard capsules consist of a white powder and are packaged in blisters attached to the body of the capsules and delivered in the blister strip . they are packaged into blisters with each blister strip and each strip contains
adasuve contains the active substance loxapine and belongs to a group of medicines called antipsychotics . it works by blocking receptors in the brain that are involved in the production of substances called dopamine and serotonin . these have been shown to have calming effects and relieving aggressive behaviour . adesuve is used to treat acute symptoms of mild - to - moderate agitation in patients with schizophrenia or bipolar disorder , diseases characterised by symptoms such as ( for example , schizophrenia ) hearing things that are not there ( called mistaken beliefs ), incoherent speech and behaviour and emotional flatness . people with this condition may also feel depressed , guilty , anxious or tense . in patients suffering from bipolar disorders , the condition may include difficulty in sleeping , depression , anxiety and depression .
do not take adasuve if you are allergic to loxapine or amoxapin . warnings and precautions talk to your doctor or pharmacist before taking adafruit 25 if : you have symptoms like wheezing or shortness of breath , which may be signs of lung problems like asthma , chronic obstructive pulmonary disease ( copd ), which results in narrowing of the airways ( bronchospasm ). you have wheeze , cough , chest tightness or shorten of breath 25 you have neuroleptic malignant syndrome ( nms ). if this happens , symptoms may be similar to those found in patients taking antipsychotic medicines . if these symptoms occur , you should contact your doctor who may prescribe adesuve for you . high fever and rigid muscles . this is particularly common
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is 9 . 1 mg once a day . your doctor may increase your dose to 2 mg once daily . however , your doctor will prescribe the strength that is right for you , depending on your condition . adasuve is for oral use . swallow the tablet whole , with a glass of water . do not crush , chew or dissolve the tablet . you can use the device for any combination of two or three different ways depending on the type of hand - to - mouth , or with / without food . try to use the tablet at the same time each day , until it is time for your next scheduled dose . it may be necessary to adjust the dose of adafruit or water , and to
like all medicines , this medicine can cause side effects , although not everybody gets them . if you get any side effects talk to your doctor or nurse , who might be able to help . tell them straight away if they get any breathing symptoms ( wheezing , cough , shortness of breath , chest tightness , or irritating airways that you have asthma or copd ). light - headedness or fainting . your blood pressure may be lowered . worsening agitation , confusion , fever or muscle stiffness . these may be signs of a severe condition called neuroleptic malignant syndrome . other side effects very common ( may affect more than 1 in 10 people ): dizziness rash common ( might affect up to 1 in10 people ). diarrhoea , nausea , vomiting , flatulence , cons
keep this medicine out of the sight and reach of children . do not use adasuve after the expiry date which is stated on the outer carton , pouch and the pouch after exp . the expiration date refers to the last day of that month . store in the original package in order to protect from light and moisture . this product does not require any special temperature storage conditions . aduve is for single use only . any opened or tear pouch that has been opened may cause serious injury .
what adasuve contains - the active substance is loxapine . each single - dose inhaler contains 5 mg of lox apina and delivers 4 . 5 mg / kg of doxapin . what аdasuVE looks like and contents of the pack adave 4  . 4 mg inhalation in a blister is supplied in : a single , disposable white plastic inhalateur containing loxane - each inhalers is packaged in  a sealed foil pouch . pack sizes : one inhalator with 1 or 5 inhalations . not all pack sizes may be marketed .
what azacitidine betapharm is azaсitidine betatapharm , an anti - cancer agent , belongs to a group of medicines called ' anti  - metabolites '. azacitabetapharm contains the active substance ' aza citidine ', which belongs to the group of substances called cytokines . what zacitine betaphar is used for azacutidine betabharm is used in adults who are not able to have a stem cell transplantation to treat :  higher - risk myelodysplastic syndromes ( mds ).  chronic myelamonocytic leukaemia ( cmml ). * acute myeloid leukocytosis ( aml ), which are diseases that affect the bone marrow and can cause problems with normal blood cell production
do not take azacitidine betapharm - if you are allergic to azacitacitide or any of the other ingredients of this medicine ( listed in section 6 ). - have advanced liver cancer . - are breast - feeding . warnings and precautions talk to your doctor or pharmacist before taking azaсitidine betatapharm ( see section 4 ). you may have decreased counts of platelets , red or white blood cells . you have kidney disease . You have liver disease ; you have ever had a heart condition or heart attack or any history of lung disease ). blood test you will have blood tests before you start treatment with azacipitidine bitapharm and at the start of each period of treatment ( called a ' cycle '). this is to check that you have enough blood cells and that your liver and kidneys are working properly . talk to you doctor or
before giving you azacitidine betapharm , your doctor will give you another medicine to prevent nausea and vomiting at the start of each treatment cycle . the recommended dose is 75 mg per m2 body surface area . your doctor or nurse will work out your dose of this medicine based on your general condition , height and weight . you will normally receive azacitacitine betaphar every day for one week , followed by a rest period of 3 weeks . this " treatment cycle " will be repeated every 4 weeks , until you reach a maintenance period of 6 months . azacricittine betapHAR is given as an injection under the skin ( subcutaneously ) by  a doctor or a nurse . it may be given under the same skin on your thigh , tummy or upper arm . should you have any further questions on the use of this medicinal
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience any of the following side effects as these may be signs of drowsiness , shaking , jaundice , abdominal bloating and easy bruising . these may also be symptoms of liver failure and can be life - threatening . swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting and reduced appetite . common : confusion , restlessness and fatigue . symptoms may include : - very common , may affect more than 1 in 10 people - feeling sick - being sick , - vomiting , joint pain - diarrhoea , pain in the muscles , discomfort in the abdomen , fever , chill
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the vial after exp . the expiration date refers to the last day of that month . unopened vials : azacitidine betapharm must be stored in a refrigerator ( 2 8 ). do not freeze . after preparation of the suspension , allow the vialus to come up to room temperature ( approximately 25 ) before use . if the azaсitidine betatapharm suspension is prepared using water for injections that has not been refrigerated , the suspension must be placed in the refrigerator ( 20 - 25 ). if refrigerate the zacitine betaphar suspension with water for injects that is prepared by adding water for 8 hours , it should be allowed to come back to room temp ( approximately 8
what azacitidine betapharm contains - the active substance is azacitacitide . one vial contains 100 mg azaсitidine . after reconstitution with 4 ml of water for injections , the reconstituted suspension contains 25 mg / mL azaCitidine ( as monohydrate ). -the other ingredient is mannitol ( e421 ). what zacitine betaphar looks like and contents of the pack azacricittine betapHAR is a white to off - white powder for suspension for injection and is supplied in a glass vial containing 100 mg of aza citidine - each pack contains one viam .
cerdelga contains the active substance eliglustat for the long term treatment of gaucher disease type 1 . gaucher Disease type 1 is an inherited condition in which certain substances called glucosylceramide build up in various parts of the body , such as the spleen , liver and bones . elicitlustat helps to reduce the amount of glukylceramine that gets into your affected organs and may improve your ability to do normal daily activities . you will be given this medicine along with a diet reduced in sugar in the form of glucose . this medicine can be used if you already have taken too much elgа , but this medicine is not likely to cause slow speed or poor metabolisms . your doctor will discuss this with you . before you are given cer delg , you will have a simple laboratory test to check how well your
do not take cerdelga if you are allergic to eliglustat or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor or pharmacist tells you to take medicines containing moderate cyp2d6 inhibitors ( e . g . quinidine or terbinafine 31 or moderate yp3a inhibitors such as erythromycin or itraconazole ). these medicines reduce your body ' s ability to fight infection . do not stop taking cer delg unless your doctor tells that you are taking medicines that have a poor metaboliser such as medicines that are strong ccp3d6 such as itraconeone . medicines that reduce your level of cd4 protein in the blood may reduce your ' ability to break down and digest the medicine . talk to your doctor
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . cerdelga contains a concentrated form of metaboliser called metabolizer . you can take cerdlgá with or without food . the recommended dose is one tablet once a day in the morning . after breakfast , take the tablet at about the same time each day . this will help you remember to take the medicine . swallow the tablet whole with a glass of water . it is best to take a tablet before the morning meal . how to take take 84 cerdeslg you can swallow the tablets with or just after food ; 84 tablets are for oral use . to take more cerderlgа than you should if someone else accidentally takes your tablets , contact your doctor immediately . take the
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): headache dizziness change in taste ( dysgeusia ) palpitations throat irritation heartburn ( dyspepsia) feeling sick ( nausea ) diarrhoea constipation abdominal pain or stomach ache ( upper abdominal pain ) acid reflux disease ( gastrooesophageal reflux disease ) bloating ( abdominal distension ) inflammation of the stomach ( gastritis ) 34 difficulty swallowing ( dysphagia and reflux ) common ( can occur in more than one in 10 patients ) constipations inflammation of stomach ( gastroenteritis and reflux disease and reflux disorder ) abdominal pain ( abdominal pain and discomfort ) joint pain , back pain . uncommon ( can happen in up to 1 in 100
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and sleeve after " exp ". the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . sachet or sled after " use " must be discarded .
what cerdelga contains - the active substance is eliglustat . each capsule contains 84 mg of elliglustate . - other ingredients are : capsule contents : microcrystalline cellulose , lactose monohydrate ( see section 2 ' cer delgа contains lactoses '), hypromellose , glycerol dibehenate , gelatin , potassium aluminium silicate , titanium dioxide ( e171 ), yellow iron oxide ( oe172 ), indigotine ( uv ), shellac , black iron oxide , propylene glycol and ammonia solution . what cdelgara looks like and contents of the pack cerDelg a capsules are a pearl blue and green opaque capsules with " cb84 " printed
the active substance in zoledronic acid hospira is zolédronic acids , which belongs to a group of substances called bisphosphonates . zolеdronic Acid works by attaching itself to the bone and slowing down the rate of bone change . it is used : to prevent bone complications , e .g . fractures , in adult patients with bone metastases ( spread of cancer from primary site to the surrounding bone ). to reduce the amount of calcium in the blood in adult subjects where it is too high due to the presence of a tumour . tumours can accelerate normal bone change in such a way that the release of calcium from bone is increased . this condition is known as tumour - induced hypercalcaemia ( tih ).
follow carefully all instructions given to you by your doctor . your doctor will carry out blood tests before you start treatment with zoledronic acid hospira and will check your response to treatment at regular intervals . you should not be given zoleric acid aspira : if you are allergic ( hypersensitive ) to zolédronic acids , another bisphosphonate ( the group of substances to which zolechariacid belongs ) or any of the other ingredients of zolеdronic Acid hospria . warnings and precautions talk to your doctor before you are given , or before you receive zolledronic air hospa , if : you have or have had a kidney problem . they may feel pain , swelling or numbness of the jaw , feeling of heaviness in the jaw or loosening of a
- zoledronic acid hospira must only be given by healthcare professionals trained in administering bisphosphonates intravenously , i . e . through a vein . your doctor will decide if you should receive ' iv ' administration . this is to prevent dehydration . carefully follow all the other instructions given to you by your doctor , pharmacist or nurse . how much zoleric acid is given the usual single dose given is 4 mg . ask your doctor how much to give you . you have a kidney problem . the dose depends on the severity of your kidney problem and the type of treatment . before you are given zolledronic acidspira , you will be checked for bone complications due to bone metastases . infusion : zoleledronic Acid hospria may lower the amount of calcium in your blood
like all medicines , zoledronic acid hospira can cause side effects , although not everybody gets them . the most common side effects are usually mild and will probably disappear after a short time . tell your doctor about any of the following serious side effects straight away : common ( may affect up to 1 in 10 people ): - severe kidney impairment ( will normally be determined by your doctor with certain specific blood tests ). - low level of calcium in the blood . uncommon ( may effect up to1 in 100 people ).- pain in the mouth , teeth and / or jaw , swelling or non - healing sores inside the mouth and , jaw discharge , feeling of numbness or a feeling of strength in the jaw . these could be signs of bone damage in the jaw ( osteonecrosis ). tell your dentist and dentist if you experience such
your doctor , pharmacist or nurse knows how to store zoledronic acid hospira properly ( see section 6 ). after first opening , zolledronic acids hospria is intended for patients who are unable to take the medicine or who are not able to take their prescribed dose .
what zoledronic acid hospira contains - the active substance is zolédronic Acid . one vial contains zoleledronic acids . each vial provides 4 mg zolledronic al - ( as monohydrate ). - other ingredients are : mannitol , sodium citrate and water for injections . what zonedronmic acid hompira looks like and contents of the pack zoleric acid
varuby contains the active substance rolapitant . it helps to control the feeling of being sick ( nauseous ) or being sick( vomiting ) when you are having cancer treatment chemotherapy . when chemotherapy is given , nerve cells are important in the brain . they help to stop you feeling or being sickness . varubies works by blocking a receptor called ' epidermal growth factor receptor ' ( egfr ). this helps to reduce the feeling that you are being sick or being hungry . rolapant works by destroying these nerve cells , preventing nausea and vomiting .
do not take varuby : - if you are allergic to rolapitant or any of the other ingredients of this medicine ( listed in section 6 ). - when you are taking an herbal medicine containing st john ' s wort ( hypericum performatum ) which is used for depression and difficulty sleeping ( see section 2 " what varubies contains "). warnings and precautions talk to your doctor or pharmacist before taking this medicine : 27 -if you have severe liver or kidney problems - take certain medicines , e . g ., rifampicin ( used to treat tuberculosis and other infections ) - carbamazepine ( used in some types of epilepsy and nerve pain ) or phenobarbital ( used for epilepsia )- enzalutamide
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet of 180 mg once a day . your doctor may increase your dose to 90 mg once daily . swallow the tablets whole with water , with or without food . you may take varuby with orwithout food for 2 weeks before the start of your chemotherapy cycle . chemotherapy can cause sickness . sickness can occur during treatment with this medicine , especially if : you are going to be sick during your chemotherapy and you may need another chemotherapy cycle ( see section 4 ). this may make you feel sick , or make you sick during chemotherapy . if this happens , tell your doctor , pharmacist or nurse . they will tell you how long you should keep using varubies . it is very important that you keep using this medicine for as long as your prescribed dose is
like all medicines , this medicine can cause side effects , although not everybody gets them . if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . the following side effects have been reported : rare ( may affect up to 1 in 1 , 000 people ): if symptoms of an allergic reaction occur , such as sudden shortness of breath , swelling of the lips or tongue , change in taste , or swelling of skin or tissue , sudden rash , fever and faster heartbeats . tell your doctor immediately and start appropriate treatment . other possible side effect : very common ( may effect more than 1 in 10 people ]): headache ; constipation ; feeling tired common ( might affect up 1 in 100 people ). if this happens you must tell your dentist immediately . not known ( frequency cannot
what varuby contains - the active substance is rolapitant . each tablet contains 90 mg of rolavitant - other ingredients are : tablet core : lactose monohydrate ( see section 2 under ' varubies contains lactoses '), pregelatinised starch , microcrystalline cellulose , povidone ( k - 30 ), croscarmellose sodium , colloidal silicon dioxide , magnesium stearate . film - coating : polyvinyl alcohol , titanium dioxide / macrogol , polysorbate 80 . what vaubby looks like and contents of the pack varubying is a pale yellow to yellowish - yellow film , opaque , oblong tablet marked with " pfizer " on one side . the opaque tablet is blue and is printed with " 90 " on the other
what enerzair breezhaler is enersair b consists of three active substances : - indacaterol - glycopyrronium - mometasone furoate indabacaterol and glycopyrurium belong to a group of medicines called bronchodilators . they work in different ways to relax the muscles of the small airways in the lungs . this helps to open the airways and makes it easier for air to get in and out of the bronchioles . when they are taken regularly , they help the small lungs remain open . momeatasine furoates belongs to  a family of medicines known as corticosteroids ( or steroids ). corticotrooids reduce the swelling and irritation ( inflammation ) in the small aeroways in your lungs and so gradually ease breathing problems .
do not use enerzair breezhaler - if you are allergic to indacaterol , glycopyrronium , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor without taking enERzair and if any of you are not sure , talk to your doctor before taking  Enerzaire breezehaler and / or take special care with enersair . warnings and precautions talk to you doctor before using enezerzair as you may be allergic to any of these substances . - have heart problems , including an irregular or fast heartbeat . talk to yourself or your doctor if your child has thyroid gland problems . tell your caregiver about any of your medical conditions including diabetes or high blood sugar . your doctor may
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much enerzair breezhaler to use the usual dose is to inhale the content of one capsule each day . you only need to use one capsule to get the full effect of the medicine . your doctor will decide how many capsules you need to inhaled . the usual way to enersair briezhalers is to help control your asthma and relieve your symptoms . it is very important that you use enErzair brezhaleer every day , as instructed by your doctor . each pack contains an inhaler and capsules that contain the medicine inhalation service . only use the inhalers provided with the pack to take the medicine as you need it . once the capsules have been used , the inhaler can be
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects could be serious stop using enerzair breezhaler and get medical help immediately if you have any of the following : common : may affect up to 1 in every 10 people - difficulty breathing or swallowing , swelling of the tongue , lips or face , skin rash , itching and hives ( signs of allergic reaction ). other side effects other side effect include those listed below . if these side effects become severe , please tell your doctor . very common - may affect more than 1 in 10 people sore throat , runny nose , sudden difficulty breathing and feeling of tightness in chest . uncommon : might affect upto 1 in each 10 people sudden difficulty in breathing and / or feeling of stiffness in the chest , with or without breathlessness
- keep this medicine out of the sight and reach of children . - do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . store the capsules in the original blister in order to protect from moisture and light . do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what enerzair breezhaler contains - the active substances are indacaterol ( as acetate ), glycopyrronium ( as bromide ) and mometasone furoate . each delivered dose contains 150 micrograms of indаcaterol( as amide ), 63 microgram ( equivalent to glycopyronicum bromidе ) or 50 microgram [ equivalent to 5 . 5 microgram ] of glycopyranium . this delivered dose is equivalent to 160 microgram( equivalent to 9 . 0 microgram of momeatasONE furoates ). the delivered dose that leaves the mouthpiece of the inhaler is equivalent of 114 microgram ind a day . the other ingredients are glycopyronum ( AS aderol ), 56 microgram (1 equivalent to 46 microgram glycopyridine )
clopidogrel acino pharma gmbh contains the active ingredient clopigrel which belongs to a group of medicines called antiplatelet medicinal products . platelets ( so - called thrombocytes ) are very small structures , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood  clots forming ( a process called trophosis ). clopinogrell acini pharma grbh is taken to prevent blood coagulations ( thrombi ) forming in hardened blood vessels ( arteries ), a condition known as atherothrombosis which can lead to atherotrombotic events ( such as stroke , heart attack , or death ). you must take clopionogrelly
do not take clopidogrel acino pharma gmbh : if you are allergic ( hypersensitive ) to clopogrell or any of the other ingredients of clopinogrelly accino pharm ; if your doctor thinks you may have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain ; or if someone in your family has severe liver disease . if any of these apply to you , do not use clopirogrela acini pharma grbh and tell your doctor immediately . take special care with clopionogrelling acacino  Pharma gmmbh take special attention with clupidogral аcino  pharmaceutical gbh is to reduce the risk of bleeding , such as in adults , a family history of
always take clopidogrel acino pharma gmbh exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the usual dose is one 75 mg tablet of clopogrell acan pharma gamborel every day to be taken orally with or without food , and at the same time each day . if the tablet is not swallowed whole , you should take it with or immediately before food or in the evening . it is important that you take a dose of : - one tablet of the clopinogrelly aco pharma gigbh per day , for as long as your physician continues to prescribe it . when to take : the usual dosage is one tablet in the morning and one tablet at the evening as in the afternoon . do not take , crush or split the
like all medicines , clopidogrel acino pharma gmbh can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common (affects 1 to 10 users in 100 ) uncommon ( affect affects 1 to10 users in 1 , 000 ) rare ( affectes 1  to 10 user in10 ,000 ) very rare (affects less than 1 patient in 10 and 10 users of 10 , 10 . 000 ). if you experience any of these effects contact your doctor immediately . very common : fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . not known : signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice 
store in the original blister in order to protect from moisture . keep out of the reach and sight of children . do not use clopidogrel acino pharma gmbh after the expiry date which is stated on the carton and on the blister after exp . the expiration date refers to the last day of that month . this medicinal product does not require any special temperature storage conditions . store in original blister or film - coated tablets in order for safety reasons . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what clopidogrel acino pharma gmbh contains the active substance is clopinogrell . each tablet contains 75 mg of clopogreL ( as besilate ). the other ingredients are : tablet core : macrogol 6000 cellulose , microcrystalline ( e460 ) crospovidone type a castor oil , hydrogenated film - coating : microgol 5000 ethylcellulose ( 6000 ( 8000 ) titanium dioxide ( е 171 ) what cb1 looks like and contents of the pack cloprigrel ascino pmbhut 75 mg film , tablet coating ; white to off - white , marbled , round and biconvex . they are supplied in cardboard cartons containing 14 , 28 , 30 , 50 , 
delstrigo is used to treat hiv (' human immunodeficiency virus ') infection . it belongs to a group of medicines called ' antiretroviral medicines '. it contains the active substances : doravirine , a non - nucleoside reverse transcriptase inhibitor ( nnrti ), lamivudine , another nucleonside analogue reverse transcriptаse inhibitor ( ndrtis ) in addition to tenofovir disoproxil , which is a nucleopenialogue retrograde reverse transcriptainse inhibitor [ nrrtin ] in a single tablet . delStrigo will be prescribed to treat high risk hiv infection in adults 18 years of age and older . hiv is the virus that causes aids (' acquired
do not take delstrigo if you are allergic to doravirine , lamivudine , tenofovir disoproxil , or any of the other ingredients of this medicine listed in section 6 . if this applies to you , tell your doctor immediately . do not stop taking the following medicines carbamazepine / oxcarbazepine or phenobarbital /phenytoin ( medicines to prevent seizure ) rifampicin or rfapentine ( medicines for tuberculosis ) or st . margarek ' s wort ( hypericum perforatum ), a herbal remedy used for depression and anxiety , and products that contain mitotazolam or methylergometrine ( medicines used to treat depression
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is a complete regimen which includes a single tablet to treat hiv infection in adults , adolescents and children aged 1 year and above . your doctor may prescribe you certain medicines , such as doravirine . these are medicines that you must take at the same time as this medicine . taking this medicine swallow the tablet whole with some water . you can take this tablet with or without food . do not take more than the recommended dosage . how long to take delstrigo take dellstrigol every day for as long as your doctors tells you , even when you are in the hospital . if your doctor decides that you need to take a dose of delstrugo for 12 weeks , your doctor will monitor your treatment with delspigo 
like all medicines , this medicine can cause side effects , although not everybody gets them . you should stop taking this medicine and tell your doctor immediately if you experience any of the following : very common ( may affect more than 1 in 10 people ) abnormal dreams , difficulty in sleeping ( insomnia ) headache , dizziness , sleepiness , cough , nasal symptoms feeling sick ( nausea ), diarrhoea , stomach pain , vomiting , wind ( flatulence ), hair loss rash muscle symptoms ( pain or stiffness ) feeling tired , drowsy ( somnolence ) cough rash feeling weak or lack of energy , feeling weak , nervous or lack in energy . uncommon ( may effect up to 1 in 100 people ). very rare ( may impact up to1 in 10 , 000 people ] abnormal dreams dizziest , fainting
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and carton after exp . the expiration date refers to the last day of that month . keep the bottle tightly closed in order to protect from moisture . this medicine does not require any special temperature storage conditions . after first opening of the bottle , use immediately . discard any unused medicine . store in the original package in order for administration . never throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what delstrigo contains the active substance is doravirine . each tablet contains 300 mg lamivudine , or 245 mg tenofovir disoproxil ( as fumarate ) the other ingredients are : tablet core : croscarmellose sodium e468 , hypromellose acetate succinate , magnesium stearate in the core , microcrystalline cellulose e460 , silica , colloidal anhydrous , sodium stearyl fumarat . the coating material contains : carnauba wax e903 , and hypromllose in the film - coating : iron oxide yellow , lactose monohydrate , titanium dioxide e171 , triacetin . what delustrigo looks like and contents of the pack del
spravato contains the active substance esketamine . this belongs to a group of medicines called anti - depressants . you have been given this medicine to treat your depression . it is used to treat the symptoms of depression ( feeling sad , anxious or worthless ), sleeping difficulties , change in appetite , loss of interest in favourite activities , feeling of being slowed down ). if you have not been taking s Pravato for 2 weeks , you should have been treated with another antidepressant ( see section 2 under " other antidepressive medicines ").
do not take spravato - if you are allergic to esketamine ( also known as ketamine used in anaesthesia ) or any of the other ingredients of this medicine ( listed in section 6 ). - you have an aneurysm ( a weak spot on a blood vessel wall ) that bulges out and bleeding in the brain . - have recently had a heart attack within 6 weeks . this is because a temporary increase in blood pressure can cause serious complications in these conditions . warnings and precautions talk to your doctor , pharmacist or nurse before taking s Pravato as the safety and efficacy of this product have not been established . talk to you doctor if : you have a problem with poor blood flow to one of your blood vessels , or you have problems with your heart . you have had , in the past 
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the spravato nasal spray is for use in adults only . the nasal spray device is a single use only , which can be 1 spray in the morning and 2 sprays in the evening . your doctor may decide to increase your dose to 3 nasal spray devices . there is no experience with more than one nasal spray handset in use at least 4 weeks apart . you can use sprinkling in the afternoon and at least one spray device in use in the night . do not use more than 4 sprays per day . if your doctor decides to reduce your dose , you can continue using spruvato for 2 weeks . use this medicinal product to prevent nausea and vomiting . it is best to use it at the same time every day , even
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : very common ( may affect more than 1 in 10 people ) feeling disconnected from your feelings and things around you feeling dizzy , headache , change in sense of taste feeling sleepy , decreased feeling or sensitivity , especially in your mouth area , spinning sensation , vertigo , vomiting nausea common ( might affect up to 1 in every 10 people people ), feeling extremly happy , euphoria , feeling agitated , stomach pain , diarrhoea . common ( these may affect upto 1 in each 10 people in each 100 people ). feeling sick feeling sick ( nausea ) or being sick ( vomiting ) low blood sugar ( hypoglycaemia ) high blood sugar low blood glucose ( hypothyroidism
what spravato contains - the active substance is esketamine . each nasal spray device contains esesketamine hydrochloride equivalent to 28 mg eeketamine in each spray device . - other ingredients are citric acid monohydrate disodium edetate sodium hydroxide ( for ph adjustment ) water for injections what pravat looks like and contents of the pack spruvato is presented as a nasal spray solution . this medicine is a clear , colourless solution in a single - use nasal spray handset . the solution is clear . you will find sprinkling into your nostrils and is available in packs containing 1 , 2 , 3 or 6 nasal spray devices . every nasal spray gadget is sealed in  a sealed blister .
zelboraf is an anticancer medicine that contains the active substance vemurafenib . it is used to treat adults with melanoma that has spread to other parts of the body or cannot be removed by surgery . zelbaf targets proteins that are involved in the growth and spread of melama . the active ingredient in zelburaf targetes proteins that have been found to be present at increased levels in your cancer .
do not take zelboraf - if you are allergic to vemurafenib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking zelmoraf and during treatment : - any symptoms of allergic reactions may include swelling of the face , lips or tongue , difficulty breathing , rash or fainting sensation . zeloraf has not been studied in patients with severe skin reactions . allergic reactions are possible after taking zboraffe . stop taking zeboraF and tell your doctor immediately if : you experience any symptoms suggesting an allergic reaction such as swelling ofthe face . lips or tooth , or difficulty breathing or rash , fainting feeling or severe skin reaction , you should immediately contact your doctor or seek emergency medical care if your reaction is severe
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 4 mg once a day . take the tablets about 8 hours apart . after 4 weeks , the recommended daily dose is 2 mg once daily . you should swallow the tablets whole with a glass of water . do not crush or chew the tablets . if necessary , you may take the tablet at any time of the day , with or without food . this will help reduce possible side effects . your doctor may lower your dose or stop your treatment temporarily or permanently . taking zelboraf you can take it with or just after food , if needed . it is best to take zelbaf on an empty stomach . swallow the tablet whole with some water , one after the other . don ' t break or crush the tablet 
like all medicines , zelboraf can cause side effects , although not everybody gets them . serious allergic reactions may occur , with swelling of the face , lips or tongue difficulty breathing rash fainting sensation when zeloraf is administered zelbaf will be administered under the supervision of a doctor who is experienced in radiation treatment . the most common side effects are radiation related to zelburaf treatment , which can be life - threatening . radiation can affect any part of the body including the skin , epiphysis , bladder , liver , rectal , and lungs . report immediately any possible symptoms of skin rash , including blistering , peeling ; discoloration of the skin shortness of breath a clogged sputum a burning sensation when passing water ( haematoma ). this is very common with other
keep out of the reach and sight of children . do not use zelboraf after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . if you have any unwanted tablets , don ' t put them in waste water or household rubbish . ask your pharmacist how to dispose of tablets you don  '
what zelboraf contains the active substance is vemurafenib . each film - coated tablet contains 240 mg of vemorafeng ( as a co - precipitate of VEmurafatenibe ). the other ingredients are : tablet core : hypromellose acetate succinate , colloidal anhydrous silica , croscarmellose sodium , and hydroxypropyl cellulose and magnesium stearate film , iron oxide red ( e172 ), macrogol 3350 , polyvinyl alcohol , part hydrolysed , plus talc and titanium dioxide ( i171 ). what zeboraF looks like and contents of the pack zeloraf 240mg film  are pinkish white to orange , round shaped tablets marked with " 
duoplavin contains two active substances , clopidogrel and acetylsalicylic acid ( asa ) in one tablet . it belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , it can damage the blood vessels . antiplatelets medicinal products reduce the chances of blood  clots forming ( atherothrombosis ). duo plavin helps to prevent blood coagulation in hardened arteries , and reduce the risk of atherostombotic events ( such as stroke , heart attack , or death ). you must read the package leaflets for all your medical conditions .
do not take duoplavin : - if you are allergic to clopidogrel , acetylsalicylic acid ( asa ) or any of the other ingredients of this medicine ( listed in section 6 ) -if you think you may be allergic to other products , especially non - dendroloidal anti - ininflammatory products . - when you have painful and / or inflammatory conditions of muscles or joints . warnings and precautions talk to your doctor , pharmacist or nurse before taking duolavin if : you have a medical condition such as asthma , nasal discharge , runny nose , polyps ( a type of growth ) in or around your nose . you have or have had a medicinal condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . your doctor may
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the usual dose of duoplavin is one tablet a day . take the tablet at the same time each day , taking your medicine with food . duolavin can be taken with or without food , and it does not matter at what time of the day you take your medicine . if your doctor tells you to take more duoplacevin than you should if , for any reason , you have taken too many tablets , contact your doctor , pharmacist , or your nearest hospital emergency department because of the increased risk of bleeding . you must take duopravin every day ; if possible , show them the pack , which you have bought . do not take a double dose to make up for a forgotten tablet . for the
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , in rare cases , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of the Skin . this may be the signs of an allergic reaction . the following side effects have also been reported : very common side effects ( may affect more than 1 in 10 people ):  headache  diarrhoea  indi
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . store below 25 . this medicine does not require any special storage conditions . no further processing is required . tell your pharmacist if you notice any visible sign of deterioration do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what duoplavin contains duolavin 75 mg film - coated tablets : one tablet contains 75 mg of the active substances , clopidogrel and acetylsalicylic acid ( asa ). each tablet contains 7 . 5 mg of clopigrel ( as hydrogen sulphate ) and 75 mg / 0 . 75 mg detachment of aceylSalicyLIC acid . the other ingredients are mannitol , macrogol 6000 , microcrystalline cellulose , low substituted hydroxypropylcellulose . ingredients in the tablet core are maize starch , hydrogenated castor oil . see section 2 ' duopagvin contains hydrogenated castle oil '.
simbrinza contains two active substances : brinzolamide and brimonidine tartrate . brinzolam belongs to a group of medicines called carbonic anhydrase inhibitors . brimoniidine tartrat belongs to another group of medications called alpha - 2 adrenergic receptor agonists , which help to reduce pressure within the eye . simbrINza is used to treat conditions that affect the eyes , such as certain eye conditions , like glaucoma or ocular hypertension ( high pressure in the eyes that cannot be controlled ).
do not take simbrinza if you are allergic to brinzolamide , brimonidine tartrate or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor thinks you may be allergic to sulphonamides , medicines used to treat diabetes or infections , diuretics ( water tablets ), or any other type of medicine known as a monoamine oxidase ( mao ) inhibitor ( medicines used for depression or parkinson ' s disease ) or to certain antidepressants . warnings and precautions talk to your doctor , pharmacist or nurse before taking simbrine if : you have severe kidney problems you have too much acidity in your blood ( hyperchloraemic acidosis ) you drink large amounts of alcohol ( see section 2 under " other medicines and simbrinerza "). you have liver problems
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . only use simbrinza for your eyes ( ocular use ). do not swallow or inject . simbrine should only be used in your eyes . wash your hands before you start . step 1 : before you begin , take the first drop of simbrINza , wait 2 hours after the cap has been removed , and then wait until the cap is completely closed , before using the medicine . if the drops are discoloured or if there is a ' snap collar ' at the back of the bottle , insert the medicine into a small opening to release the medicine and press it down until it is time to use it . press down with your thumb and fingers until it can reach the ceiling . tilt your head back . pull down
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : if you experience a reaction to the medicine ( frequency not known ), you may need to stop taking the medicine . if this happens , tell your doctor or nurse immediately . an allergic reaction may occur . severe skin reactions ( rash , redness or itching all over your body or eyes trouble breathing , chest pain or irregular heart beat ) tell your doctors or nurse right away . you may experience extreme tiredness or dizziness . side effects with simbrinza may occur with other medicines : brinegar tablets : very common ( may affect more than 1 in 10 people ): - very common : may affect up to 1 in 20 people - severe skin reaction ( e .g ., rash or redness )
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and the carton after " exp ". the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . after opening the bottle : do not refrigerate or freeze . keep the bottle tightly closed in order to protect from moisture . throw away the bottle 4 weeks after first opening to prevent infections and use a new bottle . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what simbrinza contains - the active substances are brinzolamide and brimonidine tartrate . one ml of suspension contains 10 mg of brinzolam and 2 mg of brimoniidine tartration equivalent to 1 . 3 mg brimondidine . -the other excipients are benzalkonium chloride ( see section 2 " simbrine contains benzallenium chlorides "). - other ingredients are propylene glycol , carbomer 974p , boric acid , mannitol . the other ingredients in the suspension are sodium chloride , toyloxapol , hydrochloric acid / sodium hydroxide . purified , acid and water for injections . what siminza looks like and contents of the pack simbrenza is a clear , colourless liquid . it is
what filgrastim ratiopharm is filgraStim ratioppharm contains the active substance filgraştim . filgrassant is a protein produced by biotechnology in bacteria called escherichia coli . it belongs to a group of proteins called cytokines and is very similar to : a natural protein ( granulocyte - colony stimulating factor [ g - csf ]) produced by your own body . Filgrastig stimulates the bone marrow ( the tissue where new blood cells are made ) to produce more blood cells , especially certain types of white cells . white cells are important as they help your body fight infection . what filgratstim is used for filgraßtim ratioopharm is used to stimulate the production of more white blood cells in your body , and help your immune system to fight infection in all age groups .
do not use filgrastim ratiopharm : if you are allergic ( hypersensitive ) to filgraStim or any of the other ingredients of filgraştim ratioppharm . warnings and precautions talk to your doctor or pharmacist before using filgrassant ratiopham . filgrasten ratioparm may cause a cough , fever and difficulty breathing . this may be a sign of a pulmonary disorder , which may be serious . tell your doctor if any of these side effects are serious , as they may be caused by sickle cell disease 57 if your doctor gets left upper abdominal pain or pain at the tip of your shoulder . it may be due to a sore throat or other possible side effects . regular blood tests during treatment with filgrastastim rapportpharm your doctor will check the number of neutrophils and other white blood cells in your blood before and
filgrastim ratiopharm can be found in the following table . you will find a doctor who is experienced in the use of filgrasestim ratioppharm . always take filgrassant ratioparm exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . do not take filgratstim ratepharm without your doctor ' s advice . filgrasten ratiopham treatment the recommended dose of filgratgrattim ratioppepharm for chemotherapy is 0 . 5 million international units ( miu ) per kilogram body weight . this means you will usually receive 60 million international unit ( mius ). your treatment will usually last for about 14 days . in some disease types , however , longer treatment lasting up to about one month may be required . when filgrar ratiophand is given after bone marrow transplantation the usual dose is 1
you should not be given filgrastim ratiopharm if you have sickle cell disease 57 if your doctor determines that you have left upper abdominal pain or pain at the tip of your shoulder . it could be a consequence of a spleen disorder ( see section 4 . possible side effects ). your doctor will do regular blood tests while you are being treated with filgraStim ratioppharm , to check the number of neutrophils and other types of white blood cells in your blood . this will be checked before and during treatment . taking other medicines please tell your doctor if any of the above apply to you . your doctor may need to change your dose or if there are any other medicines , including medicines obtained without a prescription . pregnancy and breast - feeding ask your doctor for advice before taking any medicine . you must tell your healthcare professional if : you are pregnant ,
keep out of the reach and sight of children . do not use filgrastim ratiopharm after the expiry date which is stated on the outer carton and on the pre - filled syringe after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . filgraStim ratioppharm should not be used if it is cloudy . medicines should not être disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what filgrastim ratiopharm contains - the active substance is filgraştim . each ml of solution for injection or infusion contains 60 million international units [ miu ] ( 600 microgram ) of filgrassant . filgrarstim ratepharm 30 miu in 0 . 5 mL solution for infusion : each vial contains 30 million international unit [ miù ]( 300 micrograms ) filgraraztim in a 0. 5 millilitre . film coating : filgragrastig ratioph 48 miu per 0x 8 mlly solution for treatment : one vial provides 48 million international international units ( miu *) filgranstim in an 0 8 . 8 % solution for injecting . - other ingredients : sodium hydroxide , glacial acetic acid , 
what riluzole zentiva is the active substance of rilluzol zentive is rilsuzola which acts on the nervous system . what röluzolе zenturia is used for rluzule  Zentiva belongs to a group of medicines called amyotrophic lateral sclerosis ( amy ). this is a form of motor neurone disease where attacks of the nerve cells responsible for sending instructions to the muscles lead to weakness , muscle waste and paralysis . the destruction of nerve cells in motor neurones is caused by too much glutamate ( a chemical messenger ) in the brain and spinal cord . riuzoler zenivia blocks the action of glutamates and this may help to protect the nerve cell' s messages .
do not take riluzole zentiva - if you are allergic to rilluzola or any of the other ingredients of this medicine ( listed in section 6 ). - tell your doctor if any of these apply to you : - you have any liver disease or increased blood levels of some enzymes of the liver ( transaminases ). this is because you may be pregnant . warnings and precautions talk to your doctor before taking rilsuzol zentivea if : you have or have had any liver problems , including yellowing of your skin or the whites of your eyes ( jaundice ), itching all over , feeling sick , being sick - your kidneys not working properly - fever - this may be due to a low number of white blood cells which can be a sign of infection . children and adolescents r
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . try to take the tablet at the same time each day , so that you can easily remember when to take it . you can take the tablets with or without food . it is best to take your tablet at about the same times each day and with food , preferably in the morning and evening . if your doctor advises you to take more tablets than you should if possible , show them to your doctor , pharmacist or nurse . adults and adolescents 12 years of age and older should take riluzole zentiva for as long as your physician continues to prescribe it , even if there is still some medicine left in the body . contact your doctor immediately or go to the nearest emergency department immediately . keep the tablet bottle with
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever ( increase in temperature ). riluzole zentiva can cause a decrease in the number of white blood cells . your doctor will have taken a blood sample to check the number and type of whiteblood cells , which are important in fighting infections . - you may experience one or more of the following symptoms : yellowing of your skin or the whites of your eyes ( jaundice ), itching all over , feeling sick , being sick . this may be due to liver disease ( hepatitis ). you will have regular blood tests while you are taking rilsuzola zenturia . tell your doctor if : you develop cough , difficulties in breathing . these may be signs of a
what riluzole zentiva contains - the active substance is rilluzola . -the other ingredients are : core : anhydrous dibasic calcium phosphate , micro crystalline cellulose , anhydrOUS colloidal silica , magnesium stearate , croscarmellose sodium , indigo carmine ( e132 ), hypromellose , macrogol 6000 , titanium dioxide ( е171 ). what riciluzo zentive looks like and contents of the pack the tablets are white to off - white , oval shaped and embossed with " liluZe " on one side and " nvr " on the other side . tablet dimensions : 50 mm , biconvex , debossed on one face and "
emgality contains the active substance galcanezumab , a medicine that interferes with the calcitonin gene . migraine is caused by increased levels of cgrp in the blood . emmgality is used to treat migraine in adults , adolescents and children aged 4 years and above . it is used in adults to prevent migraines from occurring . the use of egality has not been studied in adults or adolescents . however , it has been shown to reduce the frequency of migraine headache but to improve your quality of life .
do not use emgality if you are allergic to galcanezumab or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor thinks you may have a serious cardiovascular disease . warnings and precautions talk to your doctor or pharmacist before using emmgality and if there is anything you do not understand , ask your doctor , pharmacist or nurse to explain . there are no reports of serious cardiovascular diseases . reporting of allergic reactions egality has been associated with serious allergic reactions and some of these reactions are reported to be more than 40 % of patients . it is possible that you could have , or might have - a seriously allergic reaction . if such signs occur , stop using a single dose and contact your doctor immediately . you can also report side effects directly via the national reporting system listed in appendix 4 . children
always use emgality exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual dose of egality is 240 mg ( one injection of 240 micrograms ) given once a week by injection under your skin ( subcutaneous injection ). you should receive your emmgality injection at the same time each week , but this will depend on how you respond to treatment . after proper training your doctor may decide to give you 240 doses . if a double dose is administered , you should give your doctor another dose to make up for a forgotten dose . you should inject emogality exactly the same day each week as your physician has instructed you , and continue to inject . do not try to inject yourself if your doctor thinks that you have not been trained . for instructions on how to inject your medicine yourself 
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects allergic reactions to emgality are rare . you may notice rash or itching . these are serious allergic reactions ( may affect up to 1 in 1 , 000 people ). you may also notice difficulty breathing or swallowing , low blood pressure , dizziness or light - headedness , swelling of the neck , face , mouth , lips , tongue or throat , severe itching of the skin , with a red rash with raised bumps . other side effects tell your doctor or nurse if you notice any of the following : very common side effects ( may effect more than 1 in 10 people ): - at the injection site : o at the site of injection - site - pain , redness or itchy skin - raised bump 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . once the viall has been opened , use immediately . however , if the solution is not clear and colourless it can be stored for up to 7 days at room temperature ( 20 30 ). store in the original package in order for the medicinal product to be used . this medicine may pose a risk to the environment .
what emgality contains the active substance is galcanezumab . each pre - filled pen contains 120 mg galcanab in 1 ml solution . the other ingredients are l - histidine , l- historide hydrochloride monohydrate , polysorbate 80 , sodium chloride , and water for injections . what a emmgality looks like and contents of the pack egality is a solution for injection supplied in a clear glass syringe . its colour may vary from colourless to slightly yellow . not all pack sizes may be marketed . please note that the sYringe is labelled as a single - dose pen . pack sizes of 1 , 2 or 3 single  dose pens are available .
defitelio is a medicine that contains the active substance defibrotide used to treat a condition called hepatic veno - occlusive disease ( hepv - overlusive ) in adult patients , in which the blood vessels in the liver become damaged and blocked by blood clots . defitementio belongs to a group of medicines which are given prior to , or shortly after , a stem cell transplantation .defibrotides helps to relax the blood vessel walls and prevent the blood coagulation that have formed during treatment with this medicine .
do not use defitelio : - if you are allergic to defibrotide or any of the other ingredients of this medicine ( listed in section 6 ) - use other medicines to prevent blood clots ( such as tissue plasminogen activator warnings and precautions ) talk to your doctor or nurse before using this type of medicine . this is important as it may cause bleeding which may be potentially life threatening . if heavy bleeding occurs , it may be necessary to have a blood transfusion . warnings about complications of surgery , such as problems with blood circulation and a constant blood pressure . children and adolescents defit lia is not recommended for use in children under 1 year of age . other medicines and defitlion tell your doctor if your doctor has given you other medicines or medicines to reduce blood coagulation , for example : the
your doctor will decide on the most appropriate treatment for you or your child . your doctor or nurse will give you defitelio after having been given stem cells transplantation . it will be given to you or the child by a doctor or a nurse . defitlion will be infused into your veins ( known as an ' intravenous infusion ' or drip ). this treatment will be administered over 21 minutes , depending on your symptoms . if you are given more defit lia than you should if , in the unlikely event that you have been given too much defitalione , tell your doctor , nurse or pharmacist . you will usually receive an additional dose , usually over 18 minutes . depending on the dose you receive , your doctor may decide to give you more deflateloo than you need . tell your nurse or doctor
like all medicines , defitelio can cause side effects , although not everybody gets them . defitlion may cause side impacts , some of which may be serious . if you get any of these side effects talk to your doctor or nurse immediately . very common ( may affect more than 1 in 10 people ): low blood pressure common ( might affect up to 1 in every 10 people): bleeding in general bleeding which may include the nose bleeding , the brain bleeding in the gut vomiting blood bleeding in various parts of the lungs bleeding ; blood in the urine ; the mouth bleeding . problems with the skin coagulopathy ( disturbance , which leads to blood clotting ) not known ( frequency cannot be estimated from the available data ) : dizziness feeling sick ( nausea ) or feeling sick - like symptoms , such as nausea , vomiting , diarrho
defitelio will be stored by the healthcare professionals at the hospital or clinic where it is given . the storage details are as follows : keep the container tightly closed . store in a refrigerator ( 2 - 8 ). do not freeze . do not administer defitlion if you notice that the solution is cloudy . throw away the vial immediately .
what defitelio contains - the active substance is defibrotide . each 2 . 5 ml vial contains 200 micrograms of defibroTide - each mL solution contains 80 microgram ( g ) of debrotide at the date and time of calibration . - other ingredients are sodium citrate dihydrate , hydrochloric acid , sodium hydroxide ( for ph - adjustment ) and water for injections . what deFITelilio looks like and contents of the pack defitalia is a clear to slightly opalescent , colourless to pale yellow solution . it is supplied in 2 mlitres of concentrate for solution for infusion . one pack contains 10 vials of 2 , 5 . 4 mll concentrate .
daklinza contains the active ingredient daclatasvir . it is used to treat hepatitis c , an infectious disease that affects the liver , caused by the hepatis - c virus . this medicine stops the hpatitistis b virus from multiplying and infecting new cells . daklinning stops the growth of heptis
do not take daklinza if you are allergic to daclatasvir or any of the other ingredients of this medicine ( listed in section 6 ) or taken by mouth with the following medicines : phenytoin , carbamazepine , oxcarbazepine and phenobarbital ( used to treat epileptic seizures ) rifampicin / rfabutin - riffapentine ( antibiotics used to prevent and treat tuberculosis ) dexamethasone ( a steroid used to correct allergic and inflammatory diseases ) medicines containing st . john ' s wort ( spfizer ) ( antibiotic used to suppress the immune system ) daklinacone is a medicine used to help prevent and prevent infections . it is also
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of daklinza is 60 mg once a day . take the tablet at about the same time each day , preferably in the morning . this helps to get the right levels of body blood . you may get a different , unpleasant taste when you take dakling . your doctor may prescribe you some other medicines before you start taking daklinning . if your doctor prescribes one of these medicines , you should continue to take your daily dose of diklinze until your doctor tells you otherwise . depending on how you respond to the treatment , your doctor might prescribe daklines with other medicines for hepatitis c infection . ask your doctor if any of these medicine apply to you , or if they do not work well enough 
like all medicines , this medicine can cause side effects , although not everybody gets them . when daklinza is used in combination with sofosbuvir and ribavirin the following side effects have been reported : very common ( may affect more than 1 in 10 people ) headache fatigue common ( might affect up to 1 in every 10 people in a 100 - person household ) difficulty sleeping dizziness migraine nausea ( feeling sick ) diarrhoea abdominal pain joint pain aching and tender muscles have been seen in patients receiving daklimza in combination of sofofosbvir and also rib avirine . these side effects are expected to be mild and usually go away after a few days . children and adolescents the following additional side effects were reported . very common : may affect less than 1 person in 10 : headache common ; may affect upto 1
what daklinza contains - the active substance is daclatasvir . each film - coated tablet contains 30 or 60 mg of daclaatasVir ( as dihydrochloride ). - other ingredients are : tablet core : anhydrous lactose , microcrystalline cellulose , croscarmellose sodium , silicon dioxide , magnesium stearate . tablet coating : hypromellose , titanium dioxide . macrogol 400 , indigo carmine aluminium lake , yellow iron oxide ( e172 ). 51 what daclinza looks like and contents of the pack daklitazvir 30 mg film . the film  screen is white , oval with " bms 30 " debossed on one side . daklince is available in packs containing one blister of 30 tablets .
proquad is a vaccine to prevent measles , mumps , rubella and chickenpox ( varicella ) viruses . when a person is given the vaccine , the immune system ( the body ' s natural defence system ) will make antibodies against the meases and mops caused by rubella or varicellin ( a type of varicelli virus ). the antibodies help the body to develop diseases caused by these viruses , especially when they are infected with meause , and preventing mashes caused by varicellella and chickpoix ( varicela ). when , when given the vaccination , your child will make proteins that protect you against 12 months of age . proquade is intended for use in children 9 years of age and older who have not yet been nationally vaccinated with other types of meadles
do not receive proquad : - if you are allergic to any varicella vaccine , to measles , mumps , rubella vaccine or any of the other ingredients of this vaccine ( listed in section 6 ) or to neomycin . - have a blood disorder or type of cancer that affects the immune system . warnings and precautions talk to your doctor , pharmacist or nurse before receiving proquade . before treatment with medications that affect the immune System ( such as low - dose corticosteroid therapy , asthma or replacement therapy ). - you have - or have weakened immune system because of a disease ( including aids ), congenital or hereditary immunodeficiency ( cd09 ), or lack of immune competence , or active untreated tuberculosis ( aids or aids therapy
proquad is given as an injection into the muscle just under the skin ( thigh or upper arm ). it is given by injections into the same muscle as the tummy area or upper arms area . it is usually given as a single injection into a muscle , preferably in the thhigh area or in the upper arm area , but may also be given as separate injections . if you have a blood clotting disorder or low levels of platelets , the vaccine should be given under the dermatology in order to reduce bleeding . the vaccine will only be given to you or your child by a doctor or nurse . proquade must never be given into , or into  a vein . however , proquadu can only be administered into - a normal blood vessel by injection . your doctor or healthcare professional will show you how to prepare and inject proquaD properly
like all vaccines and medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions , such as hives , may occur rarely . some of these reactions may be serious and may cause difficulty in breathing or swallowing . if you have an allergic reaction , stop using the vaccine and talk to your doctor immediately . other side effects with proquad : may affect up to 1 in 100 people - seizures - fits with a fever . may affect less than 1 in 1 , 000 people , - bronchiolitis ( difficulty breathing , cough , and unsteadiness with walking ). the following side effects have been reported with proqud . common ( may affect more than 1in 10 people ) - injection site complaints - nausea , vomiting , diarrhoea , nausea and vomiting . uncommon ( may effect
what proquad contains the active substances are : measles virus1 , edmonston strain , 3 . 00 micrograms mumps virus1 produced in per . 2 million cells , by recombinant dna technology . jeryl lynn TM ( level b ) strain : 4 . 30 microgram slugger of rubella virus2 , strain 3 .00 microgram ( s ) varicella virus3 , and merck strain 3.99 microgram( ss ). what proqud looks like and contents of the pack proquadic is a white to off - white , white to red , oval , scored , tissue culture . it is produced by dilution of plaque - forming units ( mrc ). the other ingredients are ; powder
jylamvo is an anticancer medicine that works by preventing unwanted reactions . it is an immunosuppressive agent with an anti - inflammatory effect jYlamva is used in adults to treat rheumatic and skin diseases including active rhumatoid arthritis , polyarthritic forms that involve the joints , and severe juvenile idiopathic arthritis ( jia ) for patients aged 3 years and older who have not responded to non - statin - related drugs ( nsaids ), and who have inadequate o severe or disabling psoriasis when treatment with phototherapy with psentoralen is contraindicated or blocked by ultraviolet a radiation ( puva ) therapy .
do not take jylamvo if you are allergic to methotrexate or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor or pharmacist has told you that you have a severe kidney impairment if the doctor or nurse has told me that you suffer from a liver impairment , or blood disorders ( such as bone marrow hypoplasia , leukopenia or thrombocytopenia ) that is severe or if there is significant anaemia if any of these apply to you , do not use jYlamva . warnings and precautions talk to your doctor , pharmacist or nurse before taking jyeramvo and if : you have been told that you currently have , have - or have : - a weakened immune system as a result of a serious infection such as tuber
jylamvo will only be prescribed to you by a doctor with experience in treating patients with rheumatoid arthritis . it will only help you with the treatment of severe juvenile idiopathic arthritis , with or without severe psoriasis . severe ppsoriatic arthritis jYlamva is used as a long - term treatment . jyeramvo is prescribed for the treatment and prevention of rhumatic and skin diseases associated with jia , including psesoriases and ppsiatic arthritis in adults . how much and how often to take jinamvo are prescribed for each individual patient group . the recommended dose of the medicine for adult rhusatod arthritis is 7 . 5 to 7 , respectively . for phoriaasia and 
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience : wheeziness , difficulty in breathing , swelling of the eyelids , face or lips , rash or itching ( especially affecting your whole body ). other side effects may include : breathing problems , feeling of illness , dry , irritating cough , shortness of breath or difficulty in breath , chest pain ( fever ), spitting or coughing blood , serious peeling with blistering , redness or blistering in the mouth , mouth - like rash , itching , changes in the way your breathing works . this is usually mild to moderate . if it does not improve , tell your physician . other side effect may include very common ( may affect more than 1 in 10 people ): diarrh
keep this medicine out of the sight and reach of children . do not use the medicine after the expiry date which is stated on the label after exp . the expiration date refers to the last day of that month . store below 25 . keep the medicine in the original package in order to protect from light and accidental spillage . after first opening , the product should be used immediately . if not used immediately, in - use storage times and conditions prior to use are the responsibility of the user . disposal of 3 ml of waste material , including cytotoxic products , should be disposed of in accordance with local requirements .
what jylamvo contains - the active substance is methotrexate . each ml of solution contains 2 mg of methotréxate ( as besilate ). - other ingredients are : macrogol 400 , glycerol , orange flavour , sucralose , epithyl parahydroxybenzoate , sodium methyl parahydroxybenzoate ( e219 ), citric acid , tri - sodium citrate , purified water . see section 2 " jYlamva contains ethyn parahydroxy benzoate and sodium hydroxybenzobiate ". what if jyervo looks like and contents of the pack jyinglamvre is presented as a brown glass bottle containing 60 mbq ( msq ) solution . it is supplied in a child 
what enurev breezhaler is this medicine contains a medicine called glycopyrronium bromide . this belongs to a group of medicines called bronchodilators . what  Enurev is used for this medicine is used to make breathing easier for adult patients who have breathing difficulties due to : a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten . that makes breathing difficult . how enuresv enUREv BREezhale works this medicine blocks the tightening of these muscles in the lungs , making it easier for air to get in and out of the pulmonary system . if you use this medicine once a day , it will help to reduce the effects of copd on your everyday life .
do not use enurev breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before using enurév BREezhalER : - patients with kidney problems - suffer from an eye problem called narrow - angle glaucoma - patient with difficulty passing urine . during treatment with enuresv brewinger , stop using this medicine and tell your doctor immediately if : you experience tightness of the chest , coughing , wheezing or breathlessness immediately after using  Enurev breather . this may be a sign of bronchospasm . if this occurs , contact your doctor . you experience difficulties in breathing or swallowing . swelling of the tongue , lips or face or
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much enurev breezhaler to use the usual dose is to inhale the content of one capsule each day . you only need to inhale the content and the smell of the medicine . the maximum recommended dose is 24 capsules in each blister , which contains 75 capsules . do not swallow the capsules whole . this medicine is for inhalation use . when you are using this medicine , you will find an inhaler and capsules ( in blisters ) that contain the medicine as inhalations powder . only use the capsule with the inhalers provided in this pack ( enuresv bruezhalers inhalateur ). the capsule must be used once a day , unless you have used one of
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious . uncommon ( may affect up to 1 in 100 people ) irregular heart beat high level of blood sugar ( hyperglycaemia : typical symptoms include excessive thirst or hunger and frequent urination ) rash , itching , hives , difficulty breathing or swallowing , dizziness ( signs of allergic reaction ) swelling mainly of the tongue , lips , face or throat ( signs indicate angioedema ). if you get any of these side effects tell your doctor immediately . these are usually mild to moderate . if they get serious , or if your doctor thinks they may need to reduce your dose . other possible side effects include : some side effect may be more serious : very common ( may effect more than 1 in 10 people 
what enurev breezhaler contains - the active substance is glycopyrronium bromide . each capsule contains 63 micrograms of glycopyrpyrronicum bromid . one delivered dose ( the dose leaving the mouthpiece of the inhaler ) contains 44 microgram ( 5 microgram ) of glycopirronium . - other ingredients of the powder contained in the capsule are lactose monohydrate and magnesium stearate . what enturev has inhaled enuresv brewinger 44 microlitres inhalation powder . they are hard capsules containing a white powder and are separated by a device called an inhalers . then each pack contains capsules in blisters , with each blister strip containing 6 capsules of 10 capsules each . not all pack sizes may be available in your country . please note that the
what riximyo is rximya contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to the surface of a kind of white blood cell called " b - lymphocyte ". when ritzimabe sticks to this cell , the cell dies . what reiximmyo is used for ruximyon may be used for the treatment of several different conditions in adults . your doctor may prescribe riimyone for the treating of : a ) non - hodgkin ' s lymphoma this is usually a disease of the lymph tissue ( part of the immune system ) that affects a particular type of whiteblood cell called b- lymphoocytes ; the cell is called rif
do not take riximyo if you are allergic to rituximab , other proteins which are like ritsimabe , or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before taking rximya . if your doctor thinks you may have a severe active infection at the moment . tell your doctors if they know that you have  a weak immune system . warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : you have severe heart failure or severe uncontrolled heart disease , including granulomatosis with polyangiitis , microscopic polyangitis and pemphigus vulgaris . this is because richimyde could cause this . talk to you doctor if any
you will be given riximyo under the supervision of a doctor who is experienced in the use of this treatment . they will watch you closely while you are being given this medicine . this is in case you get any side effects . you will always be given this product exactly as your doctor or nurse has told you . check with your doctor , nurse or pharmacist if you are not sure . rximyon is given as a drip ( intra - venous infusion ). medicines given before each ritchimya administration are given before you are given . when rrazimyyo is given to you , other medicines ( premedication ) may be given to reduce the risk of side effects and delay your treatment if needed . for non - hodgkin ' s lymphoma patients who receive riximYo alone 
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . rarely , many of these reactions have been fatal . infusion reactions during or within the first 24 hours of the infusion you may develop fever , chills and shivering . you may also experience pain at the inffusion site , blisters , itching , sickness ( nausea ), tiredness , headache , breathing difficulties , blood pressure raised , wheezing , cough , chest pain , fever and sore throat . if you experience any of these , tell your doctor straight away . other possible side effects very common ( may affect more than 1 in 10 people ): dizziness . common (may affect up to 1 in10 people  ) side effects (
what riximyo contains the active ingredient in rituximab is called ritsimabe . the 10 ml vial contains 100 mg of ritzimaB ( 10 mg / mL ). the 50 mbq vial includes 500 mg of of  Rituximib ( 10mg /ml ). other ingredients are sodium citrate , polysorbate 80 , sodium chloride , water for injections , salt hydroxide and hydrochloric acid ( see section 2 " rximya contains sodium "). what if risseimyou looks like and contents of the pack risimyon is a clear to slightly opalescent , colourless to slightly yellowish solution , supplied as a concentrate for solution for infusion . riceimyus is supplied in
topotecan actavis contains the active substance topoten . topotent actavia is used to treat small cell lung cancer that has come back after chemotherapy . it is used in adult patients to treat advanced cervical cancer if surgery or radiotherapy is not possible . in this case topotécan actas treatment is combined with medicines containing cisplatin .
do not take topotecan actavis : - if you are allergic to topotenecan or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking topoteractavis as your dose may need to be adjusted . if your blood cell counts are too low , tell your doctor . do not change the dose of topotécan activis . tell your dentist if any of these applies to you . your doctor will tell you whether you need to take to potecan actsavis or not . take special care with topotacan actas - tell your healthcare professional if : you have any kidney problems . you should not take the medicine if the doctor thinks that you are too high or too low for you , as topoting actavises may not be suitable for
your doctor will decide how much topotecan actavis you need and for how long . the dose will depend on : - the disease being treated , - your body surface area ( m2 ), - certain blood tests carried out before and during treatment , and on your response to treatment . adults small cell lung cancer the usual dose is 1 . 5 mg per m2, of body surface surface area once daily for 5 days . this treatment cycle will normally be repeated every three weeks . cervical cancer the dose is 0 . 75 mg per square metre of body area once weekly for 3 days , but this treatment cicl will normally not be repeated . for cervical cancer , it will be given in combination with another anticancer medicines called cisplatin . your doctor may reduce the dose of cistplatin to be given to you if you have impaired kidney function . 
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side effect : - infections ( very common , may affect more than 1 in 10 people ), including fever . this may be a sign of your general condition , or local symptoms such as sore throat or burning sensation , severe stomach pain or fever , diarrhoea and bowel inflammation ( neutropenic colitis ). topotecan actavis may reduce your ability to fight infections . - lung inflammation ( very rare , might affect up to 1 in 1 , 000 people ). this may cause difficulty in breathing . you may also experience a reduction in the number of white blood cells , which reduce your body ' s defences . other side effects include : very common ( may affect
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 28 ). do not freeze . keep the vialist in the outer carton in order to protect from light . after reconstitution and dilution chemical and physical stability of the concentrate has been demonstrated for 24 hours at 25  2 , in normal light conditions . from a microbiological point of view , the product should be used immediately . if not used immediately it can be stored at 2 - 8 , protected from light until the drug product solution is ready to be used . for difution in solutions for infusion ( nacl 0 . 9 % and glucose 5 %) has been shown to be stable for
what topotecan actavis contains - the active substance is topotacan . each vial contains 1 mg or 4 mg of topoten ( as hydrochloride ). after reconstitution 1 ml concentrate contains 1 g of to potecan - other ingredients are mannitol ( e421 ), tartaric acid ( 84 % w / w), hydrochoralic acid ( 85 %) and sodium hydroxide . what to potacan actas looks like and contents of the pack topotercan activis is supplied in a pack containing grey bromobutylic stopper and aluminium seals with plastic flip - off caps . the cap is wrapped in  a protective sleeve . pack sizes : 1 x 1 or 5 x1 x 2 x 10 x
the active substance of rivastigmine hexal is rivabstigmine the active ingredient in rivainstigmine is rastigemine . rivashestigmine belongs to a class of substances called cholinesterase inhibitors . in patients with alzheimer ' s dementia or dementia due to parkinson 's disease , certain nerve cells die in the brain , resulting in low levels of the neurotransmitter acetylcholine ( a substance that allows nerve cells to communicate with each other ). rivstigmin works by blocking the enzymes that break down acetoline : aceylcholcholineSterase and butyrylcholineesterase . by blocking these enzymes , it allows riv astylation of aceTylCHOLINE to be increased in the functioning of the
do not take rivastigmine hexal - if you are allergic to rivrastigemine ( the active substance in rivavastigmin heexal ) or any of the other ingredients of this medicine ( listed in section 6 ). -if you have had a previous skin reaction suggestive of allergic contact dermatitis with rivainstigmine. if this applies to you , tell your doctor and do not give you rivstigine heexeal . warnings and precautions talk to your doctor before taking rivrasistigme heXal : - when you have irregular or slow heartbeat . - you have an active stomach ulcer . you ' ve got difficulties in passing urine . or if someone in your family has a history of seizures . your doctor may want to monitor you more closely . the
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how to start treatment your doctor will tell you what dose of rivastigmine hexal to take treatment usually starts with a low dose . your doctor may slowly increase your dose depending on how you respond to treatment . the highest dose that should be taken is 6 . 0 mg twice a day . you should swallow the tablet whole with  a glass of water . do not crush or chew the tablet . this will help determine how long you should take this medicinal product . take rivage heexal for more than three days . don ' t stop taking this medicine if your doctor tells you to . taking rivstigmin heXal don  t take the medicine for longer than three weeks . it is important that you
like all medicines , this medicine can cause side effects , although not everybody gets them . you may have side effects more often when you start your medicine or when your dose is increased . usually , the side effects will slowly go away as your body gets used to the medicine . very common : may affect more than 1 in 10 people feeling dizzy loss of appetite stomach problems such as feeling sick ( nausea ) or being sick ( vomiting ), diarrhoea common ; may affect up to 1 in10 people anxiety sweating headache heartburn weight loss stomach pain feeling agitated feeling tired or weak generally feeling unwell trembling feeling weak stomach pain being sick stomach pain , feeling tired ( nausea or vomiting ) feeling tired tired ( tired ) being sick( vomiting ); diarrageen lack of energy common , may affectup to 1in 10 people anxiety feeling restless sleepy , tiredness or
keep out of the reach and sight of children . do not use rivastigmine hexal after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store below 30 . keep the blister in the original package in order to protect from moisture .
what rivastigmine hexal contains 64 the active substance is rivabstigmine hydrogen tartrate . the other ingredients are hypromellose , magnesium stearate , microcrystalline cellulose , colloidal anhydrous silica , gelatin , yellow iron oxide red iron oxide ( e172 ) and titanium dioxide ( i171 ). the printing ink contains shellac . each rivainstigmine
what cabometyx is cabrometyX is a cancer medicine that contains the active substance cabozantinib used to treat adults with kidney cancer ( renal cell carcinoma ) or liver cancer , for whom a specific anticancer medicine , called sorafenib , is not recommended . what accoometychx is used for cabômetyex blocks the action of proteins called receptor tyrosine kinases ( rtks ), which are involved in the development of new blood vessels that supply them and the secretion of these proteins , which can be present in high amounts in cancer cells . if you have any questions about how cabmetyix works or why this medicine has been prescribed for you , ask your doctor .
do not take cabometyx 45 - if you are allergic to cabozantinib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking cabrometyX - in particular if : - you have high blood pressure - have or have had an aneurysm ( enlargement and weakening of a blood vessel wall ) or a tear in a wall of  ablood vessel wall tell your doctor if any of these apply to you . - suffer from diarrhoea - your doctor may want to monitor you more closely - had a recent history of significant bleeding after surgery - within the last month - any of your medical or surgical procedures ( dental surgery ) - are suffering from inflammatory bowel disease ( crohn '
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . this medicine is for oral use swallow the tablet whole . do not crush or chew the tablet . take the tablet at about the same time each day . you may need to take the tablets for a short time to get the full effect of your treatment . if there are any signs of serious side effects , your doctor may lower your dose or stop treatment , either temporarily or permanently . the usual dose of cabometyx is 60 mg ( one tablet ) taken once a day , unless your doctor tells you to . how long to take cabrometyX for you will take a total of 2 tablets , one tablet of 3 cabmetyn for at least 1 hour before or after taking the medicine . swallow the tablets whole with 
like all medicines , this medicine can cause side effects , although not everybody gets them . if you get side effects your doctor may tell you to take cabometyx at the same time as other medicines to control your side effects ( see section 2 ). tell your doctor straight away if your side affects you and you need urgent medical treatment . symptoms include pain in the abdomen , nausea ( feeling sick ), vomiting , constipation , fever , or a gastrointestinal perforation ( a hole that develops between the stomach and the intestine ). severe or uncontrollable bleeding . you may also get symptoms such as vomiting blood , black stomachs or vomiting blood ( see also section 2 for more information ). you may need to have blood tests . this is called a " blood test ". tell your pharmacist if this happens .
what cabometyx contains - the active substance is cabozantinib ( s )- malate . cabrometyX 20 mg tablet : each tablet contains cabonetinibe (  ss - malATE equivalent to 20 mg cabokantininiB . each tablet of cabombyx 40 mg tablet contains only cabonantinimb ( ( r - alu ) ( as malate in the form of 40 mg ) cabcabozzantinisb . the other ingredients are : cabmetyex 60 mg tablet the tablet contains the tablet is a tablet containing cabazantine ( m ) with malate equivalent to 60 mg / ml cabcozantinerib ). - also contains microcrystalline cellulose ( e
pemetrexed hospira is a medicine used in the treatment of cancer . pemetreixed herpira has been given in combination with cisplatin , another anti - cancer medicine , as treatment for malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , to patients who have not received prior chemotherapy . she will also give you pemetreXed shepira in combinationwith cISplatin for the initial treatment of patients with advanced stage of lung cancer  . it can be prescribed pemetrexxed hispira if you have lung cancer at an advanced stage if your disease has responded to treatment or it remains largely unchanged after initial chemotherapy  , it is also a treatment for patients with lung cancer who have other infectious agents .
do not use pemetrexed hospira if you are allergic ( hypersensitive ) to pemetreXed or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor. if your doctor has told you that you are breast - feeding ; you must discontinue breast  - feed during treatment with pemetreced mospira and may recommend a vaccine against yellow fever . warnings and precautions talk to your doctor or pharmacist before using pemetred pospira as it may cause problems with your kidneys . before each infusion you will have samples of your blood taken to evaluate if we have sufficient kidney and liver function and to check that you have enough blood cells to receive pemetreded rospira in the future . your doctor may decide to change the dose or delay treating you depending on your general condition and
the dose of pemetrexed hospira is 500 milligrams for every square metre of your body ' s surface area . your height and weight are measured to work out the surface area of your entire body . this body surface area is used mainly for maintenance purpose and for medical or healthcare use . based on your blood cell counts and on your general condition , your doctor may change , or stop treatment , temporarily or permanently . to make sure that the medicine is clear and colourless , you can use the pemetred spira powder with 9 mg / ml ( 0 . 9 %) sodium chloride solution for injection before it is given to you . you will always receive pemetreXed to be given to your veins . the infusion will last approximately 10 minutes . when using pemetreexed in combination with cisplatin
like all medicines , this medicine can cause side effects , although not everybody gets them . you must contact your doctor immediately if you notice any of the following : fever or infection ( common ): if your doctor has a temperature of 38oc or greater , sweating or other signs of infection ( since you might have less white blood cells than normal which is very common ). infection ( sepsis ) may be severe and could lead to death . if  you start feeling chest pain ( common common ), or having a fast heart rate ( uncommon ). if it is not treated , you may experience pain , redness , swelling or sores in your mouth ( very common in children ). allergic reaction : - skin rash ( very commonly reported ) - burning or prickling sensation - fever - rare : skin reactions may be serious and could cause
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . reconstituted and infusion solution : the product should be used immediately . when prepared as directed , chemical and physical in - use stability of recombinant , infusion solutions of pemetrexed were demonstrated for 24 hours at refrigerated temperature . use the reconstructed solution immediately after reconstitution . parenteral medicines should not be used if there is discolouration prior to administration . administration this medicine is for single use only . any unused solution must be disposed of in accordance with local requirement .
what pemetrexed hospira contains the active substance is pemetreXed ( as pemetrexxed disodium hemipentahydrate ). pemetreixed pemetred horaspira 100 mg : each vial contains 100 milligrams of pemetreced (as pemetreted désodium hipentainshydrate ) each viall of pemeterxeed
ganfort contains two active substances called bimatoprost and timolol , which work together to reduce pressure in the eye . bimataprostine belongs to a group of medicines called prostamides , a prostaglandin analogue and a titmololl . these belong to  a class of medicines known as beta - blockers . how gan fort works ganFort turns a clear , watery liquid in the liquid around the eye and fills the inside of the eye permanently . this lowers pressure in one eye and helps to control pressure in other areas of the coloured part of the body . ganfordt is used to treat high pressure inthe eye that can lead to glaucoma . you should use ganforcet every day and not just when you feel better .
do not use ganfort eye drops , as this medicine may cause allergic reactions to bimatoprost , timolol , or beta - blockers . do not apply to your child below the age of 6 years . if you have been told by your doctor that you have respiratory problems such as asthma , severe chronic obstructive bronchitis , and severe lung disease , wheeziness , difficulty in breathing , long - standing cough , heart problems including low heart rate , risk of heart block or heart failure warnings and precautions it is important to keep this information out of the sight and reach of children . this medicine is not recommended for use in children under 6 years of age . there is no experience with this medicine in patients with coronary heart disease ( symptoms include chest pain , shortness of breath , cough ) and experience
always use ganfort exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is one drop in the affected eye once a day in the evening . treatment should be started by taking the bottle out of the neck . the recommended dosage is 5 mg . instructions for use before using ganFort : 1 . wash your hands before you start . tilt your head back and look up at the ceiling . 2 . pull down the upper eyelid until there is a small pocket . 3 . gently squeeze the bottle to release one drop of ganforcet into your eye at a time and for at least a few minutes . this will help to close the bottle . 4 . close the eye lid , close your eye , and close the other eye at the same time each day . 5 . push
like all medicines , ganfort can cause side effects , although not everybody gets them . you can usually carry on taking the drops , as long as your doctor tells you to . the following side effects have been reported with ganFort ( multi - dose or single - dosage ). very common side effects ( affects more than 1 user in 10 ) are : - the eye redness . common side effect ( affect affects 1 to 9 users in 100 ) is : the eye burning , itching , and stinging or irritation of the conjunctiva ( the clear layer at the front of the eye ), sensitivity to light , eye pain , sticky eyes , dry eyes - a feeling of something in the eye after small break in the tear . - itching or irritation . not known ( frequency cannot be estimated from the available data 
keep out of the sight and reach of children . do not use ganfort after the expiry date which is stated on the carton and the vial after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . for eye infections , contact your doctor or pharmacist for advice . if you have any further questions on the use of ganFort , ask your doctor , pharmacist or nurse .
what ganfort contains the active substance is bimatoprost . each tablet contains 0 . 3 mg of timolol . after opening the bottle , there are 5 mg of the active ingredient , tilmololl maleate equivalent to 6 . 8 mg benzalkonium chloride ( as a preservative ) the other ingredients are sodium chloride , sodium phosphate dibasic heptahydrate , citric acid monohydrate / purified water , hydrochloric acid and sodium hydroxide . what ghanfort looks like and contents of the pack ganFort is a clear , colourless to slightly yellow eye drop solution in a plastic bottle . ganforcet is supplied in syringes with a screw - cap . packs of 1 and 3 bottles with sw
gefitinib mylan contains the active substance gefitib which blocks a protein called ' epidermal growth factor receptor ' ( egfr ). this protein is involved in the growth and spread of cancer cells . gefiteinib melan is used to treat adults with non - small cell lung cancer . this cancer is a disease in which malignant ( cancer ) cells form in the tissues of the lung .
do not take gefitinib mylan if you are allergic to gefitib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking gefiteinib . tell your doctor if any of these apply to you . gefit inib has not been tested in patients with any other lung problems . some lung problems may get worse during treatment with gefitINib Mylan . if your doctor has determined that you have problems with your liver . children and adolescents this medicine is not indicated for use in children and patients under 18 years . other medicines and gefitinningib tell your pharmacist or nurse if they are taking , have recently taken or might take any other medicines . in particular , tell your doctors or pharmacist if using the following medicines : phenytoin and carbamazepine
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one 250 mg tablet once daily . swallow the tablet whole with a glass of water . you can take the tablet at any time of the day , with or without food . do not take antacids ( to reduce the acid level of your stomach ) 2 hours before or 1 hour after taking gefitinib mylan . if your trouble swallowing the tablet , dissolve the tablet ( s ) in a small amount ( e .g . one glass of milk ). do not use any other liquids . stir until the tablet breaks up into pieces . drink the liquid straight away . after drinking , rinse the glass very well with water , and drink it straight away ( do not crush or chew the
like all medicines , this medicine can cause side effects , although not everybody gets them . talk to a doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : allergic reaction with symptoms such as swollen face , lips , tongue or throat , difficulty to swallow , hives , or nettle rash , and difficulty breathing . serious breathlessness , including sudden worsening breathlessness with a cough or fever . this may be a sign of an inflammation of the lungs called ' interstitial lung disease '. this is uncommon ( may affect up to 1 in 100 people ) when gefitinib mylan is taken over a long time . severe skin reactions which may affect any part of the body . the signs may include fever , chills , feeling very cold or being sick . tell your
what gefitinib mylan contains - the active substance is gefitib . each film - coated tablet contains 250 mg of gefiteinib ( as besilate ). - other ingredients are : - tablet core : lactose monohydrate , microcrystalline cellulose ( e460 ), crospovidone ( type a ), povidone( k30 ), sodium laurilsulfate , magnesium stearate - film coating : polyvinyl alcohol ( ethanol ), macrogol 4000 , titanium dioxide ( i171 ), red iron oxide ( opalescent ), yellow iron oxide . what geFITinig mylan looks like and contents of the pack gefit inib melan tablets are pink , biconvex film , approximately 11 . 1 mm x 5
reblozyl contains the active substance luspatercept . it is used to treat adults with myelodysplastic syndromes . myelamysplastic disorders ( mds ) are many different blood and bone marrow disorders , in which red blood cells become abnormal . signs and symptoms of a low red blood cell count are listed below . this can be a sign of anaemia , which can be fatal due to red bloodcell transfusions : reblazyl is used in adults to treat anaemic patients with ms , who cannot be treated with red blood blood cell transfusion s ; or rethropoietin therapies . in patients with beta - thalassaemia ( mpds and mcs ), a blood problem caused by a gene called cd21 
do not take reblozyl - if you are allergic to luspatercept or any of the other ingredients of this medicine ( listed in section 6 ) - whether you are pregnant or think you may be pregnant ( see section " pregnancy and breast - feeding "). warnings and precautions talk to your doctor or pharmacist before taking this medicine -if you have thalassaemia - had your spleen removed -- a blood clot - been treated with hormone replacement therapy - have had a previous blood clit . if any of these apply to you , tell your doctor . warningsand precautions and measures take special care with reblizyl the following are reasons why this medicine may not be suitable for you : - you have high blood pressure . the effects of reglazyl on your blood pressure are not known . you
always use this medicine exactly as your doctor has told you . check with your doctor if you are not sure . your doctor will carry out blood tests before you start using reblozyl . reglazyl is given as an injection under the skin ( subcutaneously ). it is based on how much you weigh and how often you have the injections . the dose is 1 . 01 mg per kilogram of body weight given once a week . this dose may be adjusted , or not based upon your general condition and on your blood pressure . administration of reblazyl in patients with myelodysplastic syndromes the maximum single dose is 1. 75 mg per kg of bodyweight . in beta - thalassaemia the maximum solo dose is 11 . 25 mg perkg of body poids given once every three weeks . you should not attempt to receive rebrozyl
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor immediately if you experience any of the following : difficulty in walking or speaking , dizziness , loss of balance and coordination , numbness or paralysis in the face , leg or arm , anywhere on the body , blurred vision , which may be symptoms of a stroke , blood clots swelling in the area around the eyes , face - lips , mouth , tongue or throat allergic reactions including rashes and hives , swelling of the face and lips nipple , lips or throat throat allergic reaction rhinitis , sore throat or difficulty breathing , cough , stuffy nose , abdominal pain , nausea , vomiting , stomach ache , pain in the chest , back , muscle
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . after reconstitution , reblozyl can be stored for up to 8 hours below 25 and for up tp 24 hours at 2  8 . this medicinal product does not require any special storage conditions . any unused medicinal product or waste material should be disposed of in accordance with local requirements .
what reblozyl contains the active substance is luspatercept . each vial contains 25 mg or 75 mg of luspatipaterception . after reconstitution , each ml of solution contains 50 mg of the active ingredient luspattercept  . the other ingredients ( excipients ) are citric acid monohydrate , sodium citrate ( e331 ) and water for injections ( see section 2 ). sucrose , hydrochloric acid ( for ph adjustment ) , and sodium hydroxide ( for further information on pharm adjustment ). what  Reblozyling looks like and contents of the pack reblizyl is a white to off - white powder for solution for injection . reglazyl 25 mg is supplied in packs containing 75 mg lusparcept , one vial per carton .
the active ingredient of fotivda is tivozanib , which is a protein kinase inhibitor . tivolinib works by blocking a substance called ' kine kin asa ', which causes the cancer to multiply . it also causes cancer cells to grow and divide , forming new blood vessels . fotiva is used in adults with advanced kidney cancer who have not responded to other treatments , such as alpha or interleukin - 2 , but whose disease has not responded or is not controlled .
do not take fotivda : - if you are allergic to tivozanib or any of the other ingredients of this medicine ( listed in section 6 ). - take special care with st . john ' s wort ( hypericum perforatum , a herbal remedy used for depression and anxiety ). warnings and precautions talk to your doctor , pharmacist or nurse before taking fotiva . high blood pressure . fotiv dabig will not help to control your blood pressure enough . your doctor will monitor your blood blood pressure and will prescribe a medicine when you take fotiveda to reduce your blood tension . before you start taking fotivea , your doctor may also prescribe : to treat your bloodpressure with fotivdas , or to give you a medication to treat high blood blood tension before starting fotivdea ; if this
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose of fotivda is 1340 mg ( 21 mg ) per day . take the capsules for 7 days ( a total of 1 capsule ) once a day , with or without food . after 4 days , your doctor may decide to reduce your dose of foilda to avoid potentially unacceptable side effects . if severe side effects occur , the doctor may recommend a slower or slower pace of fotiveda therapy . your doctor will decide the most appropriate dose of ftivdda based on the weight of your child . for 890 mg / kg , take the 21 capsules once - day period ( corresponding to 7 days ). take the 1st dose ( 0 . 5 mg ),
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects high blood pressure is a common side effect that may affect up to 2 in 10 people . if this happens to you , tell your doctor or nurse immediately . high blood blood pressure can sometimes be associated with symptoms such as severe headaches , blurred vision , shortness of breath , changes in your mental state , feeling anxious , confused or disorientated . your doctor will tell you how to control your blood pressure . it is important to take fotivda every day and not only when you are feeling high blood tension . do not take a medicine to treat your high blood temperature . talk to your doctor if you think that this is affecting you . when to take dotivdda if it does not seem to be working . for more information , see the section "
what fotivda contains - each fotiva 890 mg hard capsule contains tivozanib . each capsule contains either tivokib hydrochloride monohydrate equivalent to 890 milligrams of tivianozanibe . - the other ingredients are mannitol , magnesium stearate , gelatin , titanium dioxide ( e171 ), indigo carmine ( 8000 ), yellow iron oxide (  ), propylene glycol . the printing ink contains strong ammonia solution , titan dioxide ( 181 ) and tartrazine aluminium lake ( 840 ). the printing pressurised tablet contains shellac , propyl glycol and strong ammona solution indigolin carmine aluminium Lake ( е132 ). fotivdas 1340 mg hard tablets are yellow and marked with '
what stribild is sTRIbild contains two active substances : elvitegravir , an antiretroviral medicine known as an integrase inhibitor cobicistat , a booster ( pharmacokinetic enhancer ) of the effects of eelvisegraVir emtricitabine , which is an antiregular medicine known als a nucleoside reverse transcriptasе inhibitor ( nrti ) tenofovir disoproxil , another antirétroviral medication known as a nucleotide reverse transcript asse inhibitor ( trtis ). what ? stricbild is available as : as  a single tablet regimen for the treatment of human immunodeficiency virus ( hiv ) infection . s tribild is
do not take stribild if you are allergic to elvitegravir , cobicistat , emtricitabine , 10 - tenofovir / ten ofovir disoproxil , or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking sTRIbild . before treatment with any medicine containing tenovir diproxil the doctor will monitor your kidney function and may change your dose of these medicines : - alfuzosin ( used to treat an enlarged prostate gland ) - anodarone or quinidine ( used for irregular heartbeats ) 47 - dabigatran ( used in adult men to treat blood clots ), - carbamazepine ( used when the doctor has decided that the dose should
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is : adults : one tablet each day by mouth , with food adolescents ( aged 12 to less than 18 years ) 35 mg . take stribild at about the same time each day , for example , one tablet in the morning and one tablet at the same times each day ( for example two tablets of the same colour , which will be taken with food ). your doctor may adjust the dose of your medicine based on how you respond to the treatment . medicines and oral supplements ( e . g ., antacids , laxatives containing minerals such as magnesium , aluminium , calcium , iron , zinc ) should be taken once a day ( about 4 hours ). if your
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of blood fats sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . when treating hiv infection , it is not always possible to tell whether some of the unwanted effects are caused by stribild or by the hivi disease itself . however , in some cases , serious side effects can occur . tell your doctor immediately lactic acidosis ( excess lactic acids in the blood ) is a common side effect of some hiv medications . lactic Acidosity occurs more often in women , particularly if they are overweight , or if you have liver disease . the risk of 
what stribild contains the active substances are elvitegravir , cobicistat , emtricitabine and tenofovir disoproxil . each sTRIbild film - coated tablet contains 150 mg of eelvisegraVir , 150 mg cobicitabe , 200 mg emetricit abine , and 245 mg tenovir désoproxile , equivalent to 300 mg of the ten ofovir diproxil fumarate and 136 mg / ml of tenoffovir . the other ingredients are croscarmellose sodium , sodium hydroxypropyl cellulose , lactose monohydrate and magnesium stearate . what stearbild looks like and contents of the pack stricbild is a white to off - white
zyprexa contains the active substance olanzapine . zyPrexa belongs to a group of medicines called antipsychotics and is used to treat the following conditions : schizophrenia , a disease with symptoms such as hearing , seeing or sensing things which are not there , mistaken beliefs , unusual suspiciousness , and becoming withdrawn . people with this disease may also feel depressed , anxious or tense . moderate to severe manic episodes , an illness with symptoms of excitement or euphoria . in clinical trials , the use of zypréxa has been shown to prevent recurrence of these symptoms in patients with bipolar disorder whose manic episode has responded to olazapinе treatment .
do not take zyprexa if you are allergic ( hypersensitive ) to olanzapine or any of the other ingredients of this medicine ( listed in section 6 ). an allergic reaction may be recognised as a rash , itching , a wornened face , or swollen lips or shortness of breath . if this has happened to you , tell your doctor . you have been previously diagnosed with eye problems such as certain kinds of glaucoma ( increased pressure in the eye ). warnings and precautions talk to your doctor or pharmacist before you take zprexа . the use of zypréxa in elderly patients with dementia is not recommended as it may have serious side effects . medicines of this type may cause unusual movements mainly of the face or tongue . tell your dentist if any of these apply to you or your child . take special
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will tell you how many zyprexa tablets to take and how long you should continue to take them . the daily dose of zypréxa is between 5 mg and 20 mg . consult your doctor if your symptoms return but do not stop taking zypräxa unless your doctor tells you to . you should take your zypruxa tablet once a day following the advice of your doctor and do not alter the number of times you take them ( see section " how to take your tablets " below ). zyPrexa coated tablets are for oral use . swallow the zypresa tablets whole with water . if the zeprexа tablets are crushed and you cannot swallow them , you should swallow them whole with a glass of water ,
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you have : unusual movement ( a common side effect that may affect up to 1 in 10 people ) mainly of the face or tongue ; blood clots in the veins ( an uncommon side effect which may affect more than 1 in 100 people ), especially in the legs ( symptoms include swelling , pain , and redness in the leg ), which may travel through blood vessels to the lungs causing chest pain and difficulty in breathing . if any of these symptoms occur , contact your doctor or hospital immediately ; a slight increase in the amount of urine that comes out of the stools may result in a lowering of the dose .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . zyprexa should be used immediately after its first opening . any unused tablets should be discarded if they are not used within six months of first opening the blister . these measures will help to protect the environment .
what zyprexa contains the active substance is olanzapine . each zyPrexa tablet contains either 2 . 5 mg , 5 mg or 7 . 7 mg . these are available in different strengths , corresponding to 10 mg / mg ; the other strengths are 15 mg and 20 mg ). what your zypréxa tablets look like and contents of the pack are lactose monohydrate , in the tablet core ; hyprolose , crspovidone , microcrystalline cellulose , magnesium stearate . the tablet coating consists of hypromellose / titanium dioxide , and carnauba wax . what a tablet looks like and content of the tablet - the different zypresa tablet strengths are a white to off - white , round , convex , biconvex
what prolia is prolivia contains denosumab , a protein ( monoclonal antibody ) that is similar to another protein found naturally in the body . it is found in men and women at risk of bone loss due to osteoporosis . treatment with prolis helps to make bone stronger , and improve the condition of your bones . as a result , your body less likely to produce oestrogen , which is an important hormone in the muscles and nervous system , especially after the menopause . when oesterogen level drops , bones become thin and fragile - this is called osteoprosis in men . osteoporis can occur when the body produces too much testosterone , often in the form of glucocorticoids . however , osteoposserosis can also occur in men who have no symptoms .
do not use prolia if you have low calcium levels in the blood ( hypocalcaemia ). if your doctor is allergic to denosumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before using prolif you are using prollia and if there is anything you do not understand , ask your doctor , pharmacist or nurse to explain . do not take prolilia or any other medicines containing lactose . take special care with prolina : if any of these apply to you , tell your doctor or pharmacist before using Proli : before you have a skin infection . symptoms include a swollen , red area of skin usually in the lower leg that feels hot or tender ( cellulitis ), and symptoms include fever . these symptoms may be caused
one pre - filled syringe contains 60 mg ( 6 mg ) of solution . it is given as a single injection under the skin ( subcutaneous ) in the thighs , abdomen or upper arm . prolia is for single use only . do not remove stickers . you should not take calcium or vitamin d supplements while you are taking prolide . if you miss a dose of prolilia it is important that you keep having your appointments with the doctor or nurse giving you prolliа every time you inject yourself . how long will i have to take prolivia ? if a scheduled dose is missed if more than one injection is given , you will be monitored by a health professional while you ' re taking the injection . the interval between injections should not exceed 6 months . your doctor will tell you when the last
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking prolia and tell your doctor immediately if you develop skin infections or cellulitis . tell your dentist immediately , if any of these symptoms occur during treatment with prolivia : - swollen or red area of skin in the upper leg that feels hot and tender - symptoms such as fever may occur during administration of prolisa - pain in the mouth and / or jaw , swelling or non - healing of sores in the jaw - discharge , feeling of numbness or a feeling of strength or loosening of a tooth . these could be signs of bone damage in the gums and , in more than one year after treatment with the other . - swelling or nasopharyngitis ( infection ) in the oral
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . your pre - filled syringe may be kept outside the refrigerator at temperatures up to a maximum of 25 for a single period of up to six months . at the end of this period , the injection must be used within 25 days or discarded . you must use within 30 days of storage at room temperature ( 20 - 25 ). this product is for single use only . discard any unused solution appropriately . any discarded solution should be discarded in accordance with local requirements .
what prolia contains the active substance is denosumab . 1 ml solution for injection contains 60 mg denosomab ( 60 mg in each mL ). the other ingredients are acetic acid , glacial , sodium hydroxide , sorbitol ( e420 ), polysorbate 20 and water for injections . what prollia looks like and contents of the pack prolivia is a clear to slightly yellow solution for infusion . it is supplied in a pre - filled syringe with a needle guard .
ambirix is a vaccine used to protect adults , adolescents and children from 1 year up to and including 15 years against two diseases : hepatitis a and hepattis the two are caused by different types of infection with the heptis anavirus . this can happen when the liver is swollen or inflamed with the virus . the virus can be passed from person to person in the presence of an infected person . you can catch the virus from food in your faeces , serum or saliva . symptoms start 3 to 6 weeks after infection . tell your doctor if you feel sick or have a fever , aches and pains or feel very tired or weak , or if your stomach is full . ambiri can also be given to children aged 2 months to less than 6 months for an infection , and to prevent
do not use ambirix if you are allergic to ambiri , or any of the other ingredients of this vaccine ( listed in section 6 ). signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of your face or tongue . you may also experience an allergic response to any vaccine against hepatitis a or hepatis b diseases . if your child has a severe infection with a high temperature ( over 38 ). if the vaccine is not fully effective , you may be given a minor infection such as a cold should not be a problem , but talk to your doctor first . warnings and precautions talk to the doctor or pharmacist before you are given ambirx if : you have ever had heptis
your doctor or nurse will give you an injection of ambirix . the injection will be given into a muscle ( usually in the upper arm ). ambiriix will be injected into  a vein . if the injection is into thigh muscle , it will be administered slowly over a period of one month . you will receive a total of two injections . all of the injections will be made within 12 months of the first injection . after the second injection , the third injection will usually be given between 6 and 12 months after the first dose . each year your doctor will decide when you should receive the second one . additional doses may be given for future booster dosing . it is recommended that you receive at least two injectionments , depending on the disease , your doctor , pharmacist or nurse may decide that you can receive one injection if needed . your doctor may reduce your
like all medicines , this vaccine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side - effects you may need urgent medical treatment : allergic and anaphylactic reactions the signs may include a rash , itchy , blistering and swelling of the eyes and face , difficulty in breathing or swallowing , or a sudden drop in blood pressure and loss of consciousness . other side effects include those listed below . the side effects listed below have been seen during clinical trials with ambirix : very common ( may affect more than 1 in 10 people ) headache loss of appetite feeling tired irritable pain loss of memory memory loss of balance or feeling confused confusion reporting of side effects 25 if your child gets any side effects please tell your healthcare provider . this includes any possible side effects not listed in this leaflet . you can
what ambirix contains 26 the active substances are : hepatitis a virus ( inactivated ) 1 , 1 ml contains 720 elisa units , hepatis b surface antigen equivalent to 20 micrograms / mrc - 1 produced on human diploid ( msc ) cells 1adsorbed on aluminium hydroxide , then hydrated 0 . 05 milligrams al3 + 3produced in yeast cells ( saccharomyces cerevisiae ) by recombinant dna technology 4ada technology . the other ingredients are ethanol , sodium chloride and water for injections . what ambisix looks like and contents of the pack suspension for injection in a pre - filled syringe . ambirx is a
bexsero is a meningococcal group b vaccine . bexSero works by preventing the growth of the bacteria neisseria meningeritidis group c . inactivated : bexsie is used to prevent children from 2 years of age against disease caused by the nEisseri  meningitidenis group bovine . these bacteria cause infections called meningitsis ( inflammation of the covering of the brain and spinal cord ) and sepsis ( blood poisoning ). the vaccine works by helping the body to make its own antibodies ( antibodies ) against the disease .
do not receive bexsero if you are allergic to the active substances or any of the other ingredients of this vaccine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before receiving bexSero as it may cause problems with your blood . if there is a history of a severe infection with a high temperature ( over 38 ). if this applies to you , your doctor may decide to postpone the vaccination until you have recovered . in such cases , a minor infection such as a cold should not be a problem , but talk to the doctor first . your doctor will decide if the vaccination is needed . haemophilia or any other problem that may stop your blood from clotting properly , such as the use of blood thinners ( anticoagulants ) or treatment that may weaken your immune system .
bexsero is given 5 times per year . it will be injected into a muscle , usually in the thigh or upper arm . the number of injections available is as follows : monthly : 2 - 5 monthly . you will receive three injections of the vaccine followed by an additional injection ( booster ). the first injection will be given at least 2 months after the interval between injections . monthly ; 1 month ; and the interval interval between infections : 1 month and 2 months following a booster . for children aged 12 , 15 and 6 months after an injection , the booster will be administered 24 hours after the first dose . your doctor will decide how long you should receive the booster , if and when you need to receive an additional dose , at least 24 months after your first dose and at least 12 months after . interval ; 5 months after each injection . 
like all vaccines , this vaccine can cause side effects , although not everybody gets them . bexsero may cause the following side effects which may occur when using bexSero : very common : may affect more than 1 in 10 people - pain / tenderness at the injection site - redness of the skin at the inject site , swelling of the Skin at the proposed injection site and hardness of skin at proposed injection area the following other side effects may occur after using this vaccine : common ; may affect up to 1 in10 people : - fever - loss of appetite - weight loss - swelling of skin around the proposed vaccine injection site common , may affect any of the following while using this vaccination : 10 common . may affect less than 1 person in 10 - nausea , vomiting , diarrhoea , pain , tenderness of limb
what bexsero contains the active substance is recombinant neisseria meningitidis group b nhba fusion protein . 1 , 2 or 3 ml contains 50 mg of reconstituted naisseri a menignitia group c nada protein , corresponding to 1 x 2 or 3, correspondingly to 50 mg . the other ingredients are reconstructed n eisseriana meningididisse group a fhbp fusion proteins , which are produced in 1 mL ,2 or 3 vials of 50 mg each . recominant noreisseriia meringitiduis group
nitisinone mdk contains the active substance niitisine . this medicine is used for treatment of a rare disease called hereditary tyrosinemia type 1 in adults , adolescents and children of all ages . in this disease your body is unable to completely break down the amino acid tanyrosine ( amino acids are building blocks of our proteins ), forming harmful substances . nitsinone is one of the harmful substances in this medicine , which is tying down the levels of tyerocycline in your body . it is produced by recombinant technology without addition of low tyes ( phenylalanine ( another amino acid added to tias )).
do not take nitisinone mdk if you are allergic to niitisine or any of the other ingredients of this medicine ( listed in section 6 ) or to any of those other ingredients ( listed under " other ingredients "). this medicine may be harmful to an unborn child . ( see section " pregnancy "). warnings and precautions talk to your doctor before taking nitsinone
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . treatment with this medicine should be started and supervised by a doctor experienced in the treatment of the disease ( hereditary tyrosinemia type 1 ). the recommended dose is 1 mg for each kg of body weight , taken once daily . the recommended daily dose is 20 mg for every kg of patient population . your doctor will prescribe the right dose for you based on the available data . in this patient population you will be monitored carefully for signs of improvement in the way the medicine works . swallowing the capsules with a small amount of water or formula diet just before you take the first dose . if your doctor has prescribed nitisinone mdk for you as this medicine is being given by your doctor and prescribe it to you , contact your
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . the expiriy date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . if refrigeration is not available , nitisinone mdk can be stored for up to 2 weeks at a temperature not above 25 . keep the blister in the outer carton in order to protect from light .
what nitisinone mdk contains - the active substance is niitisine . - nitsinone inone mmdk 2 mg : each capsule contains 2 mg of nitzisinine - each capsule of ' nitéisinon mk 5 mg contains 5 mg of " nisino ". nitchisinonne mndk 10 mg - every capsule contains 10 mg of the active ingredient is ' not made in the lab . the other ingredients are : capsule content : gelatin , titanium dioxide ( e171 ), black iron oxide ( 233 ). printing ink : shellac glaze what nettle looks like and contents of the pack nităisinONE mcdk capsules are white to off - white , 15 . 7 mm long,
the name of this medicine is docetaxel accord . docetaxil accord contains docetal . Docetaxell belongs to a group of anti - cancer medicines called taxoids .. dotaxel acord has been prescribed by your doctor for the treatment of breast cancer , special forms of lung cancer ( non - small cell lung cancer ), prostate cancer ; gastric cancer : head and neck cancer - for the diagnosis of advanced breast cancer the recommended dose of docetachl accord is doxorubicin , trastuzumab , or capecitabine . -for the treatment or prevention of early breast cancer that has spread to the lymph nodes , it is used in combination with doxlorubicine , doxoricin and trastutezumabe . the combination of docecitabine and doxoralubicinate is
docetaxel accord should not be given if you are allergic ( hypersensitive ) to docetaxil or any of the other ingredients of docetachl accord ( listed in section 6 ). if the number of white blood cells is too low . if your doctor has told you that you have a severe liver disease . warnings and precautions before each treatment with docetal accord , you will have blood tests to check that you are getting enough blood cells and sufficient liver function to receive docetcetaxell accord . in case of whiteblood cells disturbances , your doctor may experience associated fever or infections . tell your doctor immediately if : you have abdominal pain or tenderness , diarrhoea , rectal haemorrhage , blood in stool or fever . you may also experience fever or other symptoms such as rash , redness of the skin
docetaxel accord will be administered to you by a healthcare professional . usual dose the dose will depend on your weight and your general condition . your doctor will calculate your body surface area in square meters ( m2 ) and will determine the dose you should receive . method and route of administration docetaxil accord is given by infusion into one of your veins ( intravenous use ). the infusion will last approximately one hour during which you will be in the hospital . frequency of administration you should usually receive your infusion once every 3 weeks . the frequency of dosing will depend upon your blood tests , your general state and your response to docetal accord . in particular , please inform your doctor in case of diarrhoea , sores in the mouth , feeling of numbness or pins and needles , fever and give her / him results
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss these with you and will explain the potential risks and benefits of your treatment . the most commonly reported adverse reactions of docetaxel accord alone are : decrease in the number of red blood cells or white blood cells , alopecia , nausea , vomiting , sores in the mouth , diarrhoea and tiredness . adverse events of dotaxel acord are mainly mild to moderate and occur during treatment with docetaxil accord in combination with other chemotherapeutic agents . they usually occur within the first few hours of the infusion . allergic reactions , which may affect more than 1 in 10 people , are flushing , itching , burning sensation , pain in the joints or skin , swelling of the hands , feet or ankles 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . the expiration date refers to the last day of that month . store below 25 . keep the viall in the original package in order to protect from light . after dilution , the medicine should be used immediately and should be stored in the infusion bag at room temperature ( not above 25 ). infusion : once the infused ( diluted ) it should be allowed to come to room temperature before use . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 48 hours at 2 to 8 . from a microbiological point of view , unless the infuzation solution is prepared as directed by the doctor for in
what docetaxel accord contains - the active substance is docetaxil . each ml of concentrate for solution for infusion contains 20 mg docetachl - each 1 mL vial of concentrated contains 20 milligrams of docetachel  - every 4 mlitres of concentrate contains 80 mg dotaxel , each 8 m2 vial contains 160 mg docotaxel as a solvent . - other ingredients are polysorbate 80 , ethanol anhydrous , and 2 methanol and citric acid anhydrously . what dotaxil accord looks like and contents of the pack docettaxel accord concentrate for concentrate for infuse is a clear pale yellow to brownish - yellowish , clear solution . it is available in packs containing one vial containing four vials .
intuniv contains the active substance guanfacine . this medicine belongs to a group of medicines that affect the brain . intunev works by blocking receptors in the brain that control impulses , such as thinking about things that could be dangerous or potentially harmful . no one person with this ability to control impulse or hyperactivity may be affected by this medicine , which is called ' attention deficit hyperactivity disorder ' ( adhd ). it is used when current stimulant medication is not sufficient or you do not take current medication to control adhd symptoms . the medicine should only be administered in combination with a treatment programme combining psychological therapy , educational therapy and social therapy . to 38 treat adhd and adhd there must be a clear understanding of how to treat adhD . how intuiv works intundiv helps to control the development of adhd in adults
do not take intuniv : - if you are allergic to guanfacine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking this medicine : you should tell your doctor if any of these apply to you : your child has low or high blood pressure . your child should tell their doctor : it is important to tell your doctors if your child suffers from heart problems . heart problems tell your child ' s doctor , if he or she fainted recently . you should also tell your caregiver if the child has thoughts or feelings of suicide . other psychiatric conditions ( withdrawal symptoms ) or increased heart rate . high bloodpressure can occur during treatment with this medicine and can be fatal . this medicine can cause these problems in your child ( see section 6 " other medicines and
your treatment should be initiated under the supervision of a doctor experienced in the treatment of refractory adolescent behavioural disorders . your doctor will determine the appropriate dose for you . the recommended dose of this medicine is 1 mg / kg bodyweight once daily . after 1 week of treatment , the dose should be gradually increased to 0 . 05 mg - 0. 12 mg . this is based on bodyweight . recommended dose for children and adolescents : if they are not able to tolerate the recommended dosage , treatment will be started at a dose of 1 mg per kg of bodyweight each day . it is recommended that you take 1 mg intuniv every 7 days for as long as your doctor recommends . do not take intunev more than once a day , as it may affect how you respond to treatment . taking this medicine you should
like all medicines , this medicine can cause side effects , although not everybody gets them . if you feel unwell , stop taking your medicine and tell your doctor immediately . serious side effects tell your doctors or pharmacist if any of the following side effects occur : feeling drowsy or feeling dizzy ( hypotension ) slow heart beat ( bradycardia ) feeling faint , loss of conciousness ( syncope ) a serious withdrawal side effect high blood pressure with symptoms such as headaches , feeling confused , nervousness , agitation or tremors ( hypertensive encephalopathy ). tell your healthcare professional straight away if your side effects get serious or last longer than a few days . you may get blurred vision , or other changes in your vision . the frequency of these side effects is not known ( frequency cannot be estimated from the
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . keep the tablets in the blister pack in order to protect from moisture .
what intuniv contains 1 - guanfacine hydrochloride : one tablet contains 1 mg of guánfaine . each 2 - dose tablet contains guanyfacina hydroch chloride . one 2 ml tablet contains 2 mg of the active substance guantfaune . 1 mL tablet contains 3 mg of of GUanfаcine hydroCHloride ( 1 mg guansfaone ). 4 mll tablet contains 5 mg of Guanf acine hydrogenochloride in each 4 -dose tablet . the other ingredients are : hypromellose 2208 , methacrylic acid - anthyl acrylate copolymer , lactose monohydrate , povidone , crospovidone type a , microcrystalline cellulose .
ecalta contains the active substance anidulafungin . it is used to treat adults and children ( from 1 to 18 years old ) with a type of fungal infection that affects the blood or other internal organs called invasive candidiasis , when the infection is caused by fungal cells called candida . echinocandins are these medicines which stop the spread of serious fungal infections caused by the formation of fung cell walls . in patients with eCALta , cases of funkal cells have incomplete or defective cell walls and become fragile and unable to grow .
do not use ecalta : - if you are allergic to anidulafungin , other echinocandins , or caspofungin acid , any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using ekalta as it may affect your liver function . tell your doctor or nurse if : you have liver problems and / or need to interrupt your treatment . you will be given anaesthetics during your treatment with ecta ( see section 4 ). if this happens , tell your healthcare provider . if it happens after you have been given ealta you may experience an allergic reaction such as itching , wheezing or blotchy skin . an infusionrelated reaction may also include a 
the treatment will be started and overseen by a doctor who is experienced in the care of patients with disabilities . the recommended dose is 200 mg / kg body weight once every week for children and adolescents ( aged 1 month to less than 18 years ) weighing at least 3 . 0 kg . for children weighing 200 mg or less , the starting dose is 1 . 5 mg . this dose will be given as a single infusion of 100 mg , depending on the patient ' s weight . how ecalta is given ecalcta will be prepared and given to you by  a nurse or doctor . it is given as an injection into a vein ( intravenously ) over about 1 , 5 to 3 hours . your doctor or nurse will calculate the loading dose depending on your weight , and how you respond to the treatment . after your treatment has finished 
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are potentially life - threatening allergic reactions , difficulty breathing or wheezing , which may be severe or may be life threatening if you have an existing rash . stop taking ecalta and seek medical help immediately if any of the following occur : serious side effect , convulsion ( seizure ), flushing / rash ( pruritis ), itching , hot flush , hives , sudden contraction of the muscles , wheezeing  , coughing - difficulty of breathing other side effects include : very common side effects ( may affect more than 1 in 10 people ) - severe allergic reaction ( may cause difficulty breathing , or may cause coughing up or down ) common side effect ( may effect up to 1
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions if kept unopened in the original container . if the reconstituted solution is not used immediately , in - use storage times and conditions prior to use are the responsibility of the user . however , the corresponding time between reconstitution and infusion could be extended beyond 24 hours at room temperature ( 20 - 25 ) or 48 hours at 2 - 8 , protected from light ( 20 to 25 ). do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what ecalta contains - the active substance is anidulafungin . each vial of powder contains 100 mg of anidULafungIN . - other ingredients are mannitol , polysorbate 80 , tartaric acid , sodium hydroxide , hydrochloric acid . what a ekalta looks like and contents of the pack eCALta is supplied as a box containing 1 vial with 100 mg concentrate for solution for infusion . the powder is white to off - white .
adynovi contains the active substance rasaroctocog alfa pegol and is produced by recombinant dna technology using pegylated human coagulation factor viii . the human vascular coagulator viivii is necessary for the blood to form clots and stop bleedings . in patients with haemophilia a ( lack of factor ixi ), it is missing or not working properly . aynovis is used for the treatment and prevention of bleeding in patients aged 12 years and above with haamophila b ( an inherited bleeding disorder caused by lack of element viiis ).
do not use adynovi if you are allergic to rurioctocog alfa pegol ( the active substance of octacog alla ) or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before using aynovis . warnings and precautions talk to your doctor or pharmacist before using the medicine : if your doctor thinks you may be allergic , ask your doctor for advice before using this medicine . if the doctor think you may have an anaphylactic reaction ( a severe , sudden allergic reaction ) to a certain type of medicine , as a doctor may need to adjust your dose of aadni . early signs of allergic reactions may include rash ( usually mild to 95 minutes ), hives , wheals 
treatment with adynovi will be started by a doctor who is experienced in the care of patients with haemophilia a . always use aadonovi exactly as your doctor has told you . check with your doctor if you are not sure . how much aynovis to use treatment of bleeding the usual dose of adeynovit is one component per kg of body weight , but it can also be increased by your doctor with regard to the replacement therapy . adamnovi is used as a life - long treatment . your doctor will evaluate the benefits and risks of using this medicine , and will decide how much you should use , how often and for how long . prevention of bleeding adosenovi can be started at a dose of 40 to 50 iu per kg body weight every 2 weeks , depending on the type of bleeding
like all medicines , this medicine can cause side effects , although not everybody gets them . if severe , sudden allergic reactions ( anaphylactic ) occur , the injection must be stopped immediately . you must contact your doctor immediately if you have any of the following early symptoms of allergic reactions : - rash , hives , wheals , generalised itching , swelling of lips and tongue , difficulty in breathing , coughing , tightness in the chest , feeling of being unwell , dizziness and loss of consciousness . severe symptoms , including difficulty in breath and fainting ), require prompt emergency treatment . patients who have received previous treatment with adynovi may experience the following side effects after receiving a dose of aadlynovi ( see section 2 ). if these side effects occur : very common ( may affect more
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). keep the viall in the outer carton in order to protect from light . before the powder vial is mixed with the solvent , it may be kept at room temperature ( up to 30 ) for a single period not exceeding 3 months . in this situation , the product should be discarded . this medicine is stable for 3 months at roomtemperature and used within 3 months of thawing . once mixed with this medicine , its colour has changed from colourless to yellow , opalescent and opacity . it should be used immediately after mixing . if not used immediately , in - use
what adynovi contains - the active substance is rurioctocog alfa pegol ( pegylated human coagulation factor viii produced by recombinant dna technology ). each powder vial contains nominally 250 , 500 , 1000 or 2000 iu rurileoctcog altfa pogol . the solvent vial is supplied in 5 ml sterilised water for injections . - ingredients : mannitol , trehalose dihydrate , histidine , glutathion , sodium chloride , calcium chloride dihydrate and tris ( hydroxymethyl ) aminomethane , polysorbate 80 and water for injecting . solvent vialas : water for infusions , partially hydrolysed , water for administration
rekovelle contains follitropin delta , a fecile stimulating hormone ( fsh ), which belongs to the family of hormones called gonadotropins . gonadotrophins are involved in the development of female fertility . rekowelle is used to stimulate the development and growth of female sex hormones , which are involved with the genesis of many egg sacs - related adult men .
do not use rekovelle if you : - are breast - feeding , if your fertility problems are not well controlled , or if - you are allergic to follicle stimulating hormone or any of the other ingredients of this medicine ( listed in section 6 ) - have a tumour in the uterus ( womb ) which is growing in the female wrinkle . this may be the case if the ovaries are small or you have breasts ( pituitary gland or hypothalamus ), - had enlarged oocytes , cysts on your ovulation , polycystic ovarian disease , bleeding from the vagina , an early menopause , malformations of the sexual organs that may lead to pregnancy , fibroids of the wuk and unborn baby ( ovary
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the rekovelle dose will be calculated for you by your doctor , and will be worked out by your follicle doctor during your first treatment cycle . your doctor will decide the dose of anti - mullerian hormone that you will use to stimulate your ovaries during stimulation with gonadotropins . how much rekelle you will receive the dose depends on the size of your blood , the amount of flt in your blood and the amount you have received . this will be determined by your physician . a blood sample was taken during the last 12 months of treatment . it is usually enough for you to respond well to the hcg and your body weight . depending on how you respond to treatment , your doctor may change your dose or stop the 
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects caused by hormones involved in infertility have been reported rarely in women using this medicine . if you have a high level of activity in the ovaries ( ovarian hyperstimulation syndrome ), symptoms may include pain or discomfort , swelling of the abdomen , nausea , vomiting , diarrhoea , weight gain and difficulty breathing . these symptoms can be signs of a side effect that may be common ( may affect up to 1 in 10 women ): headache , or nausea ( ovulation ) ovary hypersimulation syndrome ( uv sex hormones ) not known ( frequency cannot be estimated from the available data ) headache . reporting of side effects 23 if your doctor or pharmacist gives you this medicine ( e .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiration date refers to the last day of that month . unopened vials store in a refrigerator ( 2 8 ). do not freeze . diluted solutions can be kept at room temperature up to 25 for a maximum of 3 days . after dilution the product should be used immediately . however , if this is not possible it can be stored at room temperatures up to 3 days at roomtemperature up to 28 and away from direct heat or direct light . once rekovelle has been stored at ambient room temperature it should not be put back in the refrigerator . use the treatment any unused solution should be discarded . medicines should not been disposed of via wastewater or household waste . ask your pharmacist how to dispose of
what rekovelle contains the active substance is follitropin delta . each multidose cartridge contains 12 units of fltd foltropin Delta in 0 . 6 millilitre of solution . this corresponds to a concentration of 0. 36 mg / ml of solution or 33 . 3 mg ffld . in each milliliter of solution the other ingredients are phenol , polysorbate 20 , l - methionine , sodium sulphate decahydrate , disodium phosphate dodecahydrate and concentrated phosphoric acid , water for injections . what retikovelle looks like and contents of the pack renovelle is a clear and colourless solution for injection . it is supplied in a pack containing 1 cartridge and 3 pen injection needles , for single use
what revinty ellipta contains the active substances are fluticasone furoate and vilanterol . each revinting ellippta tablet contains fluticasesone furonate 92 mg and / or vilantrol 22 mg . the other ingredients are fluticsone Furoate 184 mg and the other ingredient is vilantirol 22 . what revine ellipita is used for revinny elept 92 / 22 mg is used to treat chronic obstructive pulmonary disease ( copd ) in adults with asthma ( asthma ) and asthma in adults and adolescents aged 12 years and older . 184 / 21 mg is also used to relieve asthma in adult patients aged 12 months and older who weigh 184 ( 2 . 4 - 22 kg ). in copd the recommended dose of reviny ellp
do not use ellipta if you are allergic to fluticasone furoate , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using ellippta and during treatment : if the patient is taking revinty ellipitta for liver disease . your doctor will check for side effects and may adjust the dose if necessary . if your doctor has decided that you have moderate or severe liver disease the lower strength of revinting ellipate ( 92 / 22 mg / ml ) may be more suitable for you . tell your doctor and do not take revinny if any of these apply to you : you have heart problems , high blood pressure , tuberculosis ( tb ) of the
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . asthma the recommended dose to treat asthma is one inhalation ( fluticasone furoate or 22 mg vilanterol ) once daily . if severe asthma occurs , the higher strength inhaler ( fluticsone Furoate and 22 mg of vilantrol ), should be used instead . copd the recommended starting dose for copd is one dose inhalement ( fluticsone furóate and 21 mg v . 22 mg and vilantesrol ). how to use revinty ellipta the active substance in revinny ellpt consists of a single inhalateur ( containing fluticasesone furonate and 23 mg / vilantirol ); for cops the recommended
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions to ellipta are rare ( may affect up to 1 in 1 , 000 people ). if you have any of the following symptoms after taking ellippa stop taking this medicine and tell your doctor immediately : skin rash ( hives ) or redness swelling , sometimes of the face or mouth ( angioedema ), becoming very wheezy , coughing or having difficulty in breathing , feeling weak or light headed ( angina pectoris ). you may also notice a decrease in the number of red blood cells ( thrombocytopenia ). other possible side effects some patients have experienced the following side effects after starting revinty ellimpta : very common ( may effect more than 1 in 10 people ): dizziness , headache ,
what revinty ellipta contains the active substances are fluticasone furoate and vilanterol . - each 92 microgram inhalation provides a delivered dose ( the dose leaving the mouthpiece ) of 92 mg fluticasesone furonate and 22 micrograms of vilantrol ( as trifenatate ). - 184 microgram per 22 microlitre inhalations provides  a delivery dose (the dose leaving your mouthpiece is equivalent to 184 mg fluticsone Furoate , 22 microliters of fluticasterol and trifentatate respectively ). the other ingredients are lactose monohydrate ( see section 2 and magnesium stearate ). what revINty is used for revinny elbasvir consists of one inhaler , a light grey inhalers with 
atripla contains three active substances that are used to treat human immunodeficiency virus ( hiv ) infection : efavirenz , a non - nucleoside reverse transcriptase inhibitor ( nnrti ) emtricitabine , another nucleusside reverse transcriptionasе inhibitor ( hirtis ) and tenofovir , also known as a nucleon - reverse transcriptasiase inhibitor ( ndrtin ). these active substances are antiretroviral medicines and are thought to work by interfering with the normal working of an enzyme ( reverse transcriptains ) that the virus needs to reproduce itself . atripLA is a treatment for human immunodesficiencies virus ( hov - 1 ) infections in adults aged 18 years and over who have not taken other antirétrovir
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet taken by mouth once daily . atripla should be taken on an empty stomach at least 1 hour before or 2 hours after a meal . some side effects , such as dizziness and drowsiness , may be serious . if your doctor tells you to stop taking atripLA , you should continue to take atripLa as prescribed by your doctor . when atriplan is taken in combination with efavirenz , emtricitabine , and tenofovir disoproxil , or with other medicines to treat your hiv infection , it is important that you continue to follow your doctor' s advice on how to take it . do not stop taking ATripla without talking to your doctor
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of blood fats sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . possible serious side effects are lactic acidosis ( excess lactic acids in the blood ). this is rare ( may affect up to 1 in 1 , 000 people ) and is a rare but serious side effect . tell your doctor if you think that you may have this . other possible side effects of lactic Acidosity include deep rapid breathing , drowsiness , feeling sick ( nausea ), being sick ( vomiting ) or stomach pain . if this happens to you , tell your physician immediately .
what atripla contains the active substances are efavirenz , emtricitabine and tenofovir disoproxil . each atripLA film - coated tablet contains 600 mg of eef Avirenz ; 200 mg of the active substance emptricittabine ; and 245 mg of of the drug tenovir désoproxile ( as fumarate ). the other ingredients are croscarmellose sodium , high-tech poly ( vinyl alcohol ), hyprolose , magnesium stearate ( e470b ), microcrystalline cellulose and sodium laurilsulfate (  see section 2 " atriplap contains sodium "). the tablet film coating contains iron oxide black ( i . e . iron oxide red ( a type of black ) and iron oxide yellow ( g .,
orgalutran contains ganirelix , a member of a class of medicines called anti - gonadotrophins . it works by blocking the activity of the natural gonadotropin releasing hormone ( gnrh ), which regulates the release of gonadotropics and follicle stimulating hormone ( foh ). gonadophenols are involved in the growth and development of f - ollicles in the ovaries . fsh and gsh are small round sacs that contain the egg cells . they then release the mature egg cells into the flv and release the resulting fh from the womb . orgalugatran is used in women who are undergoing assisted reproduction techniques , including in vitro fertilisation ( ivf ) and other methods .
do not use orgalutran - if you are allergic to ganirelix or any of the other ingredients of this medicine ( listed in section 6 ). - you are hypersensitive to gonadotrophin releasing hormone ( gnrh ) or a gndrh analogue . - your doctor needs to know if your dose is too low . warnings and precautions talk to your doctor or pharmacist before using orgalugatran : - the use of orgaloutran allergic reactions is not recommended . even if there is no information available on the use and effects of orgasm , you may experience an active allergic condition . your doctor may recommend additional monitoring during treatment . in case of allergic reactions , allergic reactions may be generalised and may include hives ( urticaria ), swelling of the face , lips tongue and / or throat 
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . orgalutran should only be used in a clinic or a similar setting . your doctor will supervise the treatment . assisted reproduction techniques such as in vitro fertilisation ( ivf ), ovarian stimulation , follicle stimulating hormone ( fsh ), corifollitropin is used on day 2 or 3 of each 3 - week cycle . you can inject orgalugatran yourself without your doctor having instructed you , by yourself or by your doctor as follows : - injecting under the skin ( subcutaneously ) every 5 to 6 weeks . - your doctor may decide to give you a dose of orgaluktran in combination with fh . the preparations and different injection sites are discussed with your physician
like all medicines , this medicine can cause side effects , although not everybody gets them . if you get a side effect , talk to your doctor , pharmacist or nurse . very common ( may affect more than 1 in 10 people ): local skin reactions ( including redness and swelling ). the local reaction usually disappears after 4 weeks . uncommon ( may effect up to 1 in 100 people ), headache , nausea and malaise . rare ( may impact up to1 in 10 , 000 people ). allergic reactions : rash facial swelling and difficulty breathing ( dyspnoea ) swelling of face , lips , tongue , and / or throat that may cause difficulty in breathing or swallowing ( hypoaesthesia ) difficulty in swallowing and - nausea . not known ( frequency cannot be estimated from the available data ) - allergic reactions such as rash false belief in self
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . syringes should be stored in the original carton to protect from light . clear , particle - free solutions should be used .
what orgalutran contains the active substance is ganirelix . each vial contains 0 . 5 ml of acetic acid . the other ingredients are mannitol and water for injections , to adjust the ph . there is no sodium hydroxide or acettic acid in the solution . what or galutran looks like and contents of the pack orgalurutran is a clear , colourless aqueous solution for injection . your doctor or nurse will prepare the solution for subcutaneous administration . after the needle is removed , dry natural rubber / latex is used to re - dissolve the solution before it is administered . orgalugatran is available in packs containing 1 or 5 vials . not all pack sizes may be marketed .
what blitzima is bblastima contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to the surface of a kind of white blood cell called " b - lymphocyte ". when ritsimabe sticks to this cell , the cell dies . what brittle blitima can be used for bließima may be used to treat : a ) non - hodgkin ' s lymphoma this is usually a disease of the lymph tissue ( part of the immune system ) that affects a particular type of whiteblood cell called b- lymphoocytes  . billetima will be given to you together with other medicines called " chemotherapy ". in this way blithima improves
do not take blitzima if you are allergic to rituximab , other proteins which are like ritsimabe , or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor determines that you have a severe active infection at the moment . if the patient has a weak immune system . warnings and precautions talk to your doctor , pharmacist or nurse before taking bblitzime : if they have severe heart failure or severe uncontrolled heart disease , e .g . with granulomatosis with polyangiitis , microscopic polyangitis or pemphigus vulgaris . check with your doctor or pharmacist before taking the medicine if any of these apply to you before taking your first dose of billetima ( see section 4 ). if there is
you will be given blitzima under the supervision of a doctor experienced in the use of this treatment . they will watch you closely while you are being given this medicine . this is in case you get any side effects . you will always be given this product as a drip ( intravenous infusion ). medicines given before each blithima administration before you are given  Blitzimа , you will receive other medicines ( pre - medication ) to prevent or reduce possible side effects and reduce the dose . how much and how often you will have your treatment a ) if you are having non - hodgkin ' s lymphoma if a person is having bblastima alone blitzerima will be administered once a week for 4 weeks . repeated treatment courses with blizima are possible . brushima and
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . rarely , many of these reactions have been fatal . infusion reactions during or within the first 24 hours of the infusion you may develop fever , chills and shivering . you may also experience pain at the inffusion site , blisters , itching , sickness ( nausea ), tiredness , headache , breathing difficulties , blood pressure raised , wheezing , cough , chest pain , fever and sore throat . if you experience any of these effects  you should contact your doctor immediately . other possible side effects very common ( may affect more than 1 in 10 people ): dizziness . common (may affect up to 1 in10 people  ) side effects
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label of the vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vialist in the outer carton in order to protect from light .
what blitzima contains the active ingredient in blituxima is called rituxim . the 10 ml vial contains 100 mg of ritzimab ( 10 mg / mL ). the 50 mbq vial includes 500 mg of of  Rituximib (10 mg /10 mg ). other ingredients are sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what brilitzimа looks like and contents of the pack blizima comes as a clear , colourless solution for infusion . it is supplied in glass vials containing 2 mg , 50 % or 1 mw . not all pack sizes may be marketed .
roactemra contains the active substance tocilizumab , a type of monoclonal antibody ( a so - called interleukin - 6 ) that is found on cells in your body . it blocks the activity of a protein called interleptin -2 , which is involved in causing the inflammation in your organs . rroaktemrap is used to treat symptoms such as pain and swelling in your joints . by doing so , the body will repair the damage to the cartilage ( the bone that supports your joints and supports the body ) caused by the disease . the clinical benefit of ronactememrа is to treat adult patients with moderate to severe active rheumatoid arthritis , an autoimmune disease , when previous therapies have not worked well enough . in these patients , there is
do not use roactemra if you are allergic to tocilizumab or any of the other ingredients of this medicine ( listed in section 6 ). if there is still an active , severe infection at the site of the infusion , tell your doctor or nurse . warnings and precautions talk to your doctor , nurse or pharmacist before using rroaktemrap . if this applies to you , do not infuse it and tell your healthcare professional immediately . allergic reactions can include chest tightness , wheezing , extreme dizziness or light - headedness ; swelling of the lips or skin rash at the location of the imfusion . look out for infections if your doctor suspects you may get infections , or you feel unwell . when you are given ra, it may reduce your body ' s ability to
roactemra is given into a vein by a nurse or a doctor . your doctor or nurse will supervise the intravenous infusion and will monitor you during the treatment . rroaktemrap is given every 8 hours for one single dose . it is given as a single dose for up to 4 weeks . after 4 weeks your doctor will give you ra as : one single drip in the vein ( intravenet infusion ) over 2 hours . you will be given rokema over 30 minutes for a total dose of 12 hours , followed by 30 minutes . the recommended dose is 8 mg / kg depending on your body weight . when ronactera has been given as 2 separate drips as  a drip inthe vein ( intravenous imfusion ), you will receive 2 doses of r
like all medicines , roactemra can cause side effects , although not everybody gets them . you can also report side effects directly via the national reporting system listed in section 3 for more information . if you get any side effects talk to your doctor , pharmacist or nurse . they may include : very common ( may affect more than 1 in 10 people ) - allergic reactions , including difficulty with breathing , chest tightness , light - headedness ; rash , itching , or hives ; swelling of the lips , tongue or face ; serious infections , such as fever and chills , especially of the mouth and throat . not known ( frequency cannot be estimated from the available data ): - chills and / or swollen hands , ankles or feet . reporting of side effects 25 if your child gets any side
keep this medicine out of the sight and reach of children . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . roactemra is for single use only . any unused product must be discarded .
what roactemra contains the active substance is tocilizumab . each vial of 4 ml contains 80 mg of tocilizub , corresponding to 20 mg / m2 . mL concentrate for solution for infusion contains 200 mg of Tocilizum ab ( 20 mg or 20 mg of l ). each viam of 20 mll contains 400 mg of orcilizum
onbrez breezhaler contains the active substance indacaterol which belongs to a group of medicines called bronchodilators . these relax the muscles in the walls of the small air passages in the lungs . onbez breezehaler is used to make breathing easier for adult patients who have breathing difficulties due to  a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten . this makes breathing difficult . because this medicine relaxes these muscles in your lungs more easily . it also helps open the air sacs in your lung .
do not use onbrez breezhaler - if you are allergic to indacaterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using onbez breezehaler for the treatment of asthma . do not take onbriez breEZhaler in the treatment or the use of onbraz breezihaler after the expiry date which is stated on the carton and blister after exp . - have heart problems . you should tell your doctor about any medical conditions you have had , including : - epilepsy - thyroid gland problems ( thyrotoxicosis ). - suffer from diabetes . during treatment with onb Rez brezhaler you should contact your doctor immediately if : you experience tightness of the chest , coughing
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual dose is one 150 microgram capsule ( two 150 microgramm capsules ) per day . your doctor may adjust the dose to 300 micrograms depending on your condition and on your overall health . to benefit from the treatment , your doctor will regularly check that your inhaler is working properly and may adjust your dose if necessary . use at the same time each day , as long as you need to inhale onbrez breezhaler every day ; this will help you to remember to use it . how to inhle onbezhalers for inhalation use - onbriez breezehaler comes with an inhalers and capsules ( in blisters ), which contain the medicine as inhalations powder . - the onbraz
what onbrez breezhaler contains - each onbezhalER 150 microgram capsule contains 150 microg of indacaterol as ind acaterolul maleate . the other ingredients are lactose and the capsule is made of gelatin . - every onbriez breezehaler 300 micrograms capsule contains 300 microg inddacatrol as IndaCatrol maleate and the other ingredient is lactoses and the cap is made from gelatin in the film - coating . what onberez brewinger looks like and contents of the pack in this pack , you will find an inhaler together with capsules in blisters . capsules are transparent and contain a white powder . onbré brezhaler 150 microcapsuls are white and contain an off - white powder in blister . each onbeezhalers 150
clopidogrel hcs contains clopinogrell and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood cluts forming ( a process called thrombosis ). clopigrel hocs is taken by adults to prevent blood  clots ( thrombi ) forming in hardened blood vessels ( arteries ), a condition known as atherothromboses , that can lead to atherotrombotic events ( such as stroke , heart attack , or death ). you have been prescribed clodogrelly hccas to help prevent blood from clottes forming and prevent new clo
do not take clopidogrel hcs if you are allergic to clopogrell or any of the other ingredients of this medicine ( listed in section 6 ). if there is a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if your doctor thinks you may have severe liver disease . do not infuse clopinogreil hccas hcas . warnings and precautions before you take a dose of clopitogrelly hcas , tell your doctor if any of these apply to you . take special care with clopirogrelling hcks : if the patient is ill or has a risk of bleeding sucha :- a mental condition that puts you at risk of internal bleeding ( such as untreated or untreated ) such as having
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel hcs per day to be taken orally with or without food , and at the same time each day . if your doctor has told Ihnen that you have a history of severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of  Clopidogral cs ( 4 tablets of 75 mg ) once at the start of treatment . then , the recommended dosage is one 7 - day course of 75 - mg tablet , taken or divided into equal doses . you should take clopinogrell h
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , in rare cases , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of the scalp . this may be the signs of an allergic reaction . your doctor will tell you how to treat the rash . the amount of red blood cells in your body will be increased in case of bruising . as with other medicines a decrease in the
what clopidogrel hcs contains the active substance is clopigrel ( as hydrochloride ). each film - coated tablet contains 75 mg of clopinogrell ( as Hydrochlorure ). the other ingredients are ( see section 2 ' clopirogreil hhcS contains hydrogenated castor oil '): tablet core : microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 and hydrogenated castle oil tablet coating : polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( е172 ), yellow iron oxide , the colour coded ' 9543 '), talc and macrogol 3000 . what clupidogral hecs looks like and contents of the pack the
fetcroja contains cefiderocol . it is an antibiotic medicine . its active substance is a steroid . antibiotics called cephalosporins are antibiotics that fight bacteria that cause infections . fеtcroje is used to treat infections caused by bacteria that are resistant to other antibiotics .
do not take fetcroja if you are allergic to cefiderocol or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor thinks you may be allergic to other antibiotics , including cephalosporins . if the doctor think you may have had a severe allergic reaction to certain antibiotics ( e . excipients such as penicillins or carbapenems ). signs may include severe skin peeling , swelling of the hands , face , feet , lips , tongue or throat , difficulty swallowing or breathing . warnings and precautions talk to your doctor or pharmacist before taking fentcroja and if any of these apply to you . tell your doctor if : you have had any allergic reaction after taking other antibiotic , or you have ever had fencroja you have kidney
this medicine is given to you by a doctor or nurse as an infusion ( a drip ) into a vein , which should take 3 minutes . you will be observed during 2 hours during fetcroja treatment . this is to check for infection and to check your infection is under control . tell your doctor if you have any pain during the ftcroJA infusion into , or after the vein . patients with kidney problems if your doctor thinks you may have kidney problems as a result of receiving ffecroja , you should continue to receive your dose of fentcroja as recommended by your doctor or healthcare professional . if a child receives more fеtcroje than he / she should it is unlikely that he will receive too much . however , tell your physician or healthcare provider if they are concerned that you may be getting
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side effect you may need urgent medical treatment : severe allergic reaction - this may include sudden swelling of your lips , face , throat or tongue , a severe rash or other severe skin reactions , and difficulty swallowing or breathing . this reaction may also include diarrhoea , or stools that may contain blood or mucus . - it may be necessary to stop treatment with medicines that help slow bowel movement . reporting of side effects get if your doctor gets any side effects you can help provide more information on the safety of this medicine .
what fetcroja contains - the active substance is cefiderocol sulfate tosylate . each vial contains 1 mg of cefiziderol . - other ingredients are sucrose , sodium chloride , and sodium hydroxide . what feret Croja looks like and contents of the pack ffeetkroja is a white to off - white powder for solution for infusion , supplied in a 10 ml glass vial , containing one vial per carton .
depocyte is used to treat lymphomatous meningitis in adults . lymphomatomus meningitsis is a condition in which tumour cells form in the membranes that surround the brain and spinal cord . depcyto is used in adults to reduce the number of lymphoma tumour cells .
do not take depocyte if you are allergic to cytarabine or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor thinks you may have a meningeal infection . warnings and precautions severe neurological side effects may occur after taking depoocyte . patients receiving depcyto have reported symptoms related to the nervous system such as convulsions , pain , numbness , or tingling , blindness and visual disturbances . if any of these symptoms occur , contact your doctor immediately . you may need to stop taking any depamethasone tablets as this may increase your chance of unwanted effects . talk to your doctor if these occur or if they get worse or he / she will check for them if possible . your doctor will monitor your side effects regularly and if necessary , start
the doctor treating you will use depocyte only if there is evidence of cancer in the product . the storage details are as follows : lumber sac , depoya , water for injections , 1 ml of solution for injection contains 5 mg dexamethasone . use in children and adolescents 5 years of age and over the recommended dose is 5 mmol / m2 body weight . for each depectomy dose , the doctor will monitor you for any side effects . dep cell growth is allowed to reach room temperature ( up to 22 ) within 30 minutes of withdrawing depcell from the vial . proper precautions have been taken to avoid exposure to the active substance , which may be a cytotoxic drug . appropriate handling technique is recommended . it is recommended that you inject depcytosis ( a type of medicine ) in a
like all medicines , this medicine can cause side effects , although not everybody gets them . side effects will be discussed with you and may be related to your treatment . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common ( impacts in 1 to 10 users in 100 ) uncommon ( affect affects 1 to10 users in 1 , 000 ) rare ( affectes 1 in 10 users per 10 ,000 ) very rare ( impacts on less than 1 users in 10 and less than1 user in10 not known ( frequency cannot be estimated from the available data ) adverse events that may occur while using depocyte or depected in combination with other chemotherapeutic agents are listed below . very common : may affect more than1 in 10 people nausea and vomiting weakness , confusion , fever headaches dizziness , headache
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the container . depocyte should be stored in a refrigerator ( 2 to 8 ). do not freeze . store in the original container in order to protect from light . after first opening , depoocyte should not be used for more than 4 weeks . before opening : do not store above 25c . keep the container in the outer carton in order for storage time . discard the container after the first opening date . this medicine must not be returned to the refrigerator if you notice severe discolouration , a changed appearance or a defective container , or if the medicine is not clear or colourless . your doctor will determine how much depoids to give you . the recommended dose of cytarabine is one tablet .
what depocyte contains - the active substance is cytarabine . each ml of suspension contains 10 mg ccytariabine ( 10 mg per vial ). each vial of 5 mL solution contains 50 mg / m2 of cychtarabin . - other ingredients are cholesterol , triollein , dioleoylphosphatidylcholine , dipalmitoynphosphatiddylglycerol , sodium chloride , and water for injections . what depector looks like and contents of the pack depoylent is a clear , colourless liquid for injection , supplied in a 5 - mlitre vial as a single injection in  a separate vial ( multidose vial only ).
what bemrist breezhaler is and how it works bem breezehaler contains two active substances : indacaterol and mometasone furoate . indаcaterol belongs to a group of medicines called bronchodilators . it relaxes the muscles of the small airways in the lungs . this helps to open the airways and makes it easier for air to get in and out of the bronchial spaces . when bemmristes brezhaler works , it helps the small lungs to remain open . momeatasine furoates belongs to one of a family of medicines known as corticosteroids ( or steroids ). corticotrooids reduce the swelling and irritation ( inflammation ) in the small aeroways in your lungs and so gradually ease breathing problems . corticosto
do not use bemrist breezhaler - if you are allergic to indacaterol , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before using bem. breezehaler tell your provider if any of these apply to you as well . if not , talk to your doctor . warnings and precautions talk to you doctor , pharmacist or nurse before using Bemristes brezhaler before using it : - before you start using bemarist brewinger : check with your doctor or pharmacist before using this medicine :- - when you have heart problems , including an irregular or fast heartbeat .- he or she will check whether you have thyroid gland problems . tell your dentist if : you have diabetes
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much bemrist breezhaler to inhale the usual dose is to inhaled the content of one capsule each day . you only need to use the medicine once a day because your asthma is getting worse and your symptoms will not improve if any of the above apply to you , or if they get worse . when to inhle bemmristes breezehaler inhalation use only as this will help you to remember to use it . for inhaling bem Rist BREezhalers , you will find an inhaler and capsules that contain the medicine . the inhalers contain the capsules only . only use the capsule with the inhaler provided in this pack . to use ,
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects could be serious : common ( may affect up to 1 in 10 people ) difficulty breathing or swallowing , swelling of the tongue , lips , or face , skin rash , itching and hives ( signs of allergic reaction ). uncommon ( may effect up to1 in 100 people ), swelling mainly of the mouth , tongue - lips - face or throat ( possible signs of angioedema ). other side effects that may be serious tell your doctor or pharmacist if you notice any of the following side effects you may need medical attention : very common ( might affect more than 1 in every 10 people "). trouble breathing or cough . feeling sick ( nausea ) or vomiting . common ( could affect upto 1 in each 100 people ") swelling of both the tongue and lips .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . store the capsules in the original blister in order to protect from light and moisture .
what bemrist breezhaler contains - the active substances are indacaterol ( as acetate ) and mometasone furoate . bemmristic breezehaler 125 micrograms / 62 . 5 microgram each capsule contains 173 microgram of inddacatrol adeps ( equivalent to 150 microgram ind acaterolul and 80 microgram momeTasONE furoATE ). the delivered dose ( the dose that leaves the mouthpiece of the inhaler) contains 125 Micrograms of in indаcaterol / 6 . 0 microgram ( mg ) momeatasine furoates . the delivered dosage ( the amount of bemnist briezhalers that contains 126 . 7 microgram / 173 macrograms ind
zyllt contains the active substance clopidogrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood  clots forming ( a process called thrombosis ). zyillt is taken by adults to prevent blood cluts ( thrombi ) forming in hardened blood vessels ( arteries ), a procedure known as atherothromboses , that can lead to atherotrombotic events ( such as stroke , heart attack , or death ). you have been prescribed zyllyt to help prevent blood blood coagulations and reduce the risk of these severe conditions . you have these conditions because your doctor has prescribed a
do not take zyllt if you are allergic to clopidogrel or any of the other ingredients of this medicine ( listed in section 6 ). if there is a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if your doctor thinks you may have severe liver disease . do not use zylt unless your doctor tells you to . warnings and precautions before you take yllt and while you are taking it , tell your doctor if any of these apply to you . take special care with zyillt : if the patient is ill , there is an increased risk of bleeding such a cardiovascular condition that puts you at risk of internal bleeding ( such as such as the stomach ulcer ). tell your healthcare provider if a blood disorder that makes you prone to internal bleeding . this includes bleeding inside
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of zyllt per day to be taken orally with or without food , and at the same time each day . if your doctor has prescribed zylt for the treatment of severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of zellt ( 4 tablets of 75 mg ) once at the start of treatment . then , the recommended dosage is one75 mg tablet once a day as described above . you should take zyllingt for as long as your physician continues to prescribe it . contact your doctor and the nearest hospital emergency department because of the increased
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , in rare cases , confusion ( see section 2 ). - swelling in the mouth or skin disorders such as rashes and itching , blisters of the Skin . this may be the signs of an allergic reaction . the following side effects have also been reported : very common side effects ( may affect more than 1 in 10 people ):  headache  dizziness  ringing in the ears ,  confusion  abnormal
what zyllt contains the active substance is clopidogrel . each film - coated tablet contains 75 mg of clopogrell ( as hydrogen sulphate ). the other ingredients are : tablet core : lactose ( see section 2 ' zylt contains lactoses '), microcrystalline cellulose , pregelatinised maize starch , macrogol 6000 and hydrogenated castor oil in the tablet core and hypromellose , titanium dioxide ( e171 ), red iron oxide ( 233 ), talc and propylene glycol in the film . what zellt looks like and contents of the pack the film- coated tablets are pink , round and slightly convex . boxes of 7 , 14 , 28 , 30 and 50 film  cards in each box are contained in a separate
what lamivudine teva is lamivine is a medicine that contains the active substance lamimivudines . what lamievudince tva is used for lamivaudinе tv is used to treat long term ( chronic ) hepatitis b infection in adults . lamvudinoine est , an antiviral medicine , does not contain the hepatis - b virus . it belongs to a group of medicines called nucleoside analogue reverse transcriptase inhibitors ( nrtis). heptis
do not take lamivudine teva if you are allergic to lamivine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions 28 talk to your doctor before taking lamivaudinе tva . like other similar medicines , some can cause serious side effects , including liver disease such as hepatitis c . if this applies to you , tell your doctor . you must not take this medicine if any of these apply to you ( or you are not sure ). if the results of your blood tests will be taken before you start taking your medication . see section 4 for more information . lamvudines tv may not treat your hepattis until your doctor tells you otherwise . talk to you doctor before you take lamevudinous t Eva if : you
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will have prescribed lamivudine teva to help control your hepatitis b infection . it does not matter at what time of the day you take your dose , but taking lamivine it is important that you continue to take lamivaudinе tva until your doctor tells you otherwise . when to take it - do not stop taking laminudinne to treat your illness unless your doctor told you to . - don ' t stop taking a double dose of lamvine on a regular basis . lamvudines tv should not be taken with food or between meals . swallow the tablets whole with water . you can take lamevudinous tava with
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with lamivudine teva : other conditions that can cause hepatitis b . it is important to tell your doctor if you get any of the following serious side effects during therapy with this medicine : very common ( may affect more than 1 in 10 people ): - some of the side effects are serious and may require hospitalisation . talk to your doctor before you start lamiviudinе clinical trials : tiredness , respiratory tract infections , throat discomfort , headache , stomach discomfort or pain , nausea , vomiting , diarrhoea , increases in liver enzymes . common ( might affect up to 1 in 100 people ), infections of the throat and nose , increased liver enzyme ( creatine phosphokina
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . lamivudine teva do not store above 25c . store in the original package in order to protect from moisture . keep the blister in the outer carton in order not to damage . this medicine does not require any special temperature storage conditions . don ' t throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what lamivudine teva contains - the active substance is lamizine which is present in each film - coated tablet ( tablet ) contains 100 mg of lamivine ( as monohydrate ). - other ingredients in the tablet core are microcrystalline cellulose , sodium starch glycolate , magnesium stearate . tablet film  coating : hypromellose , titanium dioxide ( e171 ), macrogol , polysorbate 80 , iron oxide yellow ( 233 ), iron oxide red ( 235 ). what lamevudines tva looks like and contents of the pack orange , round , biconvex film . each tablet is 32 mm in diameter . lamvudinoine tovudineze vudiene is available in aluminium blisters in pack sizes of 28 
nespo is an anti - anaemic . it is used to treat your anaemia . anaedia is when your blood does not contain enough red blood cells . the symptoms you get , such as fatigue , weakness and shortness of breath , are caused by lack of the natural hormone erythropoietin . erythopoiesetIN works in your kidneys and stimulates your bone marrow to produce more red blood cell cells , which leads to a higher level . this results in a very fast onset of fatigue / weakness and a shortnessof breath . when this happens , nasopharyngitis ( a substance produced by your body ) stimulates the production of a protein called darbepoetan alfa . chronic renal failure : nnespor
do not use nespo if you have high blood pressure that is not controlled with other medicines . if your doctor thinks you may be allergic to n - nabepoetin alfa or to r - hoepo . take special care with nnespor if any of the following applies to you : if for you - you have very high blood blood pressure not properly controlled with medicines - your doctor will have told you , if : you have sickle cell anaemia - have epileptic fits ( seizures ), or convulsions ( seizures or fits ) - are a medical condition in which substances like nipo and heroin are used to treat anaaemia because you have an allergy to latex . the needle and the pre - filled tiee are made of a derivative of latex
nespo will be given to you by a doctor or nurse . your doctor will carry out blood tests before you are given naespo . the dose of nnespor depends on your haemoglobin level . adults a haememologin level of 10 g / ml should be maintained at a normal level , for example if you are 12 years of age or older . how n espo is given the pre - filled syringe will be injected into a vein by your doctor or a nurse if there is chronic renal failure . it is given as a single injection under the skin or into  a channel ( intravenous ). the dose and duration of your anaemia will depend on the severity of your disease . dose the dose for nspo is based on your body weight 
like all medicines , nespo can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : 471 very common ( affects more than 10 users in 100 ) high blood pressure ( hypertension ) with fluid retention ( oedema ) uncommon ( affect affects 1 to 100 users in 1 , 000 ) blood clots ( thrombosis ) pain in the area injected rash ( redness of the skin rare ( affect fewer than 1 user in 10 ,000 ) serious allergic reactions including sudden life - threatening allergic reactions ( anaphylaxis ) swelling of the face , lips , mouth , tongue or throat which may cause difficulty in swallowing or breathing ( angioedeme ) a severe allergic reaction causing swelling of one or more of the surrounding skin
keep out of the reach and sight of children . store in a refrigerator ( 2c - 8c ). do not freeze . keep the original package in order to protect from light . nespo can be stored at room temperature ( up to 30 ) for a maximum of 7 days . do not use nnespor after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what nespo contains the active substance is darbepoetin alfa . nnespor is a pre - filled syringe that contains 10 , 15 , 20 , 30 , 40 , 50 , 60 , 80 , 100 , 130 , 150 , 300 or 500 micrograms of the active ingredient darbepepoen alf . the other ingredients of n espo are sodium phosphate monobasic , sodium phospho dibasic ( e339 ), sodium chloride , polysorbate 80 and water for injections . what nevespo looks like and contents of the pack naespo is reconstituted as a clear to slightly pearly liquid in a glass vial . it may be cloudy or distinctly yellow . pack size of 1 or 4 pre 
what macugen is macuGEN is a solution which is injected into the eye . it contains the active substance pegaptanib . this medicine works by preventing abnormal formation of new blood vessels in the eye that can damage the cells of the retina . what macugagen is used for macuGen is used in adults for the treatment of macular degeneration ( amd ). this disease causes vision loss or damage to the part of theretina , the macula . the maculate is inserted into the back of the eye and forms part of your amd called the maculation . in amd, abnormal blood vessels grow out of control and the retina becomes damaged . macuogen works by helping the macua to recognise and repair these new cells . when macugène is applied , macugenic is removed from the eye by removing these new blood cells , helping to protect the
do not use macugen : - if you are allergic to pegaptanib or any of the other ingredients of this medicine ( listed in section 6 ). - have an active or suspected infection in or around your eye . warnings and precautions talk to your doctor or pharmacist before using macuGEN . there is a small chance that you may get an infection which may be serious , including bleeding in the eye , after macugenic injection . tell your doctor immediately if : you develop one or more of the following symptoms : eye pain or increased discomfort , worsening eye redness , blurred or decreased vision , increased sensitivity to light , or small particles in your vision . these may be the case if the injection is given into your eye more likely to happen . the injection serious allergic reactions may occur , although the symptoms are usually mild to moderate . children and
macugen is given by injections into your eye . macuogen is given as a single injection into your eyes by your doctor . the recommended dose is 6 mg / kg given every 9 days . your doctor or nurse will check if the injection is working and will remove the vitreous ( the transparent layer in the front part of the eye ). macuGEN should only be used by people who are able to take antibiotic eye drops . before and after opening macu Gen will be given to your eyes under some local anaesthetic ( numbing medicine ) to reduce or prevent any pain you might have with the injection . do not use macugène if you are allergic to antibiotic eye drops or to any other medicine that is injected into your ocular lens . antibiotic treatment may reduce the risk of eye infection .
like all medicines , this medicine can cause side effects , although not everybody gets them . serious allergic reaction ( anaphylactic reaction ) with angioedema of which symptoms include breathing difficulty , wheezing , swollen mouth , face , hands or feet , itching skin , fainting / rapid pulse , stomach cramps , nausea , vomiting and diarrhoea . the frequency of these side effects is not known . you should see your doctor immediately if you notice any of the symptoms in section 2 . 2 ). these symptoms may be due to an infection in the internal portion of the eye . if this happens , macugen treatment should be stopped immediately . your doctor should check the symptoms listed in section 2. if these symptoms are serious , serious . reporting of side effects 23 if your doctor gets any side effects talk
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . if you have any suspension left in a bottle more than three weeks after it was first opened , you should not use the medicine . please return the bottle containing any left over suspension to your pharmacist .
what macugen contains the active substance is pegaptanib . each single dose pre - filled syringe contains 0 . 3 mg of pegabib in 90 microlitres . the other ingredients are sodium chloride , monobasic sodium phosphate monohydrate , dibasic salt phosphat heptahydrate ; sodium hydroxide ; hydrochloric acid ( for ph adjustment ) and water for injections , see section 2 . what macugagen looks like and contents of the pack macuGen solution for injection is presented as a single dose pack packed in a pouch inside a pre – filled yringer containing 0. 25 ml or 0, 27 mL of solution . it is supplied in much with an elastomeric plunger stopper and a pro - attached plunge
kepivance contains the active substance palifermin which is produced by recombinant dna technology in bacteria called escherichia coli . palifERmin is produced in the epithelial cells ( the cells that control food , drink and other medicine ) and is present in the mouth , digestive tract and the tissues below the skin . by modifying the function of palifersmin , kepepivace can treat oral mucositis ( soreness , dryness and inflammation of the mouth is a common side effect ). it is used in combination with other treatments to treat your blood cancer . if your blood tumor has worsened after chemotherapy , radiotherapy or autologous hematopoietic stem cell transplantation ( adsorbants ) is used to treat the disease .
do not use kepivance if you are allergic to palifermin , escherichia coli derived proteins or any of the other ingredients of this medicine ( listed in section 6 ). children and adolescents this medicine should not be used in children and teenagers below 18 years of age . other medicines and kepepivace tell your doctor or pharmacist if your child is taking , has recently taken or might take any other medicines . if any of these apply to your child , tell your physician or pharmacist before taking keparin . pregnancy and breast - feeding kepativance is not recommended for pregnant or breast . it may harm your baby if heparin is used during pregnancy or breast feeding . see also information under " other medicines of kekivance ". kedivance may harm an unborn baby . pregnant or trying to become pregnant
kepivance should only be given to you by a doctor with experience in cancer treatment . the recommended dose of kepeivance is 60 mg . keppivance will be given as an intravenous injection ( into a vein ) by your doctor or nurse . you will receive keprunce three days after chemotherapy and radiotherapy , and for three days afterwards . chemotherapy and radiation are given at different times during chemotherapy and on the 24 to 48 hours following the chemotherapy and in some cases even if you have not received the chemotherapy . your doctor will decide when you should receive the chemotherapy after the chemotherapy to be administered .
like all medicines , this medicine can cause side effects , although not everybody gets them . common ( may affect up to 1 in 10 people ) side effects reported commonly reported in clinical trials were skin rash , itching and redness ( pruritus ), erythaema ( an increase in the thickness in the mouth or tongue , change in colour of the mouth ou tongue ), generalised swelling ( oedema ), swelling of hands , ankles or feet , pain , fever and aching joints ( arthralgia ) and altered taste ( lipase ) or amylase levels increased ( increased lipasese , amylase levels increased ) in blood tests may also occur . reporting of side effects 25 if you get any side effects you can help provide more information on the safety of this medicine .
what kepivance contains - the active substance is palifermin . each vial contains 6 . 25 mg of paliferedmin - other ingredients are mannitol , sucrose , l - histidine , polysorbate 20 and diluted hydrochloric acid . what kespivace looks like and contents of the pack kepepivaces is a white powder for solution for injection that comes in vials containing 6 ml .
cinacalcet accordpharma contains the active ingredient cinacacet , which works by controlling the levels of parathyroid hormone ( pth ), calcium and phosphorous in your body . it is used to treat problems with organs called parathormon glands . the parathelis are four small glands in the neck , near the thyroid gland , that produce parat hormone ( in  - parat ). cinaccet accordpharm is used : to treat secondary hyperparathyroidism in patients with serious kidney disease who need dialysis to clear their blood of waste products to reduce calcium in the blood ( hypercalcaemia ) in patients of parAThyroid cancer to reduce the amount of calcium inthe blood ( hypocalcaeemia ). in primary hyperparatohyroidisc only after removal of the gland is possible . cinacet accord pharmacy is used in children and
do not take cinacalcet accordpharma if you are allergic to cinacacalcet or any of the other ingredients of this medicine ( listed in section 6 ). if there are still low levels of calcium in your blood . your doctor will monitor your blood calcium levels . warnings and precautions talk to your doctor before taking cinacinacalce accordpharma and if necessary , inform your doctor . before taking the tablets , tell your doctor that you are taking cinecalcet acordpharma . some patients taking ciacalcetaccordpharma have had seizures ( fits or convulsions ). the risk of having seizures is higher if your doctor thinks that you may have had them before . tell your physician if any of these apply to you . you may be at greater risk of liver problems or heart failure . cinaccet accordpharm may cause calcium levels to be raised . life threatening
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . your doctor will tell you how much cinacalcet accordpharma you must take . cinacacalcet acordpharma must be taken orally , with or shortly after food . the tablets must be swallowed whole and are not to be chewed , crushed or split . you will need to take regular blood samples during treatment to monitor your progress and will adjust your dose if necessary . for patients with secondary hyperparathyroidism the usual starting dose for cinaccet accord Pharma is 30 mg ( one tablet ) once a day . children and adolescents ( 3 to 18 years of age ) the usual dose is 0 . 20 mg cinacet accordchan is taken once - twice a morning . alternatively , cinacinacal
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience numbness or tingling around the mouth , muscle aches or cramps and seizures . these may be signs that your calcium levels are too low ( hypocalcaemia ). if this happens , you may experience swelling of the face , lips , mouth . tongue or throat which may cause difficulty in swallowing or breathing ( angioedema ). very common ( may affect more than 1 in 10 people ): nausea and vomiting . if these side effects occur , they are usually mild and usually disappear over time ( very common ). they usually disappear after a few weeks . common ( might affect up to 1 in10 people ). dizziness , headache , drowsiness , diarrhoea , flatul
what cinacalcet accordpharma contains - the active substance is cinacacalcet . each film - coated tablet contains 30 mg , 60 mg or 90 mg of cinaccet ( as hydrochloride ). - other ingredients : - tablet core : microcrystalline - crospovidone - magnesium stearate - film coating : pregelatinised - maize starch - coating ; hypromellose - titanium dioxide ( e171 ), triacetin , indigo carmine aluminum lake ( tialite ) and iron oxide yellow ( encoding ). what cinecalcet agreementpharma looks like and contents of the pack cinacinacalce accordpharma 30 mg film , tablet ( tablet ) is light green colored , oval shaped , 9 . 65 mm x 6 .
jentadueto contains two different medicines called linagliptin and metformin . linaguiptIN belongs to a class of medicines called " dpp - 4 inhibitors " ( dipeptidyl peptidase - 4- inhibitors ) metformine belongs to the class of drugs called biguanides . they work together to control blood sugar levels in adult patients with a form of diabetes called ' type 2 diabetes mellitus '. this medicine works by combining with insulin . this medicinal product is used alone or together with certain other medicines for diabetes ( e .g ., sulphonylureas , empagliflozin ) that are used alone to treat type 2 diabetic patients .
do not take jentadueto if you are allergic to linagliptin , metformin or any of the other ingredients of this medicine ( listed in section 6 ). if there is still a possibility that you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor , pharmacist or nurse before taking jsentadu : if your doctor has told you that you have severely reduced kidney function if the doctor has not checked your kidney function or if any of these apply to you . if they are not sure , talk to you doctor or pharmacist before taking this medicine . take special care with jenteduet if : you have uncontrolled diabetes , with , for example , severe hyperglycaemia ( high blood glucose ), nausea , vomiting , diarrhoea , rapid
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . jentadueto is used alone or in combination with another oral anti - diabetic medicine called insulin . your doctor will prescribe all medicines to reduce the level of sugar in your blood when you are first starting treatment with jsentaduеto . you are currently taking metformin in combination form . it is available as individual tablets of linagliptin and metformIN separately . taking this medicine with food and drink this medicine should be taken once daily to reduce your chance of an upset stomach . the recommended dose is 5 mg linagleptIN per day , taken once a day . this will be increased by 2 , 000 mg of metformine hydrochloride . when jenteduet is taken , it will help lower your
like all medicines , this medicine can cause side effects , although not everybody gets them . some symptoms need immediate medical attention you should stop taking jentadueto and see your doctor immediately if you experience any of the following symptoms : low blood sugar ( hypoglycaemia ): trembling , sweating , anxiety , blurred vision , tingling lips , paleness , mood change or confusion . hypoglcaemia is a very common ( may affect more than 1 in 10 people ). however , it can be treated more effectively with one injection of the combined jenteduet plus sulphonylurea . it is essentially a mixture of the combination jenaduaplus insulin and jENTaduoplus insulin . the combined product is more likely to cause a burning sensation when you first open the via
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton , blister or bottle after " exp ". the expiration date refers to the last day of that month . blister : store in the original package in order to protect from moisture . bottle : keep this product in the outer carton in order for us to protect it from moisture and light . sachet : do not open the bottle . does not require any special temperature storage conditions . store in original package . this medicine is for single use only . no signs of tampering are visible .
what jentadueto contains - the active substances are linagliptin and metformin hydrochloride . each jsentaduеto 2 . 5 mg / 850 mg film - coated tablet contains 2 , 5 mg of linaguiptIN and 850 micrograms of metformine hydrochromide - each juentadueto 2 5 mg/ 1 , 000 mg film- coated tablets contains 2 5 . 3 mg of the active ingredients , linagleptink and 1  , 500 microgram( 0 . 25 mg of metFORMin hydroCHloride *). - other ingredients are arginine , copovidone , magnesium stearate , maize starch , silica , colloidal anhydrous , all in the tablet core , and
edurant contains the active substance rilpivirine . it is used to treat human immunodeficiency virus ( hiv ) infection in adults , adolescents and children of all ages who are taking hiv medicines called non - nucleoside reverse transcriptase inhibitors ( nnrtis ). et is used in hiv medicine to treat adults and adolescents 12 years of age and older who are infected with hiv and who have not used hiv before . eDuring does not treat itself but it can still be used if other hiv drugs have failed to provide adequate protection . your doctor will discuss with you which combination of medicines is best for you .
do not take edurant if you are allergic to rilpivirine or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before taking ed . if your doctor has told you that you are not able to take a tablet , please tell your physician . warnings and precautions talk to your doctor or pharmacist before taking the tablet . before taking your tablet : e durant , take the following medicines : carbamazepine , oxcarbazepine, phenobarbital , and phenytoin ( medicines to treat epilepsy and prevent seizures ) rifampicin or rfapentine ( medicines used to treat some bacterial infections such as tuberculosis ): omeprazole ; esome
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is 1 . take edurant at least 18 years of age . before taking e during the day , take a tablet of edroea with food . do not chew , crush or split the tablet . e durant may be taken with or without food , either by itself or together with a glass of water . your doctor may advise you to take rifabutin , a medicine to treat some bacterial infections . when taking a dose of rifabutIN , your doctor will tell you how much e pendant you need to take each day . 2 . how to take an antacid , which is a medication used to treat diseases caused by the acid
like all medicines , this medicine can cause side effects , although not everybody gets them . you should immediately contact your doctor if you experience any of the following : headache , nausea , difficulty falling asleep , insomnia and dizziness . these may be due to changes in your routine liver tests ( transaminase ), increase in cholesterol and pancreatic amylase in your blood , abnormal dreams , rash , or stomach pain , depression , tiredness , vomiting , and drowsiness and decreased appetite . sleep disorders , stomach discomfort , depressed mood , sleep disorder and sleep disorder . common side effects ( may affect up to 1 in 10 people ): diarrhoea , constipation , dry mouth , loss of appetite , weight loss , back pain . uncommon side effects in patients with dementia , heart
what edurant contains - the active substance is rilpivirine ( as rillpivire hydrochloride ). each tablet of e durant containsrilppivirine hydroch chloride equivalent to 25 mg of riilpirine . -the film - coated tablet core contains lactose monohydrate , croscarmellose sodium , povidone k30 , polysorbate 20 , silicified microcrystalline cellulose and magnesium stearate . the film  consists of lactoses monohydrate and hypromellose 2910 ( approximately 6 mpa . min ). tablet core : titanium dioxide , macrogol 3000 and triacetin .
avandamet tablets contain two different medicines called rosiglitazone and metformin . these two medicines are used to treat type 2 diabetes . people with type 2 disease either don ' t make enough insulin ( a hormone that controls blood sugar levels ), or don  t respond normally to the insulin their body makes . rosivitazon and metFORMin work together so your body makes better use of the insulin it produces , and this helps reduce your blood sugar to a normal level . it is important that you also take avandаmet together with a sulphonylurea ( another medicine for diabetes ).
your diabetes needs treatment with avandamet . do not take avandаmet if you are allergic ( hypersensitive ) to rosiglitazone , metformin or any of the other ingredients of avand amet ( listed in section 6 ) if your doctor has told you that you have had a heart attack or severe angina , heart failure or have had heart failure in the past if the patient has severe breathing difficulties if they have liver disease if a doctor has prescribed you a different type of diabetic ketoacidosis ( a complication of diabetes causing rapid weight loss , nausea or vomiting ) take special care with a diet plan if any of these apply to you . if in doubt , tell your doctor or pharmacist . warnings and precautions talk to your doctor before taking avandagemet : 107 you may become very
always take avandamet tablets exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . how much to take the usual starting dose is one 2 mg tablet of rosiglitazone and 1000 mg of metformin a day . this dose is taken once a morning and is taken at about the same time each day , preferably in the morning . the maximum dose is 1 tablet in the evening . after about 8 hours , the maximum dosage is 4 mg of rozigliatazone a night . it is recommended that you take metform in the day ; take this dose as long as your physician tells you to . check with the doctor or nurse if this dose does not work . in some cases , it may be necessary to take extra tablets to make up for a forgotten dose . if your doctor tells
like all medicines , avandamet can cause side effects , although not everybody gets them . allergic reactions may occur rarely in patients taking avandаmet . signs include : raised and itchy rash ( hives ) swelling , sometimes of the face or mouth ( angioedema ), causing difficulty in breathing collapse . contact your doctor immediately if you have any of these symptoms . stop taking amet and tell your doctor as soon as possible . lactic acidosis : lactic acids build up in the blood ( lactic acidosis ) is a common side effect seen in patients receiving metformin for severe kidney disease . symptoms of lactic Acidoss include rapid breathing , cold sweats and / or muscle spasms . some patients have experienced the following side effects while taking metformine : common side effects seen in children
keep out of the reach and sight of children . do not use avandamet after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . if you have any unwanted tablets , don ' t put them in waste water or household rubbish . ask your pharmacist how to dispose of tablets you don  't need . these measures will help protect the environment .
what avandamet contains the active substances are rosiglitazone and metformin . avandagemet tablets come in different strengths . each tablet contains 1 mg of rosivitazon and 500 mg of metformIN . after mixing : each tablet of 2 mg of both rosviglit azone + 500 mg debossed with metformine . the other ingredients are : in the tablet core : the other ingredient is metforminer . in the film - coated tablet the other side of the tablet is rositazone plus 1000 mg of debossing with metFORMin , and in the 4 mg rosibitaone + 1000 mg metformink . other ingredients : sodium starch glycollate , hypromellose , microcrystalline cellulose , lactose monohydrate . what a 
clopidogrel mylan contains clopinogrell and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood cluts forming ( a process called thrombosis ). clopigrel is taken by adults to prevent blood  clots ( thrombi ) forming in hardened blood vessels ( arteries ), a condition known as atherothromboses , that can lead to atherotrombotic events ( such as stroke , heart attack , or death ). you have been prescribed clopitogrela mylan to help prevent blood from clottes forming and prevent new clotes from forming .
do not take clopidogrel mylan 31 if you are allergic to clopogrell or any of the other ingredients of this medicine ( listed in section 6 ). if there is a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if your doctor thinks you may have severe liver disease . do not stop taking clopinogrela mylan unless your doctor tells you to . take special care with clopirogrelan mylan check with your doctor if any of these apply to you . warnings and precautions talk to your doctor before taking : if the patient is : have a risk of bleeding such a cardiovascular condition that puts you at risk of internal bleeding ( such as such asa stomach Ulcer ). have  a blood disorder that makes you prone to internal bleeding . this includes bleeding inside
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel mylan per day to be taken orally with or without food , and at the same time each day . if your doctor has told Ihnen that you have a history of severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of clapidogral myLAN ( 4 tablets of 75 mg ) once at the start of treatment . then , the recommended dosage is one75 mg tablet , taken or divided into equal doses . you should take clopogrell mylan for as long as your physician continues to prescribe it 
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , in rare cases , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of the scalp . this may be the signs of an allergic reaction . your doctor will tell you how to treat the rash . thenumbness and tingling sensation may be associated with a burning sensation when rubbing the skin . tell your doctor if
what clopidogrel mylan contains the active substance is clopizide . each film - coated tablet contains 75 mg of clopinogrell ( as hydrochloride ). the other ingredients are microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 , hydrogenated castor oil in the tablet core and in the film  armour ( type 2 ) and clopridogrelly mylan contained hydrogenated castle oil in its film ­ coating . the other ingredient ( in the movie - coating ) are : polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( i ) ( a little yellow iron oxide ), talc and macrogol 3000 . what clapidogral myLAN looks like and contents of
doptelet belongs to a group of medicines called thrombopoietin receptor agonists . dopelet is used to treat adults with chronic liver disease with low platelet count ( thrombophlebitis ) which has not responded to , or is not fully controlled , a medical procedure , which reduces the risk of bleeding , by reducing the number of platelets . platelets are blood cells that help the blood to clot and so prevent bleeding .
do not take doptelet : - if you are allergic to avatrombopag or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking dop Telet . blood clots may form in the veins or arteries , and blood coagulation may be life - long . tell your doctor before taking this medicine :- - blood ts can form in certain patients with cancer , who are taking the contraceptive birth control pill or hormone replacement therapy , or have recently had surgery or are injured . 23 - the recommended dose is one tablet per day . - doptelt is not recommended in patients who are overweight or have advanced chronic liver disease . children and adolescents dopelet is only for use in children and in adolescents under 18 years old .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dose the recommended dose for your procedure is 5 mg once a day . your doctor may increase the dose to 8 mg once daily . you should swallow the tablet whole with some water . doptelet can be taken with or without food . the recommended daily dose of dop Telet is 20 mg , 40 mg or 60 mg once per day , depending on your platelet counts . this medicine may be taken up to 10 days before or 13 days after your planned medical procedure . swallow the tablets with a glass of water , one after another . if this happens , your doctor will increase the dosage to two tablets per day depending on the dose you are taking . it is recommended that you take the tablets at the same time each day if it is difficult to swallow . otherwise 
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with doptelet : common : may affect up to 1 in 10 people feeling tired common ; may affect less than 1 in 100 people low red blood cell count ( anaemia ) caused by blood clot in the portal vein ( a blood vessel that connects the liver and intestines ) upper abdominal pain and swelling bone pain muscle aches fever reporting of side effects get medical help or get medical advice if you get any side effects talk to your doctor or nurse . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what doptelet contains - the active substance is avatrombopag . each film - coated tablet contains avatotrojipag maleate equivalent to 20 mg avataropag - other ingredients are : lactose monohydrate ( see section 2 ' dopelet contains lactoses '), microcrystalline cellulose , crospovidone type b [ e1201 ], silica , colloidal anhydrous , magnesium stearate , and vinyl alcohol , in the tablet core : talc , macrogol 3350 , titanium dioxide ( e171 ) and iron oxide yellow ( 233 ). what dopetelet looks like and contents of the pack optelet 20 mg film kx tablets are pale yellow , round and rounded , marked with ' 20 mg' on one side
rapiscan belongs to a group of medicines called ' coronary vasodilators '. they work by helping to scan the heart arteries , which are important for heart rate . they also help to see the muscles of the heart which are working properly . rapisingcan is used for a type of heart scan called a ' myocardial perfusion imaging ' where the scan contains a radioactive substance called - a " radiopharmaceutical ' which is used to obtain these images . it also helps to obtain pictures of the muscles in the heart using a treadmill to help read and hear the information about the heart in action . the doctor may decide that a scan is necessary because a small amount of radiopharmaciaceuticals is not absorbed into the body , but it can be given into a vein .
do not use rapiscan if you have : slow heart rate , high degree heart block , sinus node disease , that is not well controlled with a pacemaker , chest pain ( unstable angina ) that does not respond to treatment , low blood pressure ( hypotension ) or heart failure , which is allergic to regadenoson ( the active substance in rapison ) more than 6 months after you last had rapistcan . warnings and precautions talk to your doctor or nurse before you have had : - a recent serious heart problem such as a heart attack - abnormal heart rhythms - problems with your heartbeat ( such as when your heart beat is very fast or uneven ). - any of the conditions you need to look out for while you are being treated with rapissecan , or when you have experienced a sudden serious heart trouble 
rapiscan will be administered to you by a doctor or nurse . rapican will take some time to get your doctor ' s attention . it will depend on your heart and blood pressure . how much rapista you will receive the dose of rapissecan is injected into a vein . the recommended dose is 400 mg / ml . when given as a 5 mL solution the injection will take about 10 minutes . your doctor will calculate your dose according to your weight . an injection of sodium chloride 9 mg ph + ( 0 . 9 %) solution for injection will be given to you in hospital . this dose will be diluted with a radioactive substance ( radiopharmaceutical ) before being given . before rapisingcan , your doctor and radiographer will calculate and inject the dose you need and will measure your heart
like all medicines , rapiscan can cause side effects , although not everybody gets them . the side effects are usually mild to moderate and occur within one week of the rapican injection . this is usually temporary and does not last for more than 30 days . tell your doctor immediately if you need any treatment for side effects such as : sudden stopping of the heart , damage to the heart or heart block , or a disorder of the hearts ' electrical signal , rapid heart beat low blood pressure fainting , mini strokes , weakness of the face and inability to speak . rapistcan may cause a stroke or cerebrovascular accident . an allergic reaction which causes rash , wheals / weals or hives , fits or drowsiness . these may be signs of an allergic response . sore throat or runny nose . it
viagra contains the active substance sildenafil which belongs to a group of medicines called phosphodiesterase type 5 ( pde5 ) inhibitors . it works by helping to relax the blood vessels in your penis , allowing blood to flow into your penises when you get sexually excited . viagra will only help you to get an erection if you are sexually stimulated . Viagra is a treatment for adult men with erectile dysfunction , sometimes known as impotence . this is when a man cannot get , or keep a hard , hard - to - sell eric penis suitable for sexual activity .
do not take viagra if you are allergic to sildenafil or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . if for you the use of medicines called nitrates has been banned , as the combination may lead to a dangerous fall in your blood pressure . tell your pharmacist if any of these medicines are not suitable for you . for example , if your doctor has prescribed angina pectoris (" chest pain "). - if the medicines are used to treat you ' re being treated with nitric oxide donors such as amyl nitsitrite , because the combination could also lead to another dangerous fall of your blood tension . ask your doctor or pharmacist . warnings and precautions talk to your doctor , pharmacist or nurse before taking viagra : -if you'
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended starting dose is 50 mg . you should not take viagra more than once a day . this is because of the higher risk of side effects . for the higher doses , use in children and adolescents less than 100 years of age should not use this medicine . your doctor will tell you how many tablets of viagra to take . do not take the tablets with grapefruit or grapefruit juice . take the tablet before a meal . swallow the tablet whole with a glass of water . it is best to take viagra at the same time each day , preferably at the exact time of the day ; if your doctor tells you to stop . viagra will only help you to get an erection if they are sexually stimulated . 
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects reported in association with the use of viagra are usually mild to moderate and of a short duration . if you experience any of the following serious side effects stop taking viagra and seek medical help immediately : an allergic reaction - this occurs uncommonly ( may affect up to 1 in 100 people ) symptoms include sudden wheeziness , difficulty in breathing or dizziness ; swelling of the eyelids , face , lips or throat . chest pains - these may occur more often if they occur during or after intercourse . get in a semi - sitting position and try to relax . do not use nitrates to treat your chest pain . prolonged and sometimes painful erections : this occurs rarely ( may effect up to1 in 1 , 000 people ). 
what viagra contains - the active substance is sildenafil . each tablet contains 25 mg of sildanafil ( as the citrate salt ). - other ingredients are : tablet core : microcrystalline cellulose , calcium hydrogen phosphate ( anhydrous ), croscarmellose sodium , magnesium stearate . film coat : hypromellose , titanium dioxide ( e171 ), lactose monohydrate , triacetin , indigo carmine aluminium lake ( s ). what viagra looks like and contents of the pack viagra film - coated tablets are blue , biconvex , of a rounded - diamond shape with a diameter of 25 mm . the tablets are provided in blister packs containing 2 , 4 , 8 or 12 tablets . not all pack sizes may be marketed
sifrol contains the active substance pramipexole and belongs to a group of medicines known as dopamine agonists , which stimulate dopama receptors in the brain . stimulation of the dopami receptors triggers nerve impulses inthe brain that help to control body movements . sIfrol is used to : - treat the symptoms of primary parkinson ' s disease in adults . it can be used alone or in combination with levodopa ( another medicine for parkinsons ' disease ). - relieve the symptoms in moderate to severe primary restless legs syndrome in adults and adolescents .
do not take sifrol - if you are allergic to pramipexole or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking sfrol . tell your doctor if any of these apply to you . sunlessrol is used in hospital , it is not known if sIFrol will affect you if or during you have ( had ) any medical conditions or symptoms , especially any of those associated with kidney disease . some patients have had hallucinations ( seeing , hearing or feeling things that are not there ). most hallucinesions are visual . dyskinesia ( e .g . abnormal , uncontrolled movements of the limbs ). if your doctor has told you that you have advanced parkinson ' s disease and you are also taking le
always take this medicine exactly as your doctor has told you . check with your doctor if you are not sure . the doctor will advise you on the right dosing . you can take sifrol with or without food . swallow the tablets with water . parkinson ' s disease the daily dose is to be taken divided into 3 equal doses . during the first week , the usual dose is 1 tablet of sIfrol 0 . 088 mg three times a day ( equivalent to 0. 264 mg daily ): 1st week number of tablets of  0 ( 0 1 . 2 mg of  sfrol - 0 088 - 1 mg daily total daily dose )  2 tablets of the 0 264 until your symptoms are controlled ( maintenance dose ). 2nd week 3rd week number 2 : s
like all medicines , this medicine can cause side effects , although not everybody gets them . evaluation of these side effects is based on the following frequencies : very common may affect more than 1 in 10 people common may effect up to 1 in every 10 people uncommon may affect up to1 in every 100 people rare may affect less than 1in every 1 , 000 people very rare may impact up to 0 in 10 ,000 people not known frequency cannot be estimated from the available data if you suffer from parkinson ' s disease , you may experience the following side effects as a result of the following : - dyskinesia ( e . g . abnormal , uncontrolled movements of the limbs ) - dizziness - nausea ( sickness ) common : urge to behave in an unusual way - hallucinations ( seeing , hearing or feeling things that are
what sifrol contains the active substance is pramipexole . each tablet contains 0 . 088 mg , 0. 18 mg / 0 de . 35 mg equilibration ( equivalent to 0, 7 mg pramipepexrol ). each tablet is labelled with 0 ( 0 in 125 mg ), 0 1 . 25 mg & 0 5 . 5 mg . this corresponds to 1 mg pramipexe dihydrochloride monohydrate . the other ingredients are mannitol , maize starch , anhydrous colloidal silica , povidone k 25 and magnesium stearate . what ifrol looks like and contents of the pack sfrol 0 088mg tablets are white to off - white , round tablets with " p
emadine is a medicine used for the treatment of seasonal allergic conjunctivitis of the eye . allergic conditions where the eye is closed , the allergic reaction may continue . in allergic conjonctivits , some materials ( allergens ) may cause allergic reactions , including itching , redness and swelling of the surface of your eye , if you feel worse .
do not use emadine if you are allergic to emedastine or any of the other ingredients of this medicine listed in section 6 . warnings and precautions talk to your doctor , pharmacist or nurse before using e madine : if your vision is blurred while you are using a dose of emasine . see section 3 , " benzalkonium chloride ". edine has not been tested in clinical trials . therefore , the safety and efficacy have not been established . if clinical trials have not shown efficacious results , your doctor will not give you emailine ; if any of these apply to you , tell your doctor or pharmacist . talk to you doctor or nurse first . tell your pharmacist if ebadine has been associated with kidney or liver problems . children and adolescents emagine
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is 3 drops in each eye . you should only use this product for your eyes if your doctor told you to . see section 3 . take the emadine bottle about 1 hour before going to bed . do not take it for more than 2 hours after you have taken it ( see section 2 ). take the bottle and the corresponding amount of drops at the same time each day . how to take take e madine bottles by mouth . wash your hands . removing the bottle , remove the cap and cap from the bottle before you go to bed ( see " snap collar " below ). hold the bottle with your thumb and a finger . tilt your head back . pull down your eyelid with a clean finger until there is a
like all medicines , this medicine can cause side effects , although not everybody gets them . you can usually carry on taking the drops , unless the effects are serious . common side effects ( may affect up to 1 in 10 people ) effects in the eye : eye pain , itchy eye , eye redness . uncommon side effects these may affect more than 1 in 100 people ). effects in and around the eye: corneal disorder ( abnormal eye sensation ), increased tear production , tired eyes , and eye irritation , blurred vision , corneal staining . not known ( frequency cannot be estimated from the available data ): eye irritation and cloudiness . reporting of side effects 25 if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . 123 . 1 . how common side effect ( may effect up to
keep out of the reach and sight of children . do not use emadine after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . store below 25 . keep the blister in the outer carton in order to protect from light and moisture . this medicine does not require any special temperature storage conditions . e madine is for single use only . once the blister has been opened , use immediately . you should not store above 25 , to prevent infections .
what emadine contains - the active substance is difumarate . - each vial contains 0 . 5 mg dilution . the other ingredients are benzalkonium chloride and trometamol , sodium chloride , hypromellose , purified water , and hydrochloric acid and sodium hydroxide to keep acidity levels ( ph levels ) normal . what  e madine looks like and contents of the pack ematine is a liquid ( a solution ) supplied in a 5 ml or 10 mlitre plastic ( drop - container ) bottle with a screw cap . not all pack sizes may be marketed .
levetiracetam is an antiepileptic medicine ( a medicine used to treat seizures in epilepsy ). levetiractam actavis is used : on its own in adults and adolescents from 16 years of age with newly diagnosed epilepilepsy , to treat a certain form of epileeptic . epilepra is a condition where the patients have repeated fits ( seizures ). Levetiracetham is used for the epilepian condition in which the fits initially affect only one side of the brain , but could thereafter extend to larger areas on both sides of the body ( partial onset seizure with or without secondary generalisation ).. levetiacetam has been given to you by your doctor to reduce the number of fits . as an add - on to other antieeptic medicines to treat partial initiation seizures and myoclonic seizures .
do not take levetiracetam actavis if you are allergic to levetiractam , pyrrolidone derivatives or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking levetirasetam actingavis: if your kidney problems are any slow down in the growth or unexpected puberty development of your child . a small number of people being treated with anti - epileptics such as levetistetam acts as a precautionary measure if at any time you have thoughts of harming or killing themselves . you should tell your doctor if any symptoms of depression and / or suicidal ideation are severe . tell your doctors if during treatment you have any of these side effects : abnormal thoughts , feeling irritable or reacting more aggressively than usually , or if
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . take the number of tablets following your doctor' s instructions . levetiracetam actavis is taken twice a day , once in the morning and once inthe evening , at about the same time each day . monotherapy dose in adults and adolescents ( from 16 years of age ): general dose : between 1 , 000 mg and 3 , 3 . 5 mg each day you will take levetiractam actingavis as a single tablet . in children and adolescents , the usual dose is 2 tablets of 1  , 500 mg each morning . add - on therapy dose in children ( 6 to 17 years ) weighing 50 kg or more : general dosage : zwischen 1 . 000 mg plus 3  . 3
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately , or go to your nearest emergency department , if you experience : weakness , feel light - headed or dizzy or have difficulty breathing , as these may be signs of a serious allergic ( anaphylactic ) reaction ; swelling of the face , lips , tongue and throat ( quincke ' s oedema ); flu - like symptoms and a rash on the face followed by an extended rash with a high temperature ( 38 . 5oc or higher ), increased levels of liver enzymes seen in blood tests and an increase in a type of white blood cell 56 ( eosinophilia ) and enlarged lymph nodes ( drug reaction with an increase of titration ); vomiting , diarrh
what levetiracetam actavis contains the active substance is called levetiractam . levetiacetam actsavis 250 mg : each capsule contains 250 mg of levetirasetam the active ingredient in levetistetam is crospovidon . povidone , silica colloidal anhydrous , magnesium stearate . what levatiracetham actavises looks like and contents of the pack levetiratitam actingavis is a white to off - white lyophilised tablet . it is available in packs containing one tablet ( 270 mg ) or two tablets ( 280 mg ). levetiratetam actionavis 750 mg / 750mg : one tablet contains 750 milligrams of leviracetnam . one tablet is 270 millilitres . another tablet is an
what incruse ellipta is this medicine contains the active substance umeclidinium bromide , which belongs to a group of medicines called bronchodilators . what increse is used for incruses ellippta can be used for this medicine is used to treat chronic obstructive pulmonary disease ( copd ) in adults . copd is a long - term condition in which the airways and air - sacs in the lungs gradually become blocked or damaged , leading to breathing difficulties that slowly get worse . difficulties in breathing is added to by tightening of the muscles around the airway , this medicine blocks the tightener of these muscles , making it easier for air to get in and out of the pulmonary system . when used regularly , it can help control your breathing difficulties and reduce the effects of copd on your
do not use incruse ellipta 27 - if you are allergic to umeclidinium or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before using this medicine . warnings and precautions talk to your doctor , pharmacist or nurse before using incruses ellippta : - patients with asthma do not using incrise
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation every day at the same time of day . you only need to inhale once a day because the effect of this medicine lasts for 24 hours . don ' t use more than your doctor tells you to use . use incruse ellipta regularly it is very important that you use increse itpt  every day , as instructed by your doctor . this will help to keep you free of symptoms throughout the day and night . do not use this product to relieve a sudden attack of breathlessness or wheezing . if this happens you must use a quick - acting reliever inhaler ( such as salbutamol ). how to use the inhalers see ' step 
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions are uncommon ( may affect up to 1 in 100 people ). if you have any of the following symptoms after taking incruse ellipta , stop using this medicine and tell your doctor straight away : itching skin rash ( hives ) or redness 29 other side effects may include : common ( may effect up to1 in 10 people ) faster heart beat painful and frequent urination ( may be signs of a urinary tract infection ) common cold infection of nose or throat cough feeling of pressure or pain in the cheeks and forehead ( may indicate inflammation of the mucous membranes ) uncommon ( might affect upto 1 in 10 , 000 people ), but can also occur with this medicine : swelling of the face , lips , tongue or throat ( may represent
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the label of your inhaler after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 to 8 ). do not freeze . keep the inhalation in the sealed tray in order to protect from light . after first opening of the tray , the inhaled tray can be left out of sight for a maximum of 6 weeks . once you have used the inhales , put the inhanhaler back into the refrigerator immediately after use . write the date of use on the label in the space provided . for best results , inhale in content that has been stored in the tray for more than 30 days . before you use the inhazers please write the day the inhabitant has been out of its
what incruse ellipta contains - the active substance is umeclidinium bromide . each single inhalation provides a delivered dose ( the dose leaving the mouthpiece ) of 55 micrograms umeklidinium ( equivalent to 65 microgram of umecidinium brmide). - other ingredients are lactose monohydrate ( see section 2 under ' incrusite ellippa contains lactoses ') and magnesium stearate . what increse incrussant ellipase consists of an inhalations powder . the ellipita inhaler consists a grey plastic body , a light green mouthpiece cover and a dose counter . it is packaged in a foil laminate tray with a peelable foil lid . inside the tray , there is a desiccant packet 
nucala contains the active substance mepolizumab , which is a monoclonal antibody , a type of protein that works by attaching itself to a specific target substance in the body . nucalа is used to treat severe asthma in adults , adolescents and children aged 6 years and older . severe asthma is caused by the presence of many eosinophils , another white blood cell , that dominates the lungs . eopenic asthma is the most common type of asthma . asthma nucală is used : to help prevent asthma attacks in adults who are already taking medicines called high dose inhalers . to help control your asthma your doctor may also prescribe these medicines . in addition to medicines called oral corticosteroids , nucalum can help control and reduce your asthma if you already have taken mepolizub . it also contains an enzyme called
do not use nucala if you are allergic to mepolizumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions this medicine may be used in adults and children who are more at risk of worsening asthma . in some patients 58 who have asthma - related side effects , their asthma is likely to worsen if they do not take nucalala . this is because your asthma needs nucalation . do not stop nucalа treatment if your asthma is not controlled with nucale . allergic - injection site reactions medicines of this type ( monoclonal antibodies ) can cause severe allergic reactions if their body is exposed to inhaled ( see section 4 , possible side effects and information ). if someone else in your family has had a similar reaction to nucalam . talk to your doctor or pharmacist before using nucal
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . nucala is given by injection under the skin ( subcutaneous injection ). the recommended dose for adults and adolescents 12 years of age and over is 100 micrograms once a day for 1 injection in the morning . use the pre - filled pen to inject nucalá at the same time each day . you can inject nukala yourself if your doctor tells you differently . your doctor will decide how long you need to take nucalа . do not stop treatment with nucalala without talking to your doctor first . if the treatment with Nucala does not improve , your asthma symptoms or attacks may come back or get worse . consult your doctor if a change in your asthma problems are not resolved after you have received injections of nucalam . it is important that
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with nucala : allergic reactions allergic or allergic - like reactions are common ( may affect up to 1 in 10 people ). they usually happen within minutes to hours after the injection , but can sometimes be severe . symptoms include : chest tightness , cough difficulty breathing fainting dizziness feeling lightheaded ( due to a drop in blood pressure ) swelling of eyelids , face , lips , tongue or mouth hives rash tell your doctor immediately if you think you may have had a reaction to , or to re - occur after receiving nucalа . if it happens to you , stop using nucalala and tell your physician . it is very important that you tell your doctors immediately , as you may be at risk of having a
keep out of the reach and sight of children . do not use nucala after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 to 8 ). do not freeze . keep the nucalá pre - filled pen in the outer carton in order to protect from light . after first use or if carried as a spare you may carry it with you for up to 7 days ( but not above 25 ). always keep the container tightly closed in order not to damage it . once you have taken the pen out of your refrigerator , do not store it again . you should record the date when the pen is first used and the date after which it should be used . always keep in the box in order for storage at room temperature ( not above 30 ) and use within 7 days after first using it 
what nucala contains the active substance is mepolizumab . 1 ml solution contains 100 mg mepolizub - the other ingredients are sucrose , sodium phosphate dibasic heptahydrate , citric acid monohydrate . polysorbate 80 , edta disodium dihydrate and water for injections . what nukala looks like and contents of the pack nucalala is presented as a clear and colourless solution for injection ( 1 g / mL ). nucalа is available in a pack containing 1 or a multipack containing 3 packs of 1 , each containing one vial . not all pack sizes may be marketed .
what ninlaro is nINlaron is a cancer medicine that contains the active substance ixazomib , which is called a ' proteasome inhibitor '. what nicotinlargo is used for nInlarone is used to treat adults with a type of a tumor of the bone marrow called multiple myeloma . ixizomibe works by stopping cell survival , and so restricts cell growth . when myelama cells have a lot of proteins called proteasoms involved in their growth and division . what is nickelaro used for and how it works ninklar is used by doctors to treat multiple myomomum . it is used when lenalidomide or dexamethasone is one of other medicines used to control multiple my
do not take ninlaro : if you are allergic to ixazomib or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before taking n inlaró . warnings and precautions talk to your doctor or pharmacist before taking the medicine if any of these apply to you ( or you are not sure ): nif you take , have recently taken or might take any other medicines , including ninelar if your doctor thinks any of them is too strong or too weak . take special care with nnlara : contact your doctor immediately if : you experience bleeding , persistent nausea , vomiting , diarrhoea , nerve problems such as tingling , numbness , swelling or a persistent rash .
ninlaro is used to treat multiple myeloma in adults . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . nINlarone must be taken together with lenalidomide , a medicine that contains dexamethasone , which is an anti - inflammatory medicine . how much n inlaron is given if your doctor decides to reduce your dose of lenaldomide or dexаmethason , it is taken on the same day of the week . the first 4 weeks of ninninglarro are taken once a week on the identical day of each week for the first 3 weeks . this 4 - week period will include one dose of : 25 mg once - daily for the second week and one dose on the third day
like all medicines , this medicine can cause side effects , although not everybody gets them . very common serious side effects ( may affect more than 1 in 10 people ) low platelet counts ( thrombocytopenia ) nose bleeds that may easily bruise nausea , vomiting , diarrhoea , numbness , feeling of tingling or burning of the hands or feet ( peripheral neuropathy ) swelling of the legs or feet( peripheral oedema ) skin rash ( itchy ) anywhere on the body . rare side effects these may affect up to 1 in 1 , 000 people ). these are signs of an infection . they are usually mild to moderate and usually go away over time . if they happen to you , they will need to be treated for them , but they can be serious . tell your doctor straight away if you notice any
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the blister or on the carton after exp . the expiration date refers to the last day of that month . store below 30 . keep the capsule in the original package in order to protect from light and moisture . once the capsule has been opened , use immediately . this medicine does not require any special temperature storage conditions . tell your pharmacist if you notice any damage or signs of tampering of medicine packaging .
what ninlaro contains the active substance is ixazomib . each capsule contains 2 . 3 mg of ixizomibe . for each capsule , there are 2 , 3 mg ixazamia citrate . the other ingredients are microcrystalline cellulose , magnesium stearate and talc . - the capsule shell contains gelatin , titanium dioxide ( e171 ), red iron oxide ( е172 ) and shellac , propylene glycol , potassium hydroxide and black iron oxide . what nicotine looks like and contents of the pack the hard capsules are white , oval , with " n2 " and " 3 " printed in black ink . one capsule of nninlano contains 3 mg in ixozomid . there are 3 mg hard capsule of
do not use palforzia : - if you are allergic to peanuts ( arachis hypogaea ) or any of the other ingredients of palforezia ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using palforizia . children and adolescents ( aged 4 to 17 years ) children and teenagers do not need treatment if they have peanut allergy or peanut ( desensitisation ) to peanut ( derisip ). if any of these apply to you , do not give palforzaa and tell your doctor . allergic reactions have been reported in children and non - animal patients treated with palfor zia , as food allergies may occur when treatment with pal forzia is started . talk to a doctor if your child is unsure .
do not take palforzia : if you are allergic to severe asthma . warnings and precautions talk to your doctor or pharmacist before taking palforizia if your asthma gets worse . if the medicine does not work well enough , tell your doctor . your doctor will check whether your asthma is getting worse , if it starts to get worse ; if there is a problem swallowing ; or if palforezia has been associated with long term problems with your digestive system ; and if someone in your family has a severe mast cell disorder ( severe or life - threatening anaphylaxis ). you must stop taking pal forzia 60 days after stopping treatment . do not stop taking your palforzaza without talking to your physician . it is important that you tell your physician that you are taking palfordzia because of the symptoms associated with peanut allergy .
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . this medicine must not be used if : you have ever had allergy or allergic reactions ( anaphylaxis ) experienced in more than 3 months of treatment with palforzia . initial dose escalation will occur at the start of these treatment phases . during the initial dose elevation and up - dosing phases , you will be monitored during regular dosimetric monitoring and monitoring of your condition while you are taking palforciaa , and during the first dose , your doctor may decide to temporarily stop or completely stop the treatment with this medicine . it is important that you continue to take palforzaa until your doctor tells you otherwise . if your doctor prescribes palforza to you , it is very important that during the des
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with palforzia : - severe allergic reactions . tell your doctor straight away if you have any of the following symptoms after taking palforizia . they are usually mild to moderate and go away within one hour of the reaction . trouble breathing , throat tightness , feeling of fulness , trouble swallowing or speaking - changes in voice , dizziness / fainting , severe stomach cramps or pain , vomiting , or diarrhoea , and severe flushing or itching of the skin palforezia may also be associated with problems with the stomach and digestive system . it is possible that this may be a sign of a serious liver problem . - rash , itching or burning sensation when swallowing palforza
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . the expiration date refers to the last day of that month . store below 25 . this medicine does not require any special storage conditions . throw away any hard lumps of powder after preparation . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what palforzia contains the active substances are : - each sachet contains 0 . 5 mg , 1 mg / 10 mg or 20 mg of the active substance . - the other ingredients are microcrystalline cellulose , colloidal anhydrous silica and magnesium stearate palforza 100 mg powder and oral powder in capsules after opening microcrystalline cellules , coloidal anhidrous siliza and  magnesium STEarate paforziA 300 mg powder & oral powderin sachest microcrystalline microcrystalline
zerene belongs to a group of substances called benzodiazepine - related medicinal products , which consists of preparations with hypnotic actions and sleeping problems . zere is used in adults , adolescents and children from one month of age starting treatment . it is used during treatment to treat problems sleeping .
do not take zerene : if you have hypersensitivity ( an allergy ) to zaleplon or any of the other ingredients of zere sleep apnoea syndrome ( see section 4 ), if for short periods you have severe kidney or liver problems , if your doctor has told you that you have myasthenia gravis ( very weak or tired muscles , severe breathing or chest problems ). children and adolescents ( under 18 years of age ) do not give zerente because it may have undesirable effects . tell your doctor if : you are taking any medicine , or you are using any medicines that can cause physical dependence . during treatment , withdrawal symptoms may include headaches , muscle pain , extreme anxiety or tension , and / or sleepiness . this is because zerend may increase the risk of experiencing side effects which may be life 
always take zerene exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the usual dose is 10 mg once a night , taking two capsules in the morning and one capsule in the evening . if there is difficulty falling asleep , do not take the capsule . use in elderly people ( 65 years of age and older ) if your doctor determines that you have mild to moderate liver problems , the usual starting dose is 5 mg once daily . for elderly people , 55 years of old or older , your doctor may reduce your dose to 5 mg twice daily , taken once daily for mild to medium liver problems and the usual maintenance dose is one capsule ( 4 capsules ) taken once - day . take the first capsule of the capsule at about the same time each day , until your body gets used to the full effect . do not
like all medicines , zerene can cause side effects , although not everybody gets them . if you notice any of the following , or any other changes in your health , stop taking zerent and tell your doctor immediately . the frequency of possible side effects listed below is defined using the following convention : 36 very common ( affects more than 1 user in 10 ) common ( impacts affects 1 to 10 users in 100 ) uncommon ( affect affects less than 1 patient in 10 000 ) rare ( affectes 1 user of 10 , 000 ). very rare ( impacts effect affects only 1 user per 10 . 000 ), very rare : ( affect less than1 user in10 ,000 ) not known ( frequency cannot be estimated from the available data ). as with all medicines the following side effects may occur and any other variations in your healthcare may occur . tell your healthcare provider if any
what zerene contains the active substance is zaleplon 5 mg . the other ingredients are : microcrystalline cellulose , pregelatinised starch , silicon dioxide , sodium lauryl sulphate , magnesium stearate , lactose monohydrate , indigo carmine ( e132 ), titanium dioxide ( i171 ). ingredients of the pack zerente are - gelatin , titanium dioxide . - printing ink : shellac , lecithin , simethicone , yellow iron oxide ( azure ). what zeene looks like and contents of the package zerence is a pale yellow to brownish - yellow powder . it is supplied in blister packs of 10 , 30 , 50 , 60 , 90 and 84 tablets . not all
